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CHAPTER 1 
INTRODUCTION 
HUMAN AMD EXPERIMENTAL OSTEOARTHRITIS 
EPIDEMIOLOGY OF OSTEOARTHRITIS 
Osteoarthritis (osteoarthrosis, degenerative joint disease) is 
the most frequent joint disorder among the human population. 
It involves any population, independent of geographic 
localization or climate (1). Comparison of osteoarthritis 
prevalence in 17 populations (white, black or indian) from 
Alaska to South Africa demonstrated no statistically 
significant difference in overall prevalence (1) . However, 
other radiographic studies among different populations showed 
that American Indians have a significantly increased 
prevalence of osteoarthritis (2) while eskimos have a 
significantly lower incidence of osteoarthritis than found in 
United States males and females (3). 
The prevalence of osteoarthritis demonstrates a high 
correlation with age. In a nationwide study in the United 
States of America all degrees of radiographic osteoarthritis 
of the extremities increased with age from 4% in the age group 
18 to 24 years to 85% among individuals 75 to 79 years of age 
(2) . In the Framington osteoarthritis study, radiographic 
evidence of knee joint osteoarthritis increased with age from 
27% in individuals younger than 70, to 44% in individuals age 
80 or older (4). Males appear to be affected more commonly 
than females before 50 years of age, but the sex ratio is 
reversed thereafter (5) . In the Framington Study cited above 
similar observations were made, the age associated increase in 
osteoarthritis was almost completely the result of the 
increase in the incidence of osteoarthritis among the women 
studied (4). 
Epidemiological studies have suggested a role for mechanical 
factors in the pathogenesis of osteoarthritis but the overall 
picture is not clear yet. Osteoarthritis shows significant 
differences by occupation and industry. Office workers had a 
lower than expected frequency of hand involvement but higher 
than expected foot involvement (6). The opposite was observed 
in craftsmen, foremen and similar workers (6) . In a cross 
sectional epidemiologic study in a urban population the 
incidence of osteoarthritis was higher in the right hand than 
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in the left hand suggesting a role for usage in the 
pathogenesis (7) . Moreover, the pattern of hand usage among 
industrial workers showed significant task-related 
osteoarthritic changes in the hands (8) . Osteoarthritis of 
elbow, wrist and shoulder and hands has been reported in users 
of pneumatic drills (9,10,11,12). However, competitive sports 
like running or American football, were not found to 
predispose to osteoarthritis oí the hips or ankles (13,14). 
PATHOGENESIS OF OSTEOARTHRITIS 
Osteoarthritis is a joint disease with a multifactorial 
etiopathogenesis in which the prominent feature is 
degeneration of articular cartilage. Osteoarthritis can be 
largely divided in two groups; primary or "idiopathic 
osteoarthritis" with unidentified etiologic factors and 
secondary osteoarthritis with known pathogenetic factors. The 
various forms of osteoarthritis can be considered as being the 
result of either abnormal mechanical stress or congenital and 
acquired aberrations of articular cartilage, or a combination 
of both. Regardless of the pathogenetic pathway, the final 
outcome is disturbed cartilage integrity. 
Articular cartilage 
Articular cartilage is a specialized form of connective tissue 
consisting of cartilage cells (chondrocytes, approximately 10% 
total volume) which synthesize and deposit around themselves 
an extracellular matrix of giant molecules. These 
macromolecules are responsible for the biomechanical and 
biochemical properties of articular cartilage making this 
tissue unique in its function as shock absorber and gliding 
surface for the diarthrodial joint. The major macromolecules 
deposited by the chondrocytes in the extracellular matrix are 
collagen type II and proteoglycans. The collagen type II 
provides the tensile strength of cartilage while the 
proteoglycans are responsible for the resiliency and water 
binding capacity of this tissue. 
A proteoglycan is "any molecule that has a core protein 
containing at least one covalently bound glycosaminoglycan 
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chain" (15). A glycosaminoglycan is a linear polymer 
consisting of repeating disaccharides containing hexosamine 
and hexuronic acid or hexose. The chains are highly negatively 
charged due to the carboxyl residues and/or sulfate ester 
groups attached to the disaccharides. The negative charges on 
the glycosaminoglycans are essential for the pressure 
resistent properties and resiliency of the cartilage 
proteoglycans. 
The major cartilage proteoglycans are high-molecular-weight 
molecules up to 3 χ IO6 consisting of a large number of 
glycosaminoglycans covalently linked to the central core 
protein (16). The carbohydrate component can contribute 90% of 
the total weight of the molecule. These cartilage 
proteoglycans may contain up to 100 chondroitin sulfate 
chains, up to 50 keratan sulfate chains and up to 50 0-linked 
and 15 N-linked oligosaccharide chains (17,18,19,20,21). The 
large cartilage proteoglycan of mice and rats has been 
reported to contain no keratan sulfate (22,23). 
Chondroitin sulfate is the most abundant glycosaminoglycan of 
articular cartilage and consists of N-acetylgalactosamine and 
glucuronic acid disaccharides. The disaccharides are sulfated 
at either the C-4 or C-6 position of the galactosamine and are 
than termed chondroitin-4-sulfate and chondroitin-6-sulfate. 
However, no chondroitin sulfate chain is solely sulfated at 
either the six or the 4 position but will be a co-polymer 
(24). The above described large cartilage proteoglycan, called 
proteoglycan monomer, interacts with another 
glycosaminoglycan, hyaluronic acid, by a globular domain at 
one end of the core protein, the hyaluronic acid binding site, 
forming in this way aggregates with a molecular weight over 108 
(25,26,27,28). The proteoglycan monomer-hyaluronic acid 
binding is stabilized by interaction with a glycoprotein, 
called link protein (29,30). The proteoglycan aggregates are 
due to their large size immobilized within the fibrous 
collagen network of articular cartilage (31). 
Alterations in osteoarthritic joints 
The changes occurring in the articular cartilage, as a result 
of the osteoarthritic process, are manyfold. In both human and 
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experimental osteoarthritis, one of the first events observed 
in osteoarthritic cartilage is an elevated hydration of the 
extracellular matrix and an increased extractability of 
proteoglycans (32-36). The increased extractability can be due 
to a weaker binding of proteoglycans within the cartilage 
matrix framework as a result of changes in the collagen 
component, or to changes in the proteoglycan structure in 
osteoarthritic cartilage. Alterations in structure of 
proteoglycans from human osteoarthritic cartilage and in 
cartilage from animals with experimental osteoarthritis have 
been reported frequently. 
In experimental knee osteoarthritis in dogs, changes in 
proteoglycan structure were detected before histologically 
detectable osteoarthritic alterations occurred (32,37-39). An 
increased galactosamine to glucosamine ratio, indicating an 
elevated proportion of chondroitin sulfate to keratan sulfate, 
was found in canine osteoarthritic cartilage proteoglycans 
(37-40). In the same model. Altman et al. reported that the 
proportion of proteoglycans involved in the hyaluronic acid-
proteoglycan aggregates was reduced but that there was no 
detectable overall reduction in proteoglycan monomer size 
(40) . Similar results, a diminished fraction of proteoglycans 
in aggregates although the extracted proteoglycans appeared to 
have a functional hyaluronic acid binding site, were reported 
by McDevitt and Muir (41,42). The reduced proportion of 
proteoglycans in the proteoglycan hyaluronic acid aggregates 
might be the consequence of hyaluronic acid depletion in the 
osteoarthritic cartilage of dogs (43) . In the osteoarthritic 
hip cartilage of dogs with hip dysplasia, the proteoglycan 
monomers in the degenerated cartilage were smaller than those 
from normal cartilage of the same age, as a result of a 
smaller chondroitin sulfate-rich region (44) . Also some of the 
molecules lacked the hyaluronic acid-binding region (44). 
In an experimentally induced model of rabbit knee 
osteoarthritis, no proteoglycan aggregates could be extracted 
from osteoarthritic cartilage notwithstanding the observation 
that the proteoglycan monomers had the normal size (33). Also 
no alterations in proteoglycan structure were observed in 
osteoarthritic cartilage of STR/IN mice and guinea pigs 
(34,36). 
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The changes in proteoglycan structure found in human 
osteoarthritic cartilage are controversial. Vasan reported a 
reduction in size of proteoglycan monomers, a reduced chain 
length of glycosaminoglycans and a diminished ability of 
proteoglycans to form aggregates with hyaluronic acid in 
osteoarthritic cartilage from human femoral heads (45) . 
However, Santer and associates were unable to detect changes 
in aggregate formation, structure and glycosaminoglycan chain 
length of proteoglycans from osteoarthritic cartilage of the 
human tibial plateau (46). 
The variation in reported proteoglycan changes in 
osteoarthritic cartilage might be the result of differences in 
cartilage sampling or differences in the stage of the 
osteoarthritic process. Variation in the anatomical site of 
cartilage sampling or differences in the depth of cartilage 
sampling can lead to dissimilar results in relation to changes 
in the proteoglycan structure. Also the sampling of the 
control cartilage might induce variation in conclusions. 
Sampling of control cartilage from normal donors or sampling 
of control cartilage from the diseased joint at apparently 
unaffected anatomical sites might explain part of the 
variation observed. Moreover, the stage of progression of the 
osteoarthritic process can interfere with the changes in 
proteoglycan structure found by different authors. 
Besides qualitative changes in proteoglycan structure, obvious 
quantitative changes in proteoglycans from osteoarthritic 
cartilage are found. Both in human and experimental 
osteoarthritis, most authors report a diminished concentration 
of proteoglycans in osteoarthritic cartilage compared to 
normal cartilage (39,47-54). This is proposed to be due to 
breakdown of cartilage proteoglycans by proteases excreted by 
chondrocytes (55-61) . In this viewpoint, osteoarthritis is an 
autodestructive process, mediated by articular cartilage 
chondrocytes, triggered by as yet unknown mechanisms (59). The 
low grade inflammation of osteoarthritic joints, as reported 
by several authors, can play an additional role in the 
destructive process by the release of inflammatory mediators 
such as interleukin 1 (54,61-70). The synovial inflammation in 
osteoarthritic joints is probably a secondary reaction on the 
initial event of cartilage destruction while in patients with 
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rheumatoid arthritis the synovial inflammation in the joints 
is the primary phenomenon followed by cartilage destruction. 
Although the concentration of proteoglycans is decreased in 
osteoarthritic cartilage the synthesis of proteoglycans 
appears to be elevated in the same cartilage, both in humans 
and animals (34,47,48,71,72). The proteoglycan synthesis shows 
a positive correlation with the severity of the osteoarthritic 
lesions up to a certain degree of disease activity, as shown 
by Mankin et al. (47,48). Notwithstanding this observation, 
the proteoglycan concentration in osteoarthritic cartilage is 
reduced. This indicates that the proteoglycan catabolism is 
even more elevated than the proteoglycan synthesis in 
osteoarthritic cartilage (73). Brocklehurst et al. observed no 
differences in the rate of proteoglycan synthesis or in 
proteoglycan concentration in cartilage from human 
osteoarthritic or control knees (35) . 
Probably in reaction to the decreased proteoglycan 
concentration in the extracellular matrix, normally non-
proliferating articular cartilage chondrocytes are stimulated 
to divide and as a result of this chondrocyte cell clusters 
are found in osteoarthritic cartilage (35,38,47,49,50,52,74-
76) . The proliferation of the chondrocytes and the elevated 
proteoglycan synthesis can be considered as a reparative 
response in an attempt to repair the damaged cartilage matrix. 
Besides changes in the articular cartilage, also other joint 
structures undergo alterations in the osteoarthritic joints. 
Osteoarthritic changes in the articular cartilage are 
associated with osteophyte formation at the joint margins 
(38,49,50,52,74-77). Another phenomenon seen in osteoarthritic 
joints is sclerosis of subchondral bone below the degenerated 
cartilage (53,75,78-80). Chondrocyte proliferation, increased 
proteoglycan synthesis, osteophyte formation and sclerosis of 
subchondral bone indicate the presence of anabolic processes 
in osteoarthritic cartilage in addition to the catabolic 
degeneration of the cartilage matrix. 
ANIMAL MODELS OF OSTEOARTHRITIS 
Since the pathogenesis of osteoarthritis can not adequately 
be studied in humans, animal models which simulate the human 
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disease have been developed. Spontaneous osteoarthritis has 
been studied in mice, guinea pigs and dogs (36,44,53,78,80-
87) . In addition to the spontaneous models, osteoarthritis has 
been induced in animal joints with essentially two different 
techniques. First, induction of joint instability by surgical 
methods and second, interference with cartilage metabolism by 
intraarticular injection of chemicals. 
Induction of knee joint instability has been carried out by 
dissection of cruciate ligaments (38,39,43,72,76,88-90) and 
tibial valgus osteotomy (91) in dogs. In rabbits, joint 
instability was surgically induced in the knee joints by 
partial meniscectomy, sometimes in combination with collateral 
ligament dissection, leading to osteoarthritic lesions within 
several weeks (33,49,50,75). A combination of meniscectomy, 
dissection of collateral ligaments and cruciate ligaments was 
used by Hulth et al. (92) and Lane et al. (93) to induce 
osteoarthritis in rabbit knees. Partial meniscectomy, alone 
(52) or in combination with collateral and cruciate ligament 
dissection (34,94), and myotomy and tendotomy (95) was carried 
out to produce joint instability and subsequently 
osteoarthritis in guinea pigs. In rats, cruciate ligament 
dissection was used to induce osteoarthritic knee joint 
lesions (96). 
Papain, iodo-acetate and several drugs have been used to 
induce osteoarthritic alterations in joints of laboratory 
animals. Multiple intraarticular injections with papain have 
been carried out to produce osteoarthritis in the knee and hip 
joints of rabbits and guinea pigs (97-106). Sodium iodo-
acetate, an inhibitor of cell metabolism, has been injected in 
the knee joints of rats, chicken and guinea pigs resulting in 
osteoarthritic changes in the injected joints (107-111). Also 
the injection of certain nonsteroidal antiinflammatory drugs 
into the knee joint cavity of hens and rats leads to 
osteoarthritic alterations (107,112,113). 
In chapter 7 and 8 the development of three osteoarthritis 
models in mice is described. A single intraarticular injection 
of papain or iodo-acetate in the knee joints of the mice leads 
to osteoarthritic alterations in the joints by way of 
interfering with the cartilage metabolism. Injection of 
collagenase results by way of damaging joint structures, such 
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as ligaments and tendons, to a instable knee joint and 
eventually to osteoarthritis. This model seems to be 
comparable to the surgically-induced osteoarthritis in larger 
animals as described above. The diversity of osteoarthritis 
models in laboratory animals demonstrate that osteoarthritis 
can be the pathological result of various etiological factors 
and most researchers agree that also human osteoarthritis is 
not a single disease entity but the final outcome of numerous 
etiologic stimuli (114). 
EFFECT OF ANTI-OSTEOARTHRITIC DRUGS ON CARTILAGE METABOLISM 
The final outcome of all variants of osteoarthritis is the 
destruction of articular cartilage leading to the loss of 
functionality of diarthrodial joints and in this way to 
disability of osteoarthritic patients. One of the main effects 
of anti-osteoarthritic drugs should be aimed at the protection 
of articular cartilage. These drugs should at least have no 
harmful effect on cartilage metabolism. However, several 
nonsteroidal antiinflammatory drugs (NSAIDs) used in the 
treatment of osteoarthritis have been reported to interfere 
negatively with articular cartilage metabolism (115-134) . 
Drugs can exert their pharmacological effects on cartilage 
metabolism in two ways: a direct effect on the biochemical 
activities of chondrocytes and/or an indirect interference 
with chondrocyte metabolism by influencing systemic factors 
determining this metabolism. 
Various direct effects Of NSAIDs on chondrocyte metabolism are 
reported in the literature. Brandt and coworkers have made 
extensive study of the inhibitory effects of salicylate on 
glycosaminoglycan synthesis (121-124,126-129). They showed 
that the salicylate-mediated inhibition was a direct effect on 
chondrocyte metabolism (124). Also other NSAIDs, such as 
salicylamide, phenylbutazone, oxyphenbutazone, Ibuprofen, 
tolmetin, naproxen, fenoprofen, indomethacine, isoxicam, 
mefenamic acid and sulindac sulfoxide, have been reported to 
decrease glycosaminoglycan metabolism by a direct mechanism 
(115,117,118,122,127,131,135). 
An indirect effect of salicylate on glycosaminoglycan 
synthesis in articular cartilage has been demonstrated in 
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experiments performed in our laboratory (136,137). A decrease 
of inorganic serum sulfate concentration in mice by way of 
salicylate-induced sulfate diuresis, apparently was the 
causative factor generating a reduced rate of sulfate 
incorporation in anatomically intact patellar cartilage 
(136,137). The reduced incorporation of sulfate can be caused 
by a diminished production of normal glycosaminoglycan chains 
or by the synthesis of a normal quantity but undersulfated 
glycosaminoglycan chains, or a combination of both. Either a 
diminished synthesis of glycosaminoglycans or the synthesis of 
undersulfated glycosaminoglycans will result in cartilage with 
inferior biomechanical and biochemical properties. Inhibition 
of cartilage metabolism by direct or indirect mechanisms might 
accelerate the cartilage destructive process in osteoarthritis 
patients. 
AIM OF THE STUDY 
The aim of the present study was to elucidate the sulfate 
depleting potential of antirheumatic drugs and the effect of 
reduced sulfate availability on glycosaminoglycan synthesis in 
articular cartilage. In addition to the above mentioned study, 
osteoarthritis models in mice, necessary for the future study 
of anti-osteoarthritic drugs in vivo, have been developed. 
In chapter 2 the potential sulfate depleting effects of 
several anti-rheumatic drugs is evaluated. The effects of 
limited sulfate availability in vitro on the rate of 
glycosaminoglycan synthesis and the structure of the 
glycosaminoglycan chains synthesized are described in chapter 
3 and 4. In vivo interference with glycosaminoglycan synthesis 
by paracetamol-induced sulfate depletion in Wistar rats is 
described in chapter 5 and 6. Chapter 7 and 8 depict the three 
newly developed murine osteoarthritis models. Chapter 9 
describes the susceptibility of glycosaminoglycan synthesis in 
articular cartilage of five different species and the 
different vulnerability of normal and diseased articular 
cartilage to changes in sulfate availability. 
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CHAPTER 2 
DECREASE OF INORGANIC BLOOD SULFATE FOLLOWING TREATMENT WITH 
SELECTED ANTIRHEUMATIC DRUGS: POTENTIAL CONSEQUENCE FOR 
ARTICULAR CARTILAGE 
Bernard J. de Vries, Peter M. van der Kraan and Wim В. van den 
Berg 
Agents and Actions: in press 
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ABSTRACT 
The elimination kinetics of inorganic blood sulfate in mice 
was followed for four hours after a single, oral administrati-
on of an antirheumatic drug. Sodium salicylate, aspirin, 
diflunisal and benorylate, all in a dose of 1.25 mmol/kg, 
reduced the sulfate level to less than half that of control. 
This phenomenon was also demonstrated by phenylbutazone, 
oxyphenbutazone (both 1 mmol/kg), chloroquine diphosphate (0.6 
mmol/kg) and tiaprofenic acid (0.02 - 0.35 mmol/kg). Niflumic 
acid (1.08 mmol/kg), Piroxicam (0.03 mmol/kg), indomethacin 
(6. 10"3 mmol/kg), diclofenac (5. 10"3 mmol/kg), ketoprofen (0.2 
mmol/kg), naproxen (0.08 mmol/kg) and Ibuprofen (0.24 mmol/kg) 
possessed no sulfate lowering properties. The potential rele-
vance of the use of sulfate lowering drugs for articular 
cartilage integrity is discussed in the light of what is 
already known about this subject. 
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INTRODUCTION 
Many phenolic agents are made hydrophilic by conjugation with 
inorganic sulfate to facilitate elimination out of the body. 
Some of these are well known drugs like salicylamide and 
paracetamol. In man, both drugs cause a decrease in circula-
ting inorganic sulfate (1,2). In mice, sodium salicylate 
decreases the level of inorganic sulfate by another process, 
i.e. sulfate diuresis (3), which is also the cause of the same 
phenomenon seen in salicylate treated rats (4,5). A potential 
conseguence of a reduced sulfate availability may be a sup-
pression of biosynthesis of the highly sulfated proteoglycans, 
abundantly present in fetal skeletal tissue and cartilage, as 
was shown in mice and rats (3,6,7), leading ultimately to 
inferior tissue properties. 
Unrepairable damage to articular cartilage is an important 
factor in the disease process by which rheumatic patients, 
suffering from osteoarthritis or inflammatory arthritis, are 
becoming disabled. It would probably be a bad choice to pres-
cribe them antirheumatic drugs which have an adverse effect on 
cartilage. Many studies are documented on the effects of drugs 
on cartilage (8,9,10,11). So far little attention has been 
paid to indirect adverse effects, mediated by drug induced 
disturbance in the supply of essential nutrients needed by 
cartilage cells, like e.g. inorganic sulfate. Here we report 
the influence of several, currently used antirheumatic drugs 
on the inorganic sulfate content in blood of mice. 
MATERIALS AND METHODS 
Healthy C57B110 male mice, aged 8-12 weeks, were injected intra-
peritoneally with carrier-free Na235S04 (0.2 ßCi/q), dissolved in 
physiologic saline. Thirty minutes later, after the maximum 
concentration of 35S was attained in the blood (12), they recei-
ved by oral gavage 200 μΐ of a 5 min ultrasonically trilled drug 
suspension or solution in 0.1 % methylcellulose or this vehicle 
alone (controls). At 30, 90 and 240 minutes after drug administ­
ration, 10 ßl blood samples were taken from the tail vein and 
suspended in 500 μΐ distilled water. These samples were subse-
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quently analysed by beta liquid scintillation spectrometry (3) 
for 35S content, which gives an estimate of relative endogenous, 
inorganic sulfate concentrations in the circulation. Since data 
from preliminary experiments demonstrated that more than 90% of 
35S in serum, derived from normal and drug-treated mice, was as-
sociated with inorganic sulfate, as checked by our benzidine 
method (13), this procedure appeared to be rapid and reliable in 
our animal model for monitoring endogenous, inorganic sulfate 
concentrations. 
Pure substance-drugs were obtained from several pharmaceutical 
companies or purchased from Sigma (St Louis, MO). 
STATISTICAL ANALYSIS 
We used the unpaired, two-tailed Student's t-test to determine 
the significance of drug induced effects. In each separate 
experiment a control group of 5 mice was run parallel with drug 
treated mice (n=5). Due to slight variations in the experimental 
conditions of the several separate experiments, comparison of 
data obtained from these separate experiments appeared not 
surveyable without normalizing the mean values. To this end 
values of 35S content in blood, originally expressed as cpm's, 
were converted to radioactivity units. Mean control values were 
always converted to 100 ± SD units; values from drug-treated mice 
were adapted accordingly. To give an idea of the deviations in 
the outcomes of control experiments, the average standard devia-
tion (SD), belonging to the control values, was calculated from 
24 separate experiments, see table 1. For each drug tested, 
statistics was applied with reference to the original control ± 
SD value. Statistical probability (P) values are mentioned 
explicitly if P<0.1; otherwise "NS" (= nonsignificant) is stated. 
RESULTS 
As already has been reported for sodium salicylate (3), several 
other salicylates are able to decrease the inorganic (radio)sul-
fate content in blood of mice after one single oral dose, see 
figure 1. Although demonstrating some delay in exerting their 
depressive effect - compared with that of sodium salicylate -
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aspirin, diflunisal and benorylate, all in a dose of 1.25 
mmol/kg, reduce serum sulfate very strongly to about 30% of the 
control level, 4 hours after administration. Another salicylate 
derivative, salicylamide, as well as paracetamol (acetaminophen) 
and phenol sodium, potent agents in depleting serum sulfate in 
rats and man by means of sulfate conjugation (14), not convin­
cingly decrease the blood sulfate level, see figure 2. Albeit a 
small and significant reduction to 70% of control is achieved at 
90 min after oral application of these drugs, it is not evident 
anymore at 4 hour post administration. 
TABLE 1 
Average standard deviation of control, blood sulfate 
values belonging to individual experiments (n=2 4) 
Min after vehicle Mean control Average standard 
administration* valueb deviation ± SD 
30 100 1 6 + 5 
90 100 19 ± 7 
240 100 23 ± 7 
"Vehicle: 200 ді 0.1% methylcellulose. 
expressed as 35S radioactivity units per 10 μΐ blood. 
Of interest, some other classes of antirheumatic drugs also 
reduce significantly the blood sulfate content, see figure 3. 
Phenylbutazone and its biotransformation product oxyphenbutazone, 
both exert a depressive effect after oral administration of a 
dose of 1 mmol/kg. However, oxyphenbutazone seems far less 
effective as phenylbutazone and provokes only at 90 min a signi­
ficant depression of the blood sulfate content (35% reduction). 
Also chloroquine diphosphate, in an oral dose of 0.6 mmol/kg, 
slowly forces the sulfate level to go down to about 60% of 
control at 4 hour drug treatment. 
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relative sulfate content in blood-
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Figure 1. 
Effect of salicylate analogues, all in a dose of 1.25 imnol/kg, on 
the inorganic (radio)sulfate content in blood at various times 
after oral administration. Results are depicted as vertical bars 
and represent the mean ± SD for five mice. For convenience, 
sulfate content in blood of control mice is stated as 100 ± 20 
radioactivity units and is represented by the horizontal bar; see 
also statistical analysis section. *P<.05; "p<.01; *"p<.001 
Quite notable is the depressive effect of tiaprofenic acid; a 
small dose of 0.06 mmol/kg is enough to decrease serum sulfate 
convincingly. Since such a small dose has such an impressive 
effect we further studied the sulfate lowering action of tiapro­
fenic acid by varying the amount of oral dose to be administered. 
Obviously, even one-third of the first-mentioned dose (0.02 mmol-
/kg) is able to decrease serum sulfate significantly at 4 hour 
post oral gavage, see table 2. Higher doses (0.12 and 0.3 5 mmol 
/kg) appear not to exceed the effects achieved with the 0.06 mmol 
dose. This finding is substantiated by measurements of endoge­
nous, inorganic sulfate (13) in serum of 4 h samples (table 2). 
Some antirheumatic drugs - in the dosages we use - have no 
reducing effect on the inorganic sulfate content in mouse blood 
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and two of these, piroxicam and indomethacin, even tend to slow 
down significantly sulfate turnover as reflected in a retention 
of radiosulfate content in blood, see table 3. 
relative sulfate content in blood 
sahcylamide 
170 nxj/kg 
paracetamol 
19C mq/kg 
phenol sodium 
"45 ~iq'kg 
Figure 2. 
Relative sulfate concentration in mouse blood, various times 
after administration of 1.25 mmol of commonly used sulfate 
lowering drugs/kg. See further legend to figure 1. 
Pilot study with volunteers 
In a small experiment a calcium salt of aspirin was examined for 
its eventual influence on serum sulfate in 5 healthy, adult, male 
volunteers, aged 27-44 year. One gram of the drug was taken by 
mouth at 0, 6, 11 and 17 hour. At 12 and 18 hour, blood was 
obtained and the amount of inorganic sulfate in the derived serum 
was quantified with our recently modified benzidine method (13). 
From serum obtained a day before - also at 12 and 18 hour - the 
normal concentration of sulfate in serum was determined. The 
results of this study are shown in table 4. There is no evidence 
for any difference in the serum sulfate content, indicating that 
aspirin does not affect inorganic sulfate in the circulation of 
normal, human subjects. The salicylate concentration in the serum 
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samples is of the same size as achieved therapeutically (15 - 40 
mg%) . 
TABLE 2 
Sulfate decreasing effect after oral gavage of tiaprofenic acid 
Dose/kg (Radio)sulfate content in 10 μΐ blood' mM S04 at 
(mg) (mmol) 30 min рь 90 min рь 240 min pb 240 minc 
5 0.02 97±9 NS 97+18 NS 75±17 0.066 0.71±0.18 
30 0.12 89±17 NS 78±14 0.018 49±10 0.001 0.58±0.10 
90 0.35 101±26 NS 85±17 NS 55±13 0.003 0.53±0.11 
100±SD 100±SD 100±SD 0.9210.16 
aValues represent the mean ± SD for five mice and are expressed 
in radioactivity units. 
bSee statistical analysis section. 
'Inorganic serum sulfate concentrations (mmol/1) are represented 
as the mean ± SD for 5 samples. 
DISCUSSION 
Except an abstract about this subject (15) , this is the first 
document dealing with the existence of several serum sulfate 
lowering, antirheumatic drugs and their potential significance 
for articular cartilage integrity. From literature it is known 
that several drugs can be metabolized in vivo to sulfate conjuga­
tes, see table 5. Of these salicylamide and paracetamol are well 
known drugs which are often used even as a tool to decrease serum 
sulfate in rats (19) and dogs (20) for experimental studies. 
Moreover, these analgesic drugs also reduce serum sulfate in man 
(14,21). Recently, we have studied the effect of paracetamol on 
the serum sulfate content and its influence on articular cartila­
ge in rats. Upon drug treatment the availability of inorganic 
sulfate in the circulation descended below a certain threshold. 
This phenomenon was shown to be responsible for the inhibition of 
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the production of newly formed proteoglycans in the cartilage 
(7) . Daily administration of paracetamol to rats over a 4 week 
period, led to articular cartilage with a significant proteogly­
can depletion (paper submitted for publication). From studies of 
the group of Maroudas (22) it is known that also proteoglycan 
synthesis in human articular cartilage is suppressed at too low 
concentrations of environmental sulfate; these circumstances 
might be created with paracetamol medication (2). 
relative sulfate content in blood 
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Figure Э. 
Relative sulfate concentration in blood of mice various times 
after oral administration per kg body weight of: 0.1 mmol phenyl­
butazone or oxyphenbutazone, 0.6 mmol chloroquine diphosphate and 
0.06 mmol tiaprofenic acid. See further legend to figure 1. 
Another mechanism of decreasing inorganic sulfate in the circula­
tion is via drug induced sulfate diuresis, first recognized with 
sodium salicylate in mice (3), of which examples will be discus­
sed later. 
Concerning our method to monitor the endogenous inorganic sulfate 
concentration in blood of mice, the following remarks: Thirty 
minutes after intraperitoneal administration of "so,, the maximum 
concentration of 35S in blood had already been passed (9) . From 
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then on "s-kinetics follows the elimination kinetics of endoge­
nous, inorganic sulfate, since more than 90% of 35S is in the 
inorganic sulfate form (see Materials and Methods section). 
Drug administration commences thirty minutes after 35S04 injecti­
on. Thus an eventual depressive effect on blood sulfate will be 
reflected in a decreased 35S content compared to that of con­
trols. However, if the drug itself is becoming sulfated or 
induces 35S incorporation into organic blood components, 3 5S-
kinetics does not necessarily follow endogenous, inorganic 
sulfate elimination kinetics. Fortunately, this is not the case 
in our mouse model, since serum specimens derived from 4 hour's 
blood samples all contained more than 90% of 35S associated with 
TABLE 3 
Effect of some antirheumatic drugs on the blood sulfate level in mice 
Oral dose/kg (Radio)sulfate content In 10 Ml blood after drug treatment 
nlflumic acid 305 1 Οβ 101 1 14 MS 85 1 22 NS 116 ± 21 ΝΞ 
diclofenac so- 1 5 0 005 
dium 
naproxen so- 20 0.0Θ 
dium 
ketoprofen 50 0 20 100 ± 6 
Ibuprofen 50 0 24 108 ± 19 
piroilcam 10 0 03 119 ± 1 5 0 037 1*5 ± 23 0.004 139 ± 31 0 060 
indomethacin 2 0 0 006 124 ± 11 0.004 1S4 1 24 0 002 146 ± 27 0 023 
aValueB represent the mean 2 SD for five mice and are ezpresaad in radioactivity unita. 
See statistical analysis section 
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inorganic sulfate and no significant difference in this matter 
existed between serum from drug-treated mice and that from 
controls (data not shown). The parallel between changes in 35S 
content and endogenous sulfate is also illustrated in table 2. 
TABLE 4 
Sulfate concentration in human serum after aspirin intake 
Sample Sampling Serum concentration of": 
time Sulfate (mM) Salicylate (mg%)b 
Control 12 h 0.27 ± 0.05 
18 h 0.33 ± 0.07 
Aspirin 12 h 0.31 ± 0.03 17 ± 5 
18 h 0.32 ± 0.04 20 ± 6 
"Data represent the mean ± SD for five volunteers. 
bDetermined as described (3). 
Not unexpected, the salicylate derivatives aspirin, diflunisal 
and benorylate, the latter is a conjugate of paracetamol and 
aspirin, provoke a decrease of inorganic sulfate in the circula-
tion. We presume that the mechanism of action is similar to that 
of sodium salicylate, a drug which decreases serum sulfate in 
rats (4) and mice (3), by an unknown mode of action on the 
kidney, causing sulfate diuresis. The observed delay in action of 
the salicylate derivatives compared to that of sodium salicylate, 
could be explained by differences in absorption-rate kinetics or 
by the time lost for biotransforming (via hydrolysis) these 
agents to the active moiety, which possesses structures resem-
bling the conjugated o-keto-enol system of salicylate. This same 
chemical structure can be adopted by phenylbutazone in a certain 
configuration (11,23), and we hypothesize that this property 
determines its sulfate lowering potential, also via a sulfaturic 
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effect. Yet, striking is the observation that the oxidized 
metabolite of phenylbutazone, oxyphenbutazone, does not possess a 
comparable sulfate lowering potency. The discrepancy between the 
mode of action of these two drugs cannot be explained by a higher 
contribution of "s in an organic blood component, e.g. sulfated 
oxyphenbutazon, since that would be less than 10% (see above). 
Salicylamide, another salicylate derivative, just poorly decrea-
sed blood sulfate in mice as also did paracetamol and phenol 
sodium. Nevertheless, these agents have been used as a potent 
sulfate lowering device in many studies. Most phenolic substan-
ces, like the three in guestion here, are made hydrophylic 
primarily by conjugation with inorganic sulfate or glucuronic 
acid to eliminate them out of the body (14,24). An exception with 
respect to sulfate conjugation is salicylic acid, and probably 
some analogues, which despite of its phenolic nature cannot be 
sulfated in vivo (3) . In species where sulfate conjugation is 
predominant over glucuronidation, the sulfation process is 
responsible for the decrease in circulating, inorganic sulfate 
observed after administration of salicylamide, paracetamol and 
phenol sodium. Of course, in this way only relatively high doses 
are able to decrease the sulfate level below a certain threshold, 
detrimental for cartilage. The doses we used were also used by 
other investigators (20,25,26). Apparently, an inefficient 
sulfate conjugation system in our mouse model could explain our 
findings; this would be in agreement with data from literature 
(25) . In addition, our results indicate that the above mentioned 
drugs do not share an efficient sulfaturic effect. 
Chloroquine diphosphate, from origin an antimalarial but today 
frequently used as a slow acting antirheumatic drug, also behaves 
like a sulfate lowering drug in our mouse model. Since here again 
most (i.e. > 90%) of serum 35S remains in the inorganic sulfate 
form, we assume that this drug is able to induce sulfate diuresis 
too. 
Various drugs were devoid of any effect, see table 3. Piroxicam 
and indomethacin, both contrast sharply with the other drugs 
tested in just provoking a retention of radiosulfate in the blood 
of mice. We believe that these drugs also act on the kidney, but 
now in another way, i.e. retarding inorganic sulfate elimination. 
Of course, this would have no consequences for the proteoglycan 
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metabolism in cartilage cells. 
TABLE 5 
Some drugs serving as substrate for sulfate conjugation 
Drug References 
Salicylamide 16, 14 
Flufenamic acid 17 
Paracetamol 14 
Phenylbutazone 16, 17 
Oxyphenbutazone 17 
Prednisolone 16 
Cortisone 16 
Hydrocortisone 17 
Chloroquine di- 16, 17, 18 
phosphate 
Hydroxychloroquine 16 
Vitamin C, D 14 
There is poor evidence in the literature about potential sulfate 
lowering drugs. Some drugs are reported to modulate the 35S 
kinetics (tracer given as "soj in rat serum, as there are 
vitamin A, tolbutamide and triiodothyronine (4). Sulfaturic 
effects have been attributed to calcitonin (27), a small peptide 
with analgesic (28) and antiphlogistic properties (29); indeed 
high doses of sodium chloride are capable to exert sulfate 
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diuresis in dogs and rats (30,26). In addition, there is some 
evidence that steroids have a role in sulfate homeostasis, since 
castration or adrenalectomy of mice of either sex led to a 
significantly decreased, inorganic sulfate level, which was held 
responsible for the simultaneously observed suppression of 
proteoglycan synthesis in cartilage (31,32). 
Although paracetamol and salicylamide medication leads to a 
decreased level of inorganic sulfate in serum of human subjects, 
this is apparently not the case with aspirin as indicated by our 
pilot study with volunteers; the same observations were made by 
other investigators (1). As already stated above, these salicyl-
ates cannot be conjugated with sulfate. Their sulfate lowering 
effects are ascribed to drug induced sulfate diuresis, at least 
in mice (3) and, as was very lately confirmed, in rats (5) . To 
our knowledge, this latter phenomenon has never been described to 
occur in man. Perhaps it is not a side effect of antirheumatic 
drug therapy. Another possibility might still be that the dose of 
aspirin given was too low to stimulate the kidney to sulfate 
diuresis. In this regard the behaviour of tiaprofenic acid is 
interesting. At the very low dose of 0.02 mmol/kg, this drug 
significantly decreased the blood sulfate concentration by 25% 
(p<0.066) in mice and this was potentiated at higher doses. The 
same drug load on the kidneys, experienced by mice, could presu-
mable be obtained in arthritic patients on tiaprofenic acid 
medication. Anyway it remains to be seen how this subject devel-
ops in the future. We currently started with screening the sera 
of osteoarthritic and rheumatoid arthritic patients, which are on 
antirheumatic drug medication, for changes in the normal serum 
concentration of inorganic sulfate. In this respect it is impor-
tant to note that women posses a slower turnover rate of inorga-
nic sulfate than men (33) ; this consequently could lead to a 
delayed recovery of a temporary sulfate depletion. Yet, if ever a 
clinical active, sulfate lowering drug is found, its effect could 
always be counteracted by a fixed amount of inorganic sulfate or 
a precursor of this metabolite (e.g. cysteine), avoiding eventual 
drug mediated harm to cartilage. One potential candidate is 
already found, a nonprescription analgesic and antipyretic drug 
which is commonly used and freely obtainable over the whole 
world, paracetamol! Yet, it still remains to be seen if it 
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attacks cartilage, via sulfate lowering, in man. 
Still an important lesson emerges from this study. Investigators 
examining direct effects of agents on proteoglycan turnover in 
experimental animals should be aware of two potential pitfalls: 
1. If these agents depress the availability of inorganic sulfate 
they might indirectly suppress proteoglycan synthesis. 
2. If radiosulfate is used as a tracer to quantify metabolic 
rates, changes in the specific radioactivity (35SO,/SO,) in drug 
treated versus control animals may occur, depending upon the 
moment of 35S-sulfate administration. As a consequence 35S incor-
poration values must be corrected for these changes in specific 
activity, otherwise outcomes are misleading. These problems are 
of utmost relevance and should always be kept in mind when 
screening a new drug. The study of the in vivo effect of parace-
tamol on rat articular cartilage by Van der Kraan et al. (7) is 
instructive in this respect. 
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Summary 
Incorporation of radiolabeled sulfate into glycosaminoglycans is a widely accepted assay to measure 
the rate of proteoglycan synthesis Although glycosammoglycan synthesis is dependent on the quantity of 
inorganic sulfate available to proteoglycan synthesizing cells, 'sulfate free' medium is regularly used in 
studies regarding proteoglycan synthesis In this study munne patellar cartilage glycosaminoglycans 
synthesized under 'sulfate free' conditions were compared with those synthesized at physiological sulfate 
concentration Under 'sulfate free' conditions synthesis was not only decreased but low sulfated 
glycosaminoglycans were made that were not synthesized during incubation at physiological sulfate 
concentration The use of 'sulfate free' medium should be avoided in proteoglycan synthesis studies 
Keywords Sulfate, Glycosammoglycan, Proteoglycan; Cartilage 
Introduction 
One of the major components of cartilage and other connective tissues are 
proteoglycans. Proteoglycans consist of one or more glycosaminoglycans covalently 
bound to a mainly linear protein core. Glycosaminoglycans are linear polymers of 
disaccharides. The glycosammoglycan chains present in proteoglycans are sulfated. 
In connective tissue studies the incorporation of radiolabeled sulfate in glyco-
Si.minoglycans is a widely accepted quantitative measure of the rate of proteoglycan 
synthesis. 
The synthesis of glycosaminoglycans in cartilage is dependent on the medium 
sulfate concentration in in vitro studies and on the serum sulfate concentrations in 
Correspondence address Ρ M van der Kraan, Department of Rheumatology, Academic Hospital St 
Radboud, University of Nijmegen, Geert Groóte Plein Zuid 8, 6525 GA Nijmegen, The Netherlands 
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studies with laboratory animals [1-3]. Reduction of the medium sulfate concentra-
tion from 0.5 mM to 0 1 mM leads to a diminished incorporation of sulfate in 
human articular cartilage [1]. Medium sulfate concentrations below 0.5 mM result in 
a significantly decreased incorporation of sulfate in the glycosaminoglycans of 
anatomically intact patellar cartilage of the mouse [2]. Sahcylate-induced sulfate 
depletion in mice leads to a diminished incorporation of sulfate in patellar glycos-
aminoglycans in vivo [2]. 
In studies of proteoglycan synthesis one should preferably use physiological 
medium sulfate concentrations. The vanous commercially available culture media 
differ markedly in their inorganic sulfate content as does the serum sulfate con-
centration in different species Human serum has the lowest sulfate concentration 
(0.3-0 4 mM) while rabbits have one of the highest serum sulfate concentrations 
(2 0 mM) [4,5] Cows (1 8 mM), fetal calfs (0 9 mM), dogs (1 2-1 8 mM) and mice 
(1 0 mM) have intermediate serum sulfate concentrations [2,5-8] However, little 
attention has been paid to the sulfate concentration in the medium in proteoglycan 
studies and 'sulfate free' medium is frequently used in these studies to increase the 
specific activity of [35S]sulfate [9,10]. 
Experimental 
We have studied the glycosaminoglycans synthesized in anatomically intact 
patellar cartilage of the mouse under 'sulfate free' conditions and physiological 
sulfate concentrations. The glycosaminoglycans were characterised by DEAE-
amon-exchange chromatography and Sepharose CL 6B gel chromatography 
The DEAE-Tnsacryl chromatogram of glycosaminoglycans synthesized under 
physiological sulfate concentrations showed the presence of one pool of sulfated 
glycosaminoglycans (Fig 1) Treatment of glycosaminoglycans with chondroitinase 
ABC (1 0 U/ml in 0.01 M Tns-HCl, pH 8.0) resulted in the total disappearance of 
this glycosarmnoglycan pool. We concluded that this pool represents chondroitin 
sulfate. 
The DEAE-Tnsacryl chromatogram of glycosaminoglycans synthesized under 
sulfate free conditions was very different from the chromatogram of glycos-
aminoglycans synthesized at physiological sulfate concentration (Fig 1) Primarily 
two glycosarmnoglycan pools were synthesized under low sulfate conditions. A high 
and a low sulfated pool are produced predominantly by the patellar cartilage 
chondrocytes but glycosaminoglycans with intermediate levels of sulfation can also 
be seen in the chromatogram. All the glycosaminoglycans synthesized under low 
sulfate conditions were sensitive to treatment with chondroitinase ABC. The glycos-
aminoglycans present in the sulfate free chromatogram but not in the physiological 
sulfate chromatogram represent plausibly undersulfated chondroitine sulfate chains. 
Results and Discussion 
Based on the specific activity of [35S]sulfate the incorporated quantity of 
[35S]sulfate under sulfate free conditions is lower than expected (approximately 
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Fig. 1 DEAE-Tnsacryl chromatogram of glycosaminoglycans synthesized in the presence of 1.0 mM 
(physiological) or 10 nM inorganic sulfate (sulfate free). Patellae from 7-9-week-old male C57B1 mice 
weighing 20-25 g were obtained according to the method of Van den Berg et al [11] Sulfate free 
BME-diploid medium (pH 7 4) was supplemented with L-glutamine (2 mM) and pyruvate (1 mM) and 
disodium sulfate was added to a final concentration of 1 0 mM or 10 nM. Groups of 10 patellae were 
incubated for 2 h in medium containing 100 цСі [35S]sulfate (earner free) and 200 μ Ο [^glucosamine 
at 37 0 С in a humidified 5% CO2 atmosphere. After incubation, patellae were washed and subsequently 
decalcified in 5% formic acid. The patellae were isolated from the surrounding tissue and digested with 
papain Treatment of the glycosaminoglycans with Slreptomyces hyaluromdase was followed by lyophili-
zation and redisolvation in elution buffer. A NaCl gradient (0.2-2.0 M in 1 mM HCl) was used to elute 
the glycosaminoglycans from the column. The specific activity of [35S]sulfate was 100 Ci/mol in the 
expenments with 1.0 mM sulfate and lOOx 105 Ci/mol in the experiments with 10 nM 0 , 3 H counts; · . 
3 5 S counts 
7000-fold). This is due to the reduced glycosaminoglycan synthesis at low sulfate 
concentrations [1-3]. In our experiments (Figs. 1 and 2) the incorporation of 
[3H]glycosamine was not diminished at low sulfate concentrations, but even slightly 
elevated at 10 nM sulfate compared to 1.0 mM sulfate. This can only for a small 
part be explained by the synthesis of low sulfated glycosaminoglycans at low sulfate 
concentrations. We think that this phenomenon can be explained by the following 
hypothesis. In the experiments with 1.0 mM sulfate the cartilage chondrocytes have 
a high rate of glycosaminoglycan synthesis and the glucose component of gluco­
samine will be derived mainly from the intracellular glycogen pool in the chondro­
cytes. A decreased synthesis of glycosaminoglycans, as a consequence of sulfate 
shortage, will result in a diminished need for saccharide precursors and therefore in 
a reduced degradation of glycogen to glucose. The reduced intracellular supply of 
glucose and consequently of unlabeled glucosamine will result in an increased 
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Fig. 2. Sepharose CL 6B chromatogram of glycosaminoglycans synthesized in ihe presence of 1.0 mM 
(physiological) or 10 nM inorganic sulfate (sulfate free) The incubation of the patellae and isolation of 
glycosaminoglycans is described in the legend of Fig. 1 An ammonium acetate buffer (pH 5 0) was used 
as elution buffer for the Sepharose CL 6B column Dextran blue (M, 2 X 106) and [ "SJsulfate were used 
to determine the void volume and the total volume of the Sepharose CL 6B column. The specific activity 
of [15S]sulfate was 100 Ci/mol in the experiments with 1 0 mM sulfate and ΙΟΟχΙΟ1 Ci/mol in the 
expenments with 10 nM sulfate. Ο, "Ή counts, · , 3 5S counts. 
specific activity of [3H]glucosainine. This might explain the high incorporation of 
glucosamine in the experiments with 10 nM sulfate in the medium. The sulfate 
concentration had no effect on the length of the chondroitine sulfate chains (Fig. 2). 
The glycosaminoglycans synthesized under both sulfate free or the physiological 
sulfate concentration had a K
a v
 of 0.5. 
The results of this study demonstrate the importance of the sulfate concentration 
in the medium in proteoglycan synthesis studies. The use of sulfate free medium 
leads to decreased synthesis and to production of glycosaminoglycans not made in 
the presence of physiological sulfate concentrations during an incubation period of 
only 2 h. The aberrant glycosaminoglycan synthesis under low sulfate conditions 
might not only lead to inaccurate conclusions about proteoglycan synthesis itself 
but also to inaccurate conclusions about the action of proteoglycan synthesis 
modifying agents. At present we study the effect of less extreme sulfate concentra­
tion (0.1-1.0 mM) on glycosaminoglycan metabolism. Incubation of murine patellae 
in medium with less than 0.5 mM sulfate led to an increased susceptibility of the 
glycosaminoglycan synthesis to salicylate [3]. 
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Remarks and a recommendation on a currently used method 
Synthesis of glycosaminoglycans can be studied by quantitation of the incorporation of radiolabeled 
sulfate or glucosamine in these glycosaminoglycans. Culture media with very low inorganic surfate 
concentrations (sulfate free medium) are frequently used in these studies to increase the specific activity 
of [3sS]sulfate. In this study we show that the use of sulfate free medium leads to the synthesis of 
glycosaminoglycans not synthesized under physiological conditions. So, we recommend that physiological 
sulfate concentrations in culture media should be used in glycosaimnoglycan synthesis studies. 
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The Effect of Low Sulfate Concentrations on the 
Glycosaminoglycan ^Synthesis in Anatomically Intact 
Articular Cartilage of the Mouse 
Peter M. van der Kraan, Bernard J. de Vries, Elly L. Vitters, Wim В. van den Berg, 
and Levinus B. A. van de Putte 
Department of Rheumatology, St. Radboud Hospital. University of Nijmegen, Nijmegen, the Netherlands 
Summary. We have studied the effect of environmental sulfate concentration 
on the glycosaminoglycan synthesis of anatomically intact patellar cartilage of 
the mouse in vitro. Incubation of mouse patellae in medium with sulfate con­
centrations below 0.5 mM resulted in a diminished incorporation of sulfate but 
in unaltered incorporation of glucosamine. This suggested the synthesis of 
undcrsulfated glycosaminoglycans under these conditions. We characterized 
glycosaminoglycans synthesized at three different sulfate concentrations: a 
sulfate concentration physiological for the mouse (1 0 mM), a sulfate concen­
tration in the range where sulfate incorporation was strongly diminished (0.1 
тЛ/), and an extremely low sulfate concentration (10 nM) Analysis of glycos­
aminoglycan disaccharides and DEAE anion chromatography of the gly­
cosaminoglycans could not confirm the synthesis of undcrsulfated glycosami­
noglycans at 0 1 mM. The chromatogram of glycosaminoglycans synthesized 
in medium containing 10 nM showed the presence of a very low sulfated 
glycosaminoglycan pool not observed at higher medium sulfate concentrations. 
Intermediately sulfated glycosaminoglycans were also synthesized during in­
cubation with 10 nM sulfate. So, our data indicate that only very low sulfate 
concentrations in the medium lead to the synthesis of undcrsulfated glycosami­
noglycans and that the sulfation mechanism of munne patellar cartilage chon­
drocytes does not seem to fit completely in an "all-or-nothing" pattern. Key 
Words: Sulfate—Cartilage—Glycosaminoglycans—Mouse—Articular 
Sulfate groups on the glycosaminoglycan chains 
of proteoglycans are essential for the pressure-
resistant function of cartilage. Undcrsulfated gly­
cosaminoglycans are synthesized by the cartilage of 
brachymorphic mice resulting in a disproportional 
short stature characterized by shortened long bones 
(18). This mutant is defective in the synthesis of 
sufficient amounts of З'-phosphoadenosine 5'-phos-
Address correspondence and reprint requests to Dr Ρ M van 
der Kraan al Department of Rheumatology, St Kddboud Hos­
pital. University of Nijmegen, Geert Groóte plein Zuid 8, 6525 
GA Nijmegen, the Netherlands 
phosulfate (21,25). Cartilage is the tissue affected 
primarily, owing to the high rate of glycosamino-
glycan synthesis (19). Patients with Lowe's syn-
drome (oculocerebrorenal syndrome), character-
ized by cataracts, renal abnormalities, growth fail-
ure, rickets, arthropathy, and mental retardation, 
excrete abnormal quantities of undcrsulfated gly-
cosaminoglycans in their unne (1,14). Fibroblasts 
from these patients synthesize undcrsulfated chon-
droitin and dermatan sulfate (10). Both humans and 
dogs with spondyloepiphyseal dysplasia are known 
to synthesize undcrsulfated glycosaminoglycans 
(3,16,17). 
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One possible cause of the synthesis of undersul-
fdled glycosaminoglycans could be a limited supply 
of inorganic.sulfate to the cells Incubation of em­
bryonic chick cartilage at low sulfate concentra­
tions leads lo the synthesis of both fully and non-
sulfated chondroitin sulfate chains (13,24) This 
"all-or nolhing" sulfation pattern was described 
earlier for the synthesis of chondroitin sulfate in 
cell-free systems (4) The sulfation of chondroitin in 
mesenchyme cultures of brachymorphic mice also 
seems to follow an all-or-nothing mechanism (19) 
Recently it was found that sulfation of chondroitin 
by bovine aortic endothelial cells at intermediate 
sulfate concentrations did not fit in an all-or-nothing 
mechanism (12) Engelbreth-Holom-Swan tumor 
cells synthesize two different pools of heparan sul­
fate chains a low sulfated and a high sulfated pool 
The high sulfated pool is synthesized predominantly 
under high-medium sulfate conditions, while the 
low sulfated pool is synthesized primarily under low 
sulfate conditions (26) The proportion of dermatan 
sulfate to chondroitin sulfate synthesized by human 
fibroblasts can also be affected by the medium sul­
fate concentration A low medium sulfate concen­
tration favors the formation of chondroitin sulfate 
(23) 
In earlier studies we found that salicylate-mduced 
sulfate depletion in mice leads to a diminished in­
corporation of sulfate in patellar glycosaminogly­
cans (5,6) We examined the synthesis of gly­
cosaminoglycans by anatomically intact articular 
cartilage of the mouse to answer the question of 
whether only synthesis is decreased or whether un-
dersulfated glycosaminoglycans are also synthe­
sized at decreased sulfate concentrations When 
calculated by the incorporation rate of glucosamine 
and sulfate into newly synthesized glycosaminogly­
cans, reduction of the medium sulfate concentration 
from 1 0 to 0 I miW resulted in a 50% decrease in 
sulfate incorporation but no decrease in glucos­
amine incorporation However, chromatographic 
analysis of the newly synthesized glycosaminogly­
cans did not confirm the presence of undersulfatcd 
or nonsulfated glycosaminoglycan chains Under-
sulfation of glycosaminoglycans occurred only at 
very low sulfate concentrations in the medium The 
discrepancy between radiolabel incorporation and 
chromatography might be caused by alterations in 
the specific activity of the labels used under condi­
tions of a diminished synthesis of glycosaminogly­
cans 
MATERIALS AND METHODS 
Materials 
[JSS]Sulfate (carrier-free, 1,200 Ci/mmol spec 
act ) and D-[6 3H]glucosamine (40 Ci/mmol spec 
act ) were obtained from the Radiochemical Centre 
(Amersham) ВМЬ-diploid medium (sulfate-free) 
and glutamme were purchased from Flow Labora­
tories and pyruvate from Boehnngcr Mannheim 
Chondroilmase ABC from Proteus vulgaris, hyal-
uromdasc from Streptomyces hyalurolyticus, and 
papain (type IV, double crystallized) were obtained 
from Sigma Sepharose CL 6B was obtained from 
Pharmacia and DEAE Tnsacryl from LKB Chon­
droitin was purchased from Serva and 24-well clus­
ter dishes from Costar Solulyte was purchased 
from J Τ Baker Chemicals 
Dissection of Patellae 
Patellae were obtained from 7- to 9-week-old 
male C57BII0 mice in good health and weighing 20-
25 g Mice were killed by cervical dislocation and 
the whole patellae, with a standard amount of sur­
rounding tissue, were dissected from the knee joints 
according to the method of van den Berg et al (27) 
The incorporation of [35S]sulfate in the patellae and 
surrounding tissue is shown in Fig 1 Radiolabel 
was found almost exclusively in the cartilage of the 
patellae Hardly any label was found in the under­
lying bone and bone marrow cells (<1%)(7) Note 
the absence of epiphyseal cartilage in the patellae 
After incubation of the patellae with surrounding 
tissue in culture medium, they were carefully iso­
lated from the surrounding tissue and only the gly­
cosaminoglycan synthesis in the patellae was exam­
ined 
Incubation of Patellae 
BME-diploid medium (pH 7 4) was supplemented 
with L-glutamine (2 mAf) and pyruvate (1 mM) 
Groups of six patellae with surrounding tissue were 
incubated in BME diploid medium (200 μΐ/patella) 
with sulfate concentrations ranging from 0 1 to 1 2 
mM for 4 h at 37°C in a humidified atmosphere con­
taining 5% C0 2 After 2 h 20 μ^πιΙ ["SJsulfate and 
40 μ^πιΐ ['Hlglucosamine were added to the incu­
bation medium Glycosaminoglycan synthesis is lin­
ear within 5 min in our incubation system (data not 
shown), so 2 h preincubation is sufficient to equili­
brate the sulfate concentrations across the tissue 
and cell membrane bamer 
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FIG. 1. Autoradiograph of a mouse patella surrounded by connective tissue labeled with [3 5]sulfate in vitro Note the absence of 
epiphyseal cartilage с cartilage b bone, bm bone marrow, pp, patellar plate, I, ligament, f fat tissue, s. subchondral bone 
Hematoxylin and eosin, x40 (A), x400 (B). 
We investigated the effect of sulfate concentra­
tion in the medium on the recycling of sulfate de­
rived from degraded glycosaminoglycans. Patellae 
were incubated for 2 h in medium containing 1.0 
mM sulfate and 20 μΟ/ιπΙ ["SJsulfate. This was 
followed by a 16-h incubation period in medium 
with various sulfate concentrations without label. 
Isolation of Glycosaminoglycans 
After incubation the patellae were washed twice 
with physiological saline to remove most nonincor-
porated label and fixed in 4% phosphate-buffered 
formaldehyde (pH 7.0). The whole patellae were 
isolated from the surrounding tissue after overnight 
decalcification in 5% formic acid. A papain mixture 
consisting of 1 mg/ml papain, 0.2 M NaCl, 0.1 M 
Na-acetate, 10 mM L-cysteine hydrochloride, 50 
mM Na^-EDTA, and 50 μg/ml chondroitin sulfate 
carrier (pH 6.0) was used to digest formaldehyde-
fixed patellae (200 μΐ/patellae) at 60°C overnight 
Undigested patellar remnants were spun down. 
To 150 μΐ supernatant of patella digest, 150 μΐ 0.2% 
cetylpyridinium chloride was added. After 2 h at 
37°C, the precipitate was centrifuged at 10,000 g for 
15 mm at 370C. The supernatant was discarded and 
the precipitate was washed twice with 0.5 ml 0.05% 
cetylpyridinium chloride. The pellet was solubilized 
for 2 h in 0.5 ml Solulyte at 60oC and after addition 
of scintillation fluid analyzed by a liquid scintilla­
tion counter. Appropriate corrections were made 
for the 3 H and .S channel overlap. 
Analysis of Glycosaminoglycans by 
Column Chromatography 
Groups of 10 patellae were pooled and incubated 
for 2 h in BME-diploid medium containing 10 πΛ/, 
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О 1 тМ, or 1 0 тМ sulfate supplemented with 100 
цО/т! [35S]sulfale and 200 μΟ/ιπΙ [3H]glucos-
amine The patellae were premcubaled for 2 h in me­
dium without label. After papain digestion as de­
scribed above and spinning down of the undigested 
remnants, the digest supematants were dialyzed for 
72 h against tap water This was followed by lyoph­
ilization and redissolution of the glycosaminoglycans 
in the elution buffers used during chromatography. 
The glycosaminoglycans of 10 pooled patellae 
were applied to a DEAE-Tnsacryl anion exchange 
column ( 1 x 1 5 cm) that had been equilibrated with 
200 ml 0 2 M NaCI in 1 mM HCl. A linear gradient 
of 0.2-2 0 M NaCI in 1 mM HCl was used to elute 
the glycosaminoglycans, as desenbed by Ito et al. 
(13). After each run the column was washed with 
100 ml 0 2 M NaCI in I mM HCl. The flow was 20 
ml/h and fractions of 2 ml were collected. The frac­
tions were assayed for radiolabeled glycosamino­
glycans by liquid scintillation counting 
The glycosaminoglycans of 10 pooled patellae 
were also applied to a Sepharose CL 6B column 
(100 x 0 7 cm) A 0.1 M ammonium acetate buffer 
(pH 5 0) was used as eluant. The flow was 15 ml/h 
and fractions of 1.25 ml were collected and assayed 
for radioactivcly labeled glycosaminoglycans. The 
void volume (V0) of the column was determined by 
dextran blue (M
r
 2 χ 106) and the total volume (Vt) 
by Na ; ["S]S0 4 . 
Enzymatic Digestion of Glycosaminoglycans 
The hyaluronate fraction of the glycosaminogly­
cans was digested by the specific S. hyaluromdase 
to demask the synthesized chondroitin. Hyaluro­
nate elutes in the same fractions as chondroitin. 
Glycosaminoglycans were dissolved in 1 ml 0 02 M 
Na-acelatc buffer (pH 5) containing 10 U/ml en­
zyme and incubated for 24 h at 37°C After incuba­
tion the samples were dialyzed for 48 h against tap 
water and subsequently lyophihzed. 
To charactenze the synthesized glycosaminogly­
cans, chondroitin sulfate was degraded after redis-
soludon of the glycosaminoglycan samples in I ml 
0 01 M Tns-HCI (pH 8) with I 0 U/ml chondroiti­
nase ABC for 24 h at 25'>C. This was followed by 
dialysis for 48 h against tap water and lyophilization 
of the samples. 
Analysis of Glycosaminoglycan Disaccharides with 
High Performance Liquid Chromatography 
Patellae were incubated with ["SJsulfate and 
[]H]glucosamine as desenbed above. Individual pa­
tellae were incubated with papain and subsequently 
treated with 5. hyaluromdase. After dialysis and 
lyophilization, the glycosaminoglycans were 
treated with chondroitinase ABC. The proportions 
of radiolabeled nonsulfated disaccharides, 4-
sulfated disaccharides, and 6-sulfated disaccharides 
were determined by the method described by 
Hjerpe et al. (Il) A Radialpak NH2 high perfor­
mance liquid chromatography (HPLC) column was 
used to separate the disaccharides. 
Statistical Analysis 
Statistical analysis of data was performed by the 
double-sided Student Г test. 
RESULTS 
The incorporation of sulfate and glucosamine m 
the glycosaminoglycans of patellar cartilage incu­
bated in medium with various sulfate concentra­
tions is shown in Fig 2 (isolation of cartilage from 
the patellae gave similar results as whole patellae, 
data not shown) The incorporated quantity was 
calculated from the incorporation of labeled sulfate 
and glucosamine corrected for the specific activities 
of these precursors used in the vanous experimen­
tal conditions. The incorporation of sulfate signifi­
cantly decreased when the medium sulfate concen­
tration was reduced from I 2 to =s0.4 mM (p < 
0.001). The incorporation of glucosamine in the 
newly synthesized glycosaminoglycans was not di­
minished by reduction of the medium sulfate con­
centration and even seemed to increase at very low 
-Sullale and Glucosamine incorporation vs SO4 cone 
SO4 concentration (mmol/l) 
RG. 2. Sulfate and glucosamine incorporation into patellar 
glycosaminoglycans at various sulfate concentrations Re­
sults are expressed as millimoles of precursors incorporated 
in 2 h per patella and represent the means ± SO of at least 
five patellae 
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sulfate concentrations These results point to the 
synthesis oÇ undersulfated glycosaminoglycans m 
vitro at lower than physiological sulfate concentra-
tions The physiological sulfate concentration of the 
mouse is 1 0 mM (8) 
To study the effect of the sulfate concentration in 
the medium on the recycling of sulfate derived from 
degraded glycosaminoglycans, mouse patellae were 
incubated for 2 h in medium with 1.0 mM sulfate 
and [^SJsulfale This was followed by a 16-h chase 
in medium with various sulfate concentrations with-
out label The results are shown in Table 1 The 
medium sulfate concentration had no effect on the 
degradation of newly synthesized glycosaminogly-
cans, moreover, the results do not indicate an ele-
vated recycling of sulfate derived from degraded 
glycosaminoglycans at low sulfate concentrations 
The results described above seem to imply the 
synthesis of undersulfated glycosaminoglycans or 
of a nonsulfated glycosaminoglycan pool besides 
the normal sulfated pool under low sulfate condi-
tions To investigate the nature of the glycosamino-
glycans synthesized under these sulfate concentra-
tions, we have analyzed glycosaminoglycans syn-
thesized in the presence of 1 0 mM, 0 1 mM, and 10 
nM sulfate by DEAE-Tnsacryl anion exchange 
chromatography. Both the 3H counts and the 35S 
counts were recovered for 85-95% after chromatog-
raphy. 
The chromatograms of the glycosaminoglycans 
showed two peaks (Fig. 3): a very low or nonsul-
fated peak that eluted in fraction 10 (0 38 M NaCI) 
and a highly sulfated peak that eluted in fraction 
24-25 (0 66 M NaCI) After treatment of the sam-
ples with chondroitmase ABC, both peaks disap-
peared from the chromatograms We found no in-
dication of undersulfation in the chromalogram of 
the glycosaminoglycans synthesized in the presence 
TABLE 1 EffeLl of lulfale concentration m the 
medium on the degradation of newly synthesized 
ghi osaminofîhcans of mouse patellae 
Sulfate 
concentration (mM) 
1 0 
I 0 
04 
0 1 
0 0 
Chase 
penod (h) 
0 
16 
16 
16 
16 
"S contení ± SD 
(cpm/palella) 
330 ± 60 
161 ± M 
150 ± 19 
186 ± 24 
171 ± 26 
Mouse patellae were incubated for 2 h in medium with I 0 mM 
sulfate and 20 μ^ΓηΙ [35b]sulfate and chased afterward in me­
dium with vanous sulfate concentrations without label Groups 
of six patellae were used 
FRACTION 
FIG. 3. DEAE-Tnsacryl chromatogram of patellar glycosami­
noglycans synthesized at 1 0 mM, 0 1 mM, and 10 nM sulfate 
Glycosaminoglycans of 10 murine patellae were pooled The 
specific activity of [35S)sulfate was 100,1 000, and 100 χ 105 
Ci/mol respectively, in the experiments with 1 0 mM, 0 1 mM, 
and 10 nM sulfate m the incubation medium (O), 3 H, ( · ) , " S 
of 0 1 mM sulfate. The chromatograms of 1.0 and 
0.1 mM were similar. Neither a shift of the sulfated 
glycosaminoglycan peak nor an increase in the pro­
portion of the nonsulfated peak was observed. 
However, calculation of the quantity of incorpo­
rated sulfate showed a 60% decrease at 0.1 mM 
sulfate as observed earlier (Fig. 2) Incubation of 
patellae in medium containing 10 nM sulfate re-
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suited in the synthesis of deviant glycosaminogly-
cans The proportion of the very low sulfaled gly-
cosammoglycan peak increased and the highly sul-
fated peak showed a widening on the left side of the 
chromatogram, indicating the ptesence of less sul-
faled glycosammoglycan chains 
Treatment of the glycosammoglycan samples 
with hyaluronidase from Streplom\ces resulted in 
the chromatograms shown in big 4 The glycosami-
noglycan peak eluting at 0 38 M NaCI disappeared 
completely in the chromatogram of 1 0 mM and al-
most completely in the chromatogram of 0 1 mM 
This demonstrates that the first peak in the chro-
matogram of 1 0 and 0 1 mM is hyaluronate The 
first peak of 0 1 mM also contained a small fraction 
of chondroilm The first peak in the chromatogram 
of 10 nM was affected to only a small extent after 
the treatment with hyaluronidase This peak repre-
sents, besides hyaluronate, a very low or nonsul-
fated glycosammoglycan pool, in all probability 
chondroilm 
These results were confirmed by analysis of the 
glycosammoglycan disacchandes by HPLC (Table 
2) The glycosammoglycan pool synthesized in the 
presence of 10 nM showed a significantly higher 
proportion of nonsulfated disacchandes than the 
glycosammoglycan pools synthesized in the pres-
ence of 0 1 or 1 0 mM sulfate (p < 0 001) In addi-
tion, significant reductions in pool size of chon-
droitin-6-sulfate (p < 0 05) and chondroitm-
4-sulfate (p < 0 001) were noticed only at 10 nM 
sulfate There was no significant difference in the 
proportion of nonsulfated disacchandes comparing 
0 1 and 1 0 mM sulfate 
The length of the chondroilm sulfate chains was 
not changed by a decrease of the sulfate concentra-
tion from 1 0 mM to 10 nM (Fig 5) Hyaluronate 
(first peak) eluted in the void volume of the Seph-
arose CL 6B column, while the chondroilm sulfate 
chains had a / iA V of 0 50 
DISCUSSION 
Incubation of mouse patellae in medium contain-
ing <0 5 mM sulfate led to a decreased incorpora-
tion of sulfate but had no effect on the incorporation 
of glucosamine However, the synthesis of under-
sulfated glycosaminoglycans could be confirmed 
only at very low sulfate concentrations in the me-
dium (10 nM) Incubation of patellae m medium 
containing 0 1 mM sulfate did result only in the syn-
thesis of a minor extent of undersulfated glycosami-
c«· 
1500 
cm 
FIG 4 DEAE Trisacryl chromatogram of patellar glycosami-
noglycans synthesized at 1 0 mM 0 1 mM and 10 nM sulfate 
after treatment with S hyaluronidase Glycosaminoglycans 
of 10 murine patellae were pooled The specific activity of 
[^SJsulfale in the experiments is indicated in the legend of 
Fig 3 (O) 3H ( · ) ^ S 
noglycans Earlier studies revealed that oral admin-
istration of sodium salicylate to mice leads to serum 
sulfate depletion (5,6) This depletion (60%) will di-
minish the rate of glycosammoglycan synthesis but 
will not alter the quality of the glycosaminoglycans 
synthesized 
We examined the effect of decreased medium sul-
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TABLE 2. Effect of sulfate concentration in the 
medium on the diwcchande proportion of пекі 
synthesized patellar glycosaminoglycant 
Nonsulfated 4-Suiratcd 6-Suiraled 
Sulfate disacch-inde disacchande disacchande 
concentralion (%) (7,) (%) 
10 ηΛί 
0 1 mM 
1 0 mM 
26 6 - 2 7 
16 6 -· 17 
15 0 ± 07 
57 2 · 2 I 
660 î 1 3 
65 4 ± 1 3 
162 ± I 7 
18 4 * I 5 
19 6 ± 1 В 
Glycosaminoglycans were Irealed with Hyaluronidase and di-
alyzed After lyophilization and redisolution, the glycosamino­
glycans were treated with chondroitmase АПС and analyzed m 
the high performance liquid chromatography system The results 
are expressed as means ± SD of five patellae 
fate concentrations on the synthesis of glycosami­
noglycans in anatomically intact articular cartilage. 
We used the whole patella of the mouse because of 
the integrity of the cartilage extracellular matrix and 
the chondrocytes. The environment of the chondro­
cytes is not changed compared with the in vivo sit­
uation (7). Slicing of articular cartilage, causing dis­
ruption of the collagen meshwork, or isolation of 
chondrocytes might alter the chondrocyte metabo­
lism. 
The incorporation rate of sulfate and glucosamine 
into glycosaminoglycans seemed to indicate the 
synthesis of undersulfated glycosaminoglycans at 
sulfate concentrations below 0.5 mM. However, the 
DEAE-Tnsacryl chromatogram of glycosaminogly­
cans synthesized in the presence of 0.1 mM sulfate 
showed the presence of undersulfated glycosamino­
glycans only to a minor extent, not enough to ex­
plain the diminished sulfate incorporation. Incuba­
tion of patellae in medium with 10 nM sulfate did 
result in the synthesis of undersulfated glycosami­
noglycans. Sobuc et al. (24) observed undersul-
fation of glycosaminoglycans synthesized by em­
bryonic chick cartilage at medium sulfate concen­
trations below 30 \LM. On the other hand, sulfate 
concentrations of >0.11 mM were required for the 
synthesis of normal sulfated glycosaminoglycans of 
bovine aortic endothelial cells (14). 
Decrease of the sulfate concentralion below 0.5 
mM led to a decreased incorporation of sulfate in 
glycosaminoglycans. Similar results are found by 
Maroudas and Evans (15) for the incorporation of 
sulfate in slices of human and bovine articular car­
tilage glycosaminoglycans and by Bayliss et al. (2) 
for rabbit annulus cartilage. Expenments with ana­
tomically intact patellar cartilage of Wistar rats also 
resulted in a diminished incorporation of sulfate in 
medium containing <0.5 mM sulfate (our observa-
FIG. 5. Sepharose CL 6B chromatogram of patellar gly­
cosaminoglycans synthesized at 1 0 mM, 0 1 mM, and 10 nM 
sullate Glycosaminoglycans of 10 murine patellae were 
pooled The specific activity of ["SJsulfate in the experi­
ments is indicated in the legend of Fig 3 (O), 3H, ( · ) , ^ S 
tion, results not shown). A decreased sulfate incor­
poration is considered to be a reflection of a dimin­
ished glycosaminoglycan synthesis. An apparent 
decrease of sulfate incorporation might also be 
caused by an elevated recycling of sulfate denved 
from degraded unlabeled glycosaminoglycans at de­
creased .sulfate concentrations. The medium sulfate 
concentration had no effect on the release of 35S 
counts from labeled glycosaminoglycans, as would 
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be expecteçl when sulfate recycling changes as a 
function of the medium sulfate concentration (Table 
1) Also, recycling of sulfate derived from lysoso-
mally degraded glycosammoglycans was not ob-
served using human fibroblasts (20). 
Inorganic sulfate is not the only sulfate source 
that can be used for the sulfation of glycosami-
noglycans. An accelerated turnover of sulfur-
conlaining amino acids at low environmental sulfate 
concentrations could also lead to an apparent re-
duction of sulfate incorporation Sulfate transport-
deficient mutants of Chinese hamster ovary cells 
obtain their sulfate for the sulfation of glycosami-
noglycans from the catabohsm of cysteine (9). 
However, cartilage-synthesizing cells make at least 
1,000-fold more glycosammoglycans than Chinese 
hamster ovary cells (9). Consequently, the sulfate 
supply from degradation of cysteine or methionine 
will not be sufficient to affect the sulfation of gly-
cosammoglycans in chondrocytes considerably 
Other authors also observed a decreased sulfate 
incorporation and an unaltered glucosamine incor-
poration in their experiments. Treatment of carti-
lage epiphyses from chick embryos with 6-
aminonicotinamide resulted in 30% decrease of sul-
fate incorporation but had no effect on glucosamine 
incorporation (22). A decreased sulfate incorpora-
tion at sulfate concentrations below 0 5 mM plausi-
bly reflects a diminished glycosaminoglycan syn-
thesis The unaltered incorporation of glucosamine 
could be the result of changes in the intracellular 
specific activity of [3H]glucosamine Intracellular 
glucosamine might be derived from glycogen 
present in the chondrocytes when the demand of 
glucosamine is high as a result of a high rate of 
glycosaminoglycan synthesis. A decreased synthe-
sis of glycosammoglycans as a consequence of de-
creased medium sulfate concentrations or glycos-
aminoglycan synthesis-inhibiting compounds, like 
6-aminonicotinamide, would result in a reduced 
breakdown of glycogen to glucose. The reduced in-
tracellular supply of glucose and by this of unla-
beled glucosamine will result in an increased spe-
cific activity of [3H]glucosamine. This could explain 
the apparent undisturbed incorporation of glucos-
amine although the synthesis of glycosammogly-
cans is inhibited. 
Other investigators have found, m culture sys-
tems differing from the one we have used in our 
experiments, an all-or-nothing pattern of glycosami-
noglycan sulfation (4,13,19,24). The sulfation of 
chondroilin sulfate chains in embryonic chick 
epiphyseal cartilage and embryonic chicken ster-
num cartilage occurred in such a fashion (13,24), 
similar results were observed when a microsomal 
preparation of chick embryo epiphyseal cartilage 
was used (4). Limb mesenchyme cultures from bra-
chymorphic mice showed also an all-or-nothing 
mechanism of sulfation, as reported by Penney-
acker et al. (19). The sulfation of glycosammogly-
cans by chondrocytes of murine articular cartilage, 
as described above, did not seem to follow this sort 
of pattern The sulfation mechanism had a predis-
position for the synthesis of a highly sulfated chon-
droitm sulfate pool and a very low sulfated chon-
droitin pool. However, also intermediately sulfated 
glycosammoglycans chains could be observed in 
the chromatogram of glycosammoglycans synthe-
sized in the presence of 10 nW sulfate 
The results of this study show that the medium 
sulfate concentration is an important determinant of 
glycosaminoglycan synthesis. Many investigators 
use "sulfate-free" medium to increase the specific 
activity of (15S]sulfate. This will undoubtedly lead 
to the synthesis of glycosammoglycans not synthe-
sized under physiological sulfate concentrations 
and will result in inaccurate conclusions about the 
synthesis of glycosammoglycans. 
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Abstract—Wc have studied the effect ot low sulfale concentrations on the glyeosaminogljean svnthesis 
in rat ρ Hell ir cartilage m ι ivo as well as m vitro The oral administration of 2(X)mg/kg paracetamol to 
male \Vistar rats resulted in a significant reduction of the strum sulfate concentration Reduced serum 
sulfate asailahililv resulted in i Mr/r decrease of gl>cosaniinogljcan svnthesis in patellar cartilage This 
is due to sulfate depletion since paracetamol had no direct effects on glycosaminoglycan synthesis and 
a slight but sigmlic ml inhibitory effect on the catabolism of radiolabeled glycosaminoglvcans ш vitro 
I he elvcosaminoglvcans svnthesized at low sulfate concentrations in ι ivo were símil ir to the 
elvcosammoglveans s\nihesi/ed at phvsiologieal sulfate concentrations Studvmg the effect ot sulfate 
availahihlv m vitro on glvcosammoglvcan synthesis in patellar cartilage wc found thai ineubaiion of ral 
patellae in medium containing less than Ü S mM inorganic sulfate led lo a decreased sulfate incorporation 
The use of polcnlial sulfate decreasing drugs can lead to inhibition of glycosaminoglycan svnthesis I his 
ireucs for a rceonsidt ration of the use of these drugs in palienls with already dysfuneiioning carni ige 
metabolism as in rheumatoid arlhrins and osteoarthrosis 
Nonsteroidal antnnflammatorv drugs (NSAIDs) are 
used in the treatment of both rheumatoid arthritis 
and osteoarthrosis (osteoarthritis) These diseases 
are associated with the pathology of articular 
cartilage However in the case of osteoarthrosis 
cartilage destruction is a primary event while in 
rheumatoid arthritis it is a secondary phenomenon 
following the infiammationof synovial tissue Several 
investigations have demonstrated that certain 
NSAIDs might affect the biochemical properties of 
articular cartilage chondrocytes 
NSAIDs can exert their pharmacological effects 
on chondrocytes in two ways a direct effect on 
the biochemical activities of chondrocytes and/or an 
indirect effect by way of influencing systemic factors 
determining the function of chondrocytes Many 
direct effects of NSAIDs are reported in the litera-
ture [1-7] Salicylates are reported by Palmoski 
and Brandt lo suppress glycosaminoglycan synthesis 
both in nitro and in υιυυ (8-11] These authors 
showed that this effect was a direct effect of salicylate 
on the chondrocyte metabolism in their experiments 
112] An indirect effect of salicylate on glycosamino­
glycan svnthesis m articular cartilage has been 
observed m our experiments [ Π , 14] A decrease 
of serum sulfate concentration in mice by way of 
salicylate induced sulfate diuresis apparently was 
the causative factor producing a diminished synthesis 
of glycosaminoglvcans in anatomically intact patellar 
cartilage [13 14] 
Herein we describe the effect of serum sulfale 
" T o whom correspondence should be addressed 
reduction on cartilage glycosammoglvcan synthesis 
in more detail We used paracetamol instead of 
salicylate to decrease sullate availability In this way 
possible direct effects of salicylate on glvcosamino 
glvcan synthesis are eliminated Paracetamol is con 
jugated with sulfate bv rat liver enzymes resulting in 
depletion of serum sulfate [ 15] We used in this study 
Wistar rats instead of mice because rats are relatively 
insensitive to paracetamol induced hepatoxicity and 
have a higher capacity of paracetamol sulfocon-
jugation than mice [16, 17] 
МАТЬ HI AI S WO МП HODS 
Effect of paracetamol on the іегшп ml]aw 
concentration Male Wistar rats (1 ^ 0-2(10 g) were 
used in all experiments They were fed with a com­
mercial pellet diet and given fresh tap water ad 
libitum Paracetamol (2(10 mg'kg) dissolved in tap 
water ( 1 m l ) was orally administered to the rats 
Control animals received a comparable volume of 
only tap water After 2 S 7 and 24 hr a blood sample 
was taken by orbita-punction under a light ether 
anesthesia Inorganic sulfate was determined by a 
modification of the benzidine method of Dogson and 
Spencer [18] as recently described [19] 
t f feet of paracetamol and ',alic\lale on 
ghunaminoghcan пл/Лелп in vitro Wistar rats 
were killed by cervical dislocation and both intact 
patellae were with a standard amount of sur 
rounding tissue dissected from the knee joints 
Patellae were incubated in RPMI 1640 DM medium 
supplemented with 2 mM L glutamine and 1 mM 
60 
pyruvate (all from Flow I aboratones Irvine 
Scotland) The sulfate concentration in the medium 
was 0 6 mM Various concentrations of paracetamol 
and sodium salicylate (1 2 and S mM) were added 
to the medium at the initiation of the 4-hr incubation 
penod Administration of 200 mg/kg paracetamol to 
male Wislar rats ( 140-200 g) as in our experiments 
will result in a maximum scrum paracetamol con 
centrationofO 24) 3mM[15] After 2 hr incubation 
20 μΟ [,sS]sulfate (Radiochemical Centre Amer 
sham U К ) was added to the medium All mcu 
bâtions were performed at 37° in a humidified 
atmosphere containing W CO; Patellae were 
washed twice with physiological saline and sub 
sequently fixed in ethanol (%</?- v/v) Decal 
cification of the patellae with 5r-i (v/v) formic acid 
was followed by stripping of the patellar cartilage 
layer [19] Patellar cartilage was digested overnight 
at 60° bv solul>te (J Τ Baker Chemicals Deventer 
The Netherlands) and the amount of incorporated 
["S]sulfate per cartilage of one patella was assayed 
by liquid scintillation analysis 
Effect of paracetamol on the catabolfim of 
["SJwZ/afe labeled glycotammoghcam Patellae 
were incubated in culture medium containing 80 μ Ο 
[^Slsulfate/ml for 2 hr as described above This 
labeling period was followed bv a chase without 
radiolabel for 16 hr in medium containing 0 1 2 or 
S mM paracetamol This was succeeded bv pro 
cessing of the patellae as described above 
Effect of midium sulfate concentration on 
glycosammoghcan synthesis 'n vitro Rat patellae 
were incubated in BMF diploid medium (Flow Lab 
oratories) with various sulfate concentrations for 2 hr 
at 37° in humidified 59Í COi atmosphere The BMF 
medium was supplemented with 2 mM L-glutamine 
1 mM pyruvate 20HCI ["S]siilfate (carrier free) and 
40/<Ci π [ft 'Hjglucosamine (RCA) per ml 
respectively Patellar cartilage was isolated from the 
surrounding tissue as described above and 
glvcosaminoglvcans were isolated To this end patel 
lar cartilage was digested overnight by papain at 60л 
The papain mixture (pHft 0) consisted of 1 mg/ml 
papain (type IV double crystallized Sigma St 
Louis MO U S A ) 0 1 M Na-acctate lOmMl 
cvsteine hydrochloride and M) mM Na
:
 LDTA Non 
hvdrol^sed remnants were spun down (10000g 
1^  mm) and HO/il 0 2rf cetylpyndinium chloride 
(CPC ) was added to 1S0/<1 supernatant After 2 hr 
incubation at 37° the precipitate was centnfuged 
(10 000g for l^mm) at 37° The supernatant was 
discarded and the pellet was washed twice with 0 S ml 
0 04% С PC 1 he pellet was solubilized for 2 hr in 
0 S ml solulyte at 60° and after addition of sein 
tillation fluid the quantity of radioactivity was ana 
lyzed with a liquid scintillation counter Appropriate 
corrections were made for channel overlap of ' 'S 
counts and M I-counts 
Effect of paracetamol on the ghcosamtnoghcan 
synthesis in vivo 1 wo hours after oral administration 
of 200 mg/kg paracetamol or tap water to male Wis 
tar rats 1 μ Ο ^ Ρ ^ ^ υ ^ Ι ε (carrier free) was injected 
intravenouslv (five rats per group) Blood samples 
were taken bv orbita-punction at 20 mm and 1 2 3 
4 and 5 hr after injection of ["Sjsulfatc Patellae 
were dissected from the knee joints S hr after 
administration of radiolabeled sulfate Patellae were 
processed for determination of the ("SJsulfate con 
tent as described above 
Total inorganic sulfate in scrum of the rats was 
quantitated as described above To determine the 
percentage of the free inorganic sulfate form of [ bS] 
in the serum of the rats inorganic sulfate was pre­
cipitated with BaC N Io SO ill of serum I ml of tri­
chloroacetic acid (4r/c w/v) was added This mixture 
was allowed to stand at room temperature for 10 mm 
and was subsequentlv centnfuged for IS mm 
(10 000 g) Five hundred microhtres of clear super­
natant was added to 125 μΐ BaCU reagent (20 g 
BaCl, 2HoO and 100 g Dextran in 11 distilled 
water) The precipitate was spun down (30 mm 
10 000 g) after overnight incubation at 4° The radio­
activity in the pellet and supernatant was assayed bv 
liquid scintillation counting At whatever time m 
the scrum of control rats always more than 93Ί- of 
total serum ["S] was precipitated In the serum of 
the paracetamol treated rats S(V óO'V of the total 
[US] was precipitable 
Charatttnzation of ghcosaminoghcans s\ntlies 
¡zed in vivo Tap water or 20(1 mg kg paracetamol 
was orallv administrated to male Wistar rats (two 
rats per group) and after 2 hr a phvsiological saline 
solution with 1 ιιί ι g [bb]sulfate and 8 »Ci g 
['Hjglucosamme was injected intravenouslv Five 
hours after injection of radiolabel the patellae were 
dissected from the knee joints and articular cartilage 
was isolated as described above After papain dnies-
tion and spinning down of the undigested remnants 
the supernatants were dialysed for 72 hr against 
tap water This was followed bv Ivophilization and 
rcdissolvingof the glycosaminoglycans in the elution 
buffers used during chromatographv 
Glvcosaminoglvcans of individual patellae were 
applied on a DLAI -frisacrvl anion exchanac 
column (1 x IS cm) equilibrated with 200 ml 0 2 M 
NaC 1 in 1 mM HCl A linear gradient ot 0 2-2 (I M 
Na( 1 in 1 mM HCl was used to elute the 
glvcosaminoglvcans trom the column Aftel eaeh run 
the column was washed with 100 ml 0 2 Μ N iC 1 in 
1 mM HC 1 The' flow was 20 ml hr and tractions ot 
2 ml were collected I he tractions were assayed tor 
radioactive labelled glvcosaminoglvcans b\ liquid 
scintillation counting 
Cjl>eobaminoglvcans of individual ρ itellae were 
also applied on ι Sepharose CL ftB gel chroma 
tography column (100 x 0 7cm) Απ 0 1M 
ammonium acetate butter (pHS(l) was used as 
eluent Ihe flow was IS ml hr and tractions of 
1 2S ml were collected and assaved tor radioactive 
labeled glycosammoglvcans The void volume (V.) 
was determined by dextran blue ( M 2x 10') and the 
total volume (V,) bv Na,| SjSOj 
Statistical anahsis Statistical analysis of data was 
performed by the two tailed Student / test A P-
value ^0 05 was considered significant 
RI-SUTS 
Decrease of serum sulfate level b\ paracetamol 
Oral administration of 200 mg/kg paracetamol to 
Wistar rats led to a significant reduction of the inor­
ganic sulfate concentration in serum (Fig 1) Five 
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Fig 1 Fffcct of the or.il .ісіпшимгаіюп of 2(X)mg/kg p<iriK.et<imi>l »η Ihc scrum sulf.itc concentration 
of male Wisuir r.ils Control rats received a comparable volume of lap water The resulls .ire expressed 
as ihc mean ± Ш ol live rats ( · paracetamol treated rats О control rats) 
hours after paracetamol administration the serum 
sulfate concentration was decreased by more than 
S07c after 7 hr the sultate depletion was still 66% 
Effect of paracetamol and salicylate on [3,S]iii//fl(e 
labeled ghcosamtnoglycan synthesis in vitro 
In-vitro incubation of anatomically intact rat patel­
lae with sodium salicylate resulted in a signifìcantly 
2 -
1 2 3 4 5 
DRUG CONCENTRATION (mM) 
Fig 2 Effect of sodium sahc) late and paracetamol on the 
incorporation of [ "S]sulfate in anatomicallv intact articular 
cartilage of ral patellae m nitro Patellae were incubated 
for 4 hr m medium containing sodium salic>late or 
paracetamol For the last 2 hr the patellae were incubated 
in the presence of 20 μ Ο ( "Ь|ьи1Гліс The resulls are 
expressed as the mean ± SI) of five patellae ( β salicvlatc. 
• paracetamol) 
decreased incorporation of ["S]sulfate already at a 
concentration of 1 mM (Fig 2) Paracetamol had up 
to a concentration of 5 m M , the highest con­
centration tested, no effect on incorporation of radio­
labeled sulfate (oral administration of 200 mg/kg will 
result in a peak serum level of approximately 0 Ι­
Ο 3 mM [15]) The incubations were carried out in the 
absence of serum, so the added drug concentrations 
were equivalent with the free drug concentrations in 
the incubation media 
Effect of paracetamol on the degradation of 
{^Sjsulfate labeled ghcosammoglycans 
Paracetamol had a slight but significant inhibitory 
effect on the catabolism of radiolabeled glycosamino-
glycans in vitro (Table 1) All three paracetamol 
concentrations tested had a significant suppressing 
effect on the breakdown of radiolabeled 
gI>cosaminoglycans but a dose response was not 
observed 
Table 1 The effect of paracetamol on the degradation of 
[1sS]suirale labeled glvcosaminoglvcans in nitro 
Paracetamol 
(mM) 
Chase 
(hr) 
"Sjsulfate content 
of patellae 
(cpm) 
— 
1) 
1 
•> 
s 
0 
16 
16 
16 
16 
19 212 ί 14(17 
10 14K ± 87S 
П()4()± ІИ1 
ПК64± 2768 
11 777 ± 1427 
Expressed are the mean values ± SD of at least five 
patellae A 2-hr labeling period was followed bv a l(i hr 
ehase period in culture medium without radiolahel 
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Effect of the sulfate concentration in medium on 
glycosammoglycan synthesis 
The incorporation of sulfate and glucosamine m 
the gl>cosaminoglycans of patellar cartilage incu-
bated in medium with various sulfate concentrations 
is shown in Fig 1 The incorporated quantity of 
sulfate and glucosamine was calculated by the incor-
poration of radiolabeled sulfate and glucosamine 
corrected for the specific activities of these precursors 
in the various experimental conditions Incubation 
of patellae in medium containing less than 0 5 mM 
sulfate resulted in significantlv reduced incorporation 
of sulfate in patellar cartilage glycosaminogkcans 
The incorporation of glucosamine in patellar car-
tilage glycosammoglycans was not diminished at sul 
fate concentrations below Ü S mM These results 
suggested the synthesis of undersulfated 
gHcosaminonlycans at sulfate concentrations below 
0 5 mM 
Effet ι of serum sulfate depletion on ghtosatmno 
glvcan 4\nthesi4 in vivo 
The m-vitro experiments described above show 
that a reduction of the sulfate concentration leads to 
a diminished sulfate incorporation and indicates the 
synthesis of undersulfated glycosammoglycans at low 
sulfate concentrations To answer the question if 
serum sulfate depletion leads to a diminished svn-
thesis of glvcosaminoglvcans in viro rats were 
injected with radiolabeled sulfate 2 hr after oral 
administration of 2(H) mg/kg paracetamol Patellae 
were dissected from the knee joints S hr after mjec 
tion of radiolabel The specific activitv of [''SJsulfate 
in the serum of the paracetamol treated and contiol 
rats in this 5-hr period is shown in Fig 4 The area 
under the specific actmtv curve of the paracetamol 
treated rats was 1 52 greater than the area under the 
curve of the control rats Moreover the specihe 
activity in the serum of the paracetamol treated rats 
decreased faster than the specific activity in the serum 
of the control rats 
The incorporation of radiolabel in the patellar 
cartilage of the paracetamol treated rats and the 
control rats is shown in Table 2 Incorporation of 
sulfate in the patellar cartilage of serum sulfate 
depicted rats was significanti) diminished (bbct ) 
I he paracetamol-induced serum sulfate depletion 
leads to a decreased svnthesis of cartilage 
glycosammoglycans 
Characterization of nenl) in vivo synthesized 
glycosammoglycans 
Our in vitro experiments indicated the synthesis 
of undersulfated glvcosaminoglvcans at low sulfate 
concentrations Iheretore in vivo newlv svnthes 
ized glvcosaminoglvcans were characterized h\ 
column chromatographv to examine the presence of 
undersulfated glvcosaminoglvcans in the cartilane of 
the paracetamol treated rats D F A E - T n s a c r v l anion 
exchange analvsis of patellar gkcosa inmoghcans 
synthesized in vivo In paracetamol treated and con­
trol rats resulted in the chromatograms shown in 
Fig 5 Both the chromatogram of the paracetamol 
treated and control rats showed the presence of one 
peak The peak in both chromatoarams clutcd at л 
NaCl concentration of 0 7 M In the chromatotiram 
of the sulfate depleted rats ( paracetamol treated) 
neither a shift of the sulfated tilvcosaininoslvcan 
о 200 -
100 
Iß 
SULFATE ( m M ) 
Fig 1 Effect of sulfate conccnlration in the medium on incorporation of sulfate .nul gluaisaminc in 
anatomically intact articular cartilage of rat patcUac Patallae were incubaied tor 2 hr in BME diploid 
medium with various sulfate concentrations I he results are expressed as thi. mean -!: SD of al Itasi live 
patellae ( # sulfate О glucosamine) 
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Fig 4 The spccihc activity ot free inorganic |"S]sulfdte in the serum of paractumol treated jnd control 
rats Paraceiamol was orali) administered 2 hr before injection of radiolabellcd sulfate (; = ()) The 
results are expressed as the mean + SD of five rats (•, paracetamol treated rats · conlrol rats) 
peak nor the presence of a поп-sulfated glycosammo-
glycan peak was observed Also the length of the 
newly synthesized glycosaminoglycan chains, as 
determined by gel chromatography with Scpharose 
CL6B, was similar for the sulfate depleted and the 
control rats (Fig 6) The KM of the glycosamino­
glycan chains was 0 44 
DISCUSSION 
The oral administration of 200 mg/kg paracetamol 
to male Wistar rats resulted in a significant reduction 
of the serum sulfate concentration This serum sul­
fate depletion led to a diminished incorporation of 
["Sjsulfate in patellar cartilage indicating a 
decreased glvcosaminoglycan synthesis Also incu­
bation of rat patellae in medium containing less than 
0 5 mM sulfate reduced the incorporation of sulfate 
However the incorporation of glucosamine was 
unaltered in these experiments at low sulfate con­
centrations in the medium Characterization of patel­
lar glycosammoglycans synthesized m vwo could 
not confirm the production of undersulfated 
glycosammoglycans as suggested by these results 
The use of sulfate decreasing drugs can lead to a 
diminished glycosaminoglycan synthesis but will not 
alter the biochemical nature of these glycosammo­
glycans, at least in short term 
In earlier studies we reported the inhibitory effect 
of salicylate induced sulfate depletion on 
glycosaminoglycan synthesis in mice [13,14] Sali­
cylate induced an elevated excretion of sulfate by 
the kidneys [13, 14) Incubation of murine cartilage 
in the presence of 5 mM salicylate inhibited sulfate 
incorporation 46% [13] while the incorporation in 
rat cartilage was inhibited by more than 90% (Fig 
2) Rat chondrocytes are more vulnerable to sali­
cylate than murine chondrocytes 
The potential direct effects of salicylate on the 
metabolism of chondrocytes makes this drug less 
suitable for in-vwo studies on the effects of sulfate 
depletion on glycosaminoglycan synthesis [8] Phe-
Tabk 2 Incorporation of [lsS]sulfdlc in patellar cartilage of paracetamol treated rats and 
control rats 
["SJsulfate incorporation in patellar cartilage 
Non-corrected 
value 
(cpm) 
Corrected 
value 
(cpm) 
Percentage 
of control 
Paracetamol treated rats 
Control rats 
62(1 S ± 692 
60M ± 550 
4135 '-455 
6051 ± 550 
66 
100 
Expressed arc mean values ± SD of the patellae of five rats The values in the second 
column are corrected for the difference between the specific activity m the serum of the 
paracetamol treated rats and in the scrum of the control rats (Fig 4 area under the curve 
ratio is 1 52) 
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[:',S]sulfate labeled glycosaminoglycans Paracet­
amol is a suitable drug to study the effect of sulfate 
depletion on glycsaminoglycan synthesis in vivo in 
the rat 
This study showed that low sulfate concentrations 
resulted both in vitro and m vwo in a diminished 
incorporation of sulfate in anatomically intact articu­
lar cartilage of the rat Similar m-vitro results were 
found in expenments of Maroudas and Evans with 
slices of human and bovine cartilage and by Bayliss 
et al for rabbit annulus cartilage [24 24] Also m-
viiro incubation of anatomically intact patellar car­
tilage of mice in medium with less than 0 5 mM 
sulfate led to a diminished sulfate incorporation [П] 
FRACTION 
Fig *) DCAE-Trisacryl anion exchange chromaiogram 
of newly synthesized patellar cartilage glycosammoglycans 
from paracetamol-treated and control rats Glycobammo-
glycans were eluied with a NaCI gradient (0 2-2 0 M NaCl 
in 1 mM HCl) Fractions of 2 ml were collected and radio­
activity was determined by liquid scintillation counting (#, 
[î5S]-(.ounts, Ο. [Ή] counts) 
nolic compounds like paracetamol and sahcylamide 
are known to decrease the inorganic scrum sulfate 
level by conjugation with sulfate [15, 20, 21] Morris 
and Levy reported a significant reduction of the 
serum sulfate concentration in healthy human vol­
unteers after a single dose of 1 5 g paracetamol [22] 
Paracetamol (200 mg/kg) decreased the serum sul­
fate level in male Wistar rats significantly The 
oral administration of this dose of paracetamol to 
male Wistar rats will result in a maximal serum 
paracetamol concentration of 0 2-0 3 mM, 1 hr after 
administration [15] Paracetamol had no effect on 
the glycosammoglycan synthesis up to the highest 
concentration tested (5 mM) while the glycosammo­
glycan synthesis was already significantly inhibited 
by 1 mM salicylate (Fig 2) Paracetamol had, m 
vitro, a slight inhibitory effect on the degradation of 
FRACTION 
Fig 6 Scpharose CL6B chromatogram of newly syn 
thesized patellar cartilage glycosammoglycans from par 
acetamol treated and control rats Glycosammoglycans 
were eluted with an ammonium acetate buffer (0 1 M 
pH 5 ()) Fractions of 1 25 ml were collected and radio 
activity was assayed b) liquid scintillation counlmg ( · 
("S] counts, Ο [Ή] counts) 
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A decreased sultatc incorporation in cartilage is 
considered to be a reflection of a diminished 
glvcosaminoghcan synthesis However the 
decreased sulfate incorporation in our m-mtro 
experiments did not show a concomitant decrease 
of glucosamine incorporation a precursor of the 
glvcosammoglxcan backbone This suggested the 
svnthesis of undersulfated glycosaminoglycans 
Seegmilleri'/«/ also found a decreased incorporation 
of sulfate and an unaltered incorporation of glu 
cosamine after treatment of cartilage epiphyses from 
chick embrsos with ή aminonicotinamide [2^] Char-
<iractcri7<ition with anion exchange chromatography 
of patellar cartilage glvcosaminoglycans synthesized 
in vivo at decreased sulfate concentrations could not 
confirm the synthesis of undersulfated glycosamino­
glycans (Fig i ) Incubation of murine patellae m 
vitro at low sulfate concentrations (<() 5 mM) also 
resulted in decreased sulfate and unaltered 
glucosamine incorporation The glycosamino-
glvcans synthesized at a high sulfate concentration 
(1 mM) were similar to those synthesized at a 
low sulfate concentration (0 1 mM) (manuscript 
submitted) 
1 he unaltered incorporation of glucosamine in the 
presence of a decreased glycosammoglycan synthesis 
could be the result of changes in the intracellular 
specific activity of [ Il |glucosamine We postulate 
the hypothesis that at a high rate of glycosammo­
glycan s\nthesis the demand for glucosamine will be 
high and the glucose component of glucosamine will 
be derived from the intracellular glycogen pool in 
the chondrocytes A decreased synthesis of 
glycosaminoglycans as a consequence of sulfate 
shortage or glycosammoglycan synthesis inhibiting 
compounds will result in a reduced degradation of 
glycogen to glucose The reduced intracellular supply 
of glucose and consequently of unlabeled glu­
cosamine will result in an increased specific activity 
of pHlglycosamine This could be an explanation for 
the apparent unaltered incorporation of glucosamine 
at low sulfate concentrations 
In this studv we demonstrate that reduction of the 
serum sulfate concentration can lead to inhibition of 
glvcosammoglycan synthesis in vivo The bio­
chemical quantities of the glycosaminoglycans syn­
thesized at low sulfate concentration were similar 
with those synthesized at physiological sulfate 
concentrations Conjugation with sulfate is a com­
mon physiological way of drug detoxification [15] 
Drugs can also effect the renal excretion of sulfate 
[13 И ] Both mechanisms can lead to sulfate deple­
tion and consequently to inhibition of glycosammo­
glycan svnthesis The glycosammoglycan synthesis in 
man will be cxtremelv sensitive for sulfate depletion 
because man has a very low serum sulfate level 
(0 3-0 4 mM) and sulfate concentrations just below 
0 3 mM do already result in a diminished synthesis 
of glvcosaminoglycans in human articular cartilage 
[22 23] The use of potential serum sulfate decreas­
ing drugs might have deleterious effects on cartilage 
especially when used for prolonged periods This 
argues for a reconsideration of the use of potential 
sulfate decreasing drugs in patients with rheumatoid 
arthritis or osteoarthritis who already have a dis­
turbed cartilage metabolism 
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ABSTRACT 
Male Wistar rats were treated with paracetamol (200 mg\kg twice a 
day) for 2, 3, 4 and 9 weeks. During the first four weeks of 
paracetamol administration the serum sulfate concentration was 
significantly decreased. However, during the fourth until the 
ninth week, the serum sulfate concentration was only diminished to 
a small and insignificant extent. The paracetamol administration 
did not lead to serious liver or renal toxicity, as determined by 
alanine aminotransferase and creatinine levels in the serum of the 
rats. 
The paracetamol-induced serum sulfate depletion, observed during 
the first four weeks of the experiment, led to a significantly 
lower glycosaminoglycan content of the patellar cartilage of the 
rats after three and four weeks paracetamol treatment. When after 
the fourth week the serum sulfate concentration rose to nearly 
normal levels also the glycosaminoglycan content in the rat 
patellar cartilage reached control levels. These data indicate 
that the serum sulfate depletion might be the causative factor for 
the observed reduction in glycosaminoglycan content of rat 
patellar cartilage. 
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INTRODUCTION 
Both rheumatoid arthritis and osteoarthritis are diseases 
associated with pathology of articular cartilage. In the case of 
osteoarthritis this is a primary phenomenon while in rheumatoid 
arthritis it is an event secondary to inflammation of the synovial 
tissue. In the treatment of both diseases nonsteroidal 
antiinflammatory drugs (NSAIDs) are frequently used for their 
analgetic and antiinflammatory properties. However, numerous 
investigations have demonstrated that certain NSAIDs might affect 
the metabolism of articular cartilage chondrocytes. 
There are essentially two ways by which NSAIDs can alter the 
metabolism of articular cartilage chondrocytes: A direct effect of 
NSAIDs on the biochemical activities of chondrocytes and/or an 
indirect effect on chondrocyte metabolism by way of influencing 
systemic factors. Several investigators have reported the drug-
induced inhibition of chondrocyte glycosaminoglycan synthesis by 
way of the first mechanism [1,2,3,4]. Also, well known is the 
suppressive effect of salicylate on glycosaminoglycan synthesis of 
cartilage both in vitro and in vivo experiments [5,6,7,8]. This 
was claimed to be a direct effect of salicylate on chondrocyte 
metabolism. 
We observed that salicylate has also an indirect effect on the 
glycosaminoglycan synthesis in articular cartilage [9,10]. A 
diminished serum sulfate concentration due to salicylate-induced 
sulfate depletion was held responsible for a decreased synthesis 
of glycosaminoglycans in anatomically intact patellar cartilage of 
the mouse [9,10]. 
In recent studies we have used paracetamol, instead of salicylate, 
to decrease the sulfate availability in male Wistar rats. 
Paracetamol is conjugated with sulfate by rat liver enzymes 
resulting in depletion of serum sulfate [11]. Paracetamol had, in 
contrast to salicylate, no direct inhibitory effect on chondrocyte 
metabolism [12]. In previous experiments we observed that a single 
oral dose of paracetamol (200 mg/kg) diminished the serum sulfate 
concentration in male Wistar rats from 0.8 mM to nearly 0.1 mM in 
five hours [12,13]. This eventually resulted in a 34% inhibition 
of glycosaminoglycan synthesis in rat patellar cartilage [12]. We 
describe the effects of long term paracetamol administration to 
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male Wistar rats on the glycosaminoglycan content of patellar 
cartilage. 
METHODS 
Paracetamol administration 
Male Wistar rats (190-210 g) were used in all experiments. They 
were fed a commercial pellet diet (RHM, Hope farms, Linschoten, 
The Netherlands) and given fresh tap water ad libitum. Paracetamol 
was orally administrated twice a day in a dose of 200 mg/kg on 
9.00 a.m. and 5.00 p.m. from monday through friday (1.5 ml). In 
the weekends they received one dose a day on 11.00 a.m.. To 
facilitate drug administration, paracetamol was suspended in a 
solution of 0.1 % methylcellulose. Control animals received a 
comparable volume of only the methylcellulose solution. 
Effect of paracetamol on serum sulfate concentrations 
Once a week (Wednesday 2.00 p.m.) blood samples were taken by 
orbita-punction under a light ether anesthesia and thereafter the 
rats were weighed. The inorganic sulfate concentration was 
determined by a modification of the benzidine method as recently 
described [14]. 
Alanine aminotransferase assay 
Although rats are relatively insensitive to paracetamol-induced 
hepatotoxicity compared to other laboratory animals or man 
[15,16,17,18], we have measured the serum alanine aminotransferase 
levels at the moment that both the paracetamol-treated and the 
control rats were sacrificed (after 2, 3, 4 and 9 weeks). The 
alanine aminotransferase activity in serum was determined by the 
method of Ellis et al. [19]. 
Creatinine assay 
Reduced or absent renal function is associated with pronounced 
retention of inorganic sulfate. A strong positive correlation is 
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observed between the serum concentrations of creatinine and 
inorganic sulfate in humans and rats with renal dysfunction 
[20,21]. Therefore we examined the effects of chronic paracetamol-
treatment on serum creatinine levels. Just following 
sacrification, after 2, 3, 4 and 9 weeks, blood was obtained from 
the paracetamol-treated and the control rats. The quantity of 
serum creatinine was determined by the method of Bartels et al. 
[22]. 
Determination of the patellar glycosaminoglycan content 
After 2, 3,4 and 9 weeks rats were killed by cervical dislocation 
and the intact patellae were dissected from the surrounding tissue 
of the knee joint. The patellae were fixed in ethanol (96% v/v) 
for 24 hours and subsequently decalcified in formic acid (5% v/v) 
overnight. The cartilage layer was stripped off [14] and digested 
overnight at 60 "C by papain (type IV, double crystallized, 
Sigma, St Louis, MO). Following the papain digestion non-
hydrolized remnants were spun down (1000 χ g, 10 min). The 
quantity of glycosaminoglycans in the supernatant was determined 
by the dimethylmethelene blue assay described by Farndale [23]. 
Chondroitin-4-sulfate (Whale, Sigma) was used as a standard. 
Statistical evaluation 
Statistical evaluation of the results was done by analysis of 
variance (F-test). A Ρ value < 0.05 was considered to be 
significant. 
RESULTS 
Effect of paracetamol on the serum sulfate concentration 
The oral administration of paracetamol resulted in a decreased 
sulfate concentration in serum of the Wistar rats, when measured 
five hours after the first daily dose (200 mg/kg) (figure 1). Only 
during the first three weeks of paracetamol treatment the serum 
sulfate concentration was diminished significantly to 
approximately 30-4 0% of the control levels. After four weeks the 
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decrease of the serum sulfate concentration was not significant 
anymore and only about 10-20%. During the entire experiment the 
serum sulfate concentration in the paracetamol treated rats was 
similar to the concentration in the control rats when determined 
before the first paracetamol administration at 9.00 a.m. (data not 
shown). The above described results show that in the first three 
to four weeks of the experiment the serum sulfate concentration 
was significantly depressed in the paracetamol treated rats during 
a major part of the day. 
|Д0 sulfate concentration (mM) 
weeks 
о control · paracetamol 
Fig 1. The effect of chronic paracetamol administration on serum 
sulfate concentration of male Wistar rats. Paracetamol was 
twice a day orally administrated in a dose of 200 mg\kg at 
9.00 a.m. and 5.00 p.m. from monday through friday. In the 
weekends the rats received one dose a day at 11.00 a.m. 
Blood was collected on Wednesday at 2.00 p.m.. The values 
are expressed as the mean ± s.d. of eight rats. 
Effect of paracetamol on the growth of male Wistar rats 
The control rats showed nearly linear growth during the nine weeks 
of the experiment, resulting in a weight gain of approximately 210 
g (figure 2). The growth of the paracetamol-treated rats seemed to 
be slightly retarded. Nonetheless, the weight of the paracetamol-
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treated and the control rats was not significantly different at 
any stage of the experiment. 
Ί
 weight (a) 
weeks 
о control · paracetamol 
Fig 2. The effect of chronic paracetamol administration on the 
growth of male Wistar rats. The administration schedule is 
described in fig. 1. The rats were weighed once a week on 
Wednesday at 2.00 p.m.. The values are expressed as the 
mean + s.d. of eight rats. 
Effect of paracetamol on the patellar glycosaminoglycan content 
The effect of chronic paracetamol treatment on the 
glycosaminoglycan content of rat patellar cartilage is presented 
in table 1. Twice a day administration of paracetamol to Wistar 
rats (200 mg/kg) resulted after two weeks in a 6% less 
glycosaminoglycan content in the patellar cartilage (not 
significant). After three and four weeks respectively, the 
quantity of glycosaminoglycans was 8% and 12% lower in the 
cartilage of the paracetamol treated rats than in the cartilage of 
the control rats (significant). There was a significant increase 
in patellar glycosaminoglycan content from the fourth to the ninth 
week in the paracetamol-treated rats (p<0.05). A non significant 
reduction of only 2% was observed between the control and the 
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paracetamol-treated rats after nine weeks. 
Table 1: The effect of chronic paracetamol administration 
(200 mg/kg twice a day) to male Wistar rats on the 
glycosaminoglycan content of patellar cartilage. The 
glycosaminoglycan content is expressed as the mean ± 
s.d. ^g/patella) of sixteen patellae. 
paracetamol Glycosaminoglycan content 
administration control paracetamol 
(weeks) (ßg) (дд) 
2 57.1 ± 6.7 53.4 ± 5.3 N.S. 
3 57.6 ± 3.6 52.4 ± 5.3 P<0.05 
4 58.5 ± 5.9 51.5 ± 1.7 P<0.01 
9 60.8 ± 6.3 59.4 ± 6.7 N.S. 
Effect of paracetamol on the serum alanine aminotransferase and 
creatinine levels 
Paracetamol administration for as long as nine weeks twice a day 
had no effect on the alanine aminotransferase activity in serum of 
the rats (table 2), indicating that the chronic paracetamol 
administration did not induce serious hepatotoxicity in our 
experiments. A reduction of ALAT activity was observed from the 
second to the ninth week in the serum of the paracetamol-treated 
and the control rats. 
The creatinine levels in the serum of the paracetamol-treated and 
the control rats are expressed in table 3. Significant differences 
between the paracetamol-treated and the control rats were not 
observed during the nine weeks of the experiments. This indicates 
that the chronic paracetamol administration to the rats had no 
effects on the renal function, as determined by serum creatinine 
levels, in this experiment. Both the control rats as well as the 
paracetamol-treated rats showed a reduction in creatinine levels 
during the experiment. 
DISCUSSION 
Paracetamol is widely used as an analgetic in the treatment of 
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both osteoarthritis and rheumatoid arthritis. In an earlier study 
we reported the effect of a single oral dose paracetamol (200 
mg/kg) on the glycosaminoglycan synthesis in rat patellar 
cartilage [12]. A decrease in the serum sulfate concentration 
caused by paracetamol, appeared to be the causative factor for a 
34% suppressed glycosaminoglycan synthesis in rat patellar 
cartilage in a short term study. The sulfate depletion had no 
effect on the degree of sulfation or on the length of the 
glycosaminoglycans synthesized [12]. 
Table 2: The effect of chronic paracetamol administration 
(200 mg/kg twice a day) on the alanine 
aminotransferase (ALAT) activity in the serum of 
male Wistar rats. The values are expressed as the 
mean ± s.d. of eight rats. 
paracetamol 
administration 
(weeks) 
2 
3 
4 
9 
control 
(units) 
39.6 ± 3.4 
39.9 ± 4.3 
34.9 ± 4.0 
35.0 ± 7.6 
A1AT activity 
paracetamol 
(units) 
43.5 ± 5.3 
42.4 + 4.3 
38.5 ± 9.9 
30.3 + 3.6 
N.S. 
N.S. 
N.S. 
N.S. 
Long term paracetamol administration led to a significant serum 
sulfate depletion during the first three weeks. However after four 
weeks the effect of paracetamol on the serum sulfate levels was 
greatly reduced (figure 1) . This unexpected phenomenon did not 
seem to be caused by paracetamol-induced liver injury since the 
alanine aminotransferase levels in the serum of the paracetamol-
treated rats were not elevated during the experiment (table 2) . 
Also paracetamol-induced renal dysfunction is not a likely cause 
for the nearly normalized serum sulfate levels after four weeks, 
since the serum creatinine levels were not elevated during the 
same period, indicating normal sulfate excretion [20,21]. 
Hendrix-Treacy and co-workers have studied the rate of paracetamol 
elimination and the pattern of paracetamol metabolism after single 
or multiple dose of the drug to humans [24]. Both a single (650 
mg) or multiple (5 χ 650 mg, in a 30 hour period) administration 
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of paracetamol resulted in decreased serum sulfate levels in 
healthy human volunteers [24]. The fraction of paracetamol 
recovered in the urine as the sulfate conjugate was less and the 
glucuronide conjugate greater after multiple dosing than after a 
single paracetamol dose. This is probably caused by the reduced 
availability of sulfate after multiple dosing [24]. In contrast, 
patients on chronic paracetamol medication showed serum sulfate 
levels even higher than the control population. Despite of the 
high serum sulfate levels, the percentage of paracetamol excreted 
as the sulfate conjugate was much less than after single or 
multiple drug dosing [24]. These observations are similar to the 
observations in rats in the herein described experiment. 
Paracetamol administration in a short period leads to serum 
sulfate depletion while prolonged paracetamol administration lacks 
this effect. The lack of serum sulfate reduction by paracetamol 
after chronic treatment might be caused by changes in the ratio 
paracetamol sulfation/paracetamol glucuronidation in the liver, 
induced by the prolonged paracetamol treatment. 
Table 3: The effect of chronic paracetamol administration 
(2 00 mg/kg twice a day) on the creatinine 
concentration in serum of male Wistar rats. The 
values are expressed as the mean ± s.d. (μΜ) of 
eight rats. 
Creatinine concentration 
Paracetamol control paracetamol 
administration (μΜ) (μΜ) 
(weeks) 
t l 
μΜ) 
5 9 . 7 ± 8. 
4 8 . 4 ± 3 . 
4 0 . 0 ± 5. 
3 8 . 6 ± 1. 
,7 
,4 
.4 
,7 
2 7 54.8 ± 3.8 U.S. 
3 4 47.5 ± 1.4 N.S. 
4 0 42.4 ± 3.7 N.S. 
9 6  39.5 ± 2.9 N.S. 
Hepatotoxicity associated with an overdose of paracetamol is well 
known in man and certain laboratory animals [16,17,18,25]. 
Theoretically, a diminished liver function could affect cartilage 
metabolism as the liver is the main organ for the synthesis of the 
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chondrocyte growth factor, insulin-like growth factor 1 (IGF-1) 
[26]. Liver damage can potentially lead to a diminished production 
of IGF-1 and by this way to a decreased glycosaminoglycan 
synthesis by articular chondrocytes. However, rats are relatively 
insensitive to the toxic effects of paracetamol [15,16,17,18] as 
confirmed by our experiments. Chronic paracetamol administration 
for 9 weeks, twice a day 200 mg\kg, did not result in 
hepatotoxicity as expressed in elevated serum alanine 
aminotransferase levels. 
The serum sulfate level was significantly depressed until the 
fourth week of the experiment and raised thereafter to nearly 
control levels. The fall and rise of the sulfate level in serum 
appeared to be concomitant with the reduced (3 and 4 weeks) and 
nearly normalized glycosaminoglycan content in rat patellar 
cartilage (9 weeks). So, the serum sulfate level seems to be the 
causative factor for the diminished glycosaminoglycan content in 
the patellar cartilage of 3-4 weeks paracetamol treated rats. 
Short term (3 weeks) paracetamol administration leads to depletion 
of serum sulfate and glycosaminoglycan content in rat patellar 
cartilage which is overcome when the paracetamol administration is 
continued. Similar effects of paracetamol on sulfate concentration 
are described in humans [24]. However, it has to be determined 
whether other potentially sulfate decreasing drugs may have 
similar effects on serum sulfate concentrations. Other sulfate 
decreasing drugs might not exhibit a reversible effect on sulfate 
pool upon long term adminstration. A more severe effect on 
glycosaminoglycan content of cartilage is expected under 
conditions of prolonged serum sulfate reduction. 
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ABSTRACT 
A single intra-articular injection with bacterial collagenase in 
the right knee joints of 10 weeks old male С57Ы10 mice led to 
osteoarthritic lesions within a few weeks in these joints. The 
collagenase-induced osteoarthritis was characterized by severe 
degenerative cartilage lesions on the medial side of the 
femorotibial joint associated with patellar dislocation to the 
medial side of the joint, sclerosis of subchondral bone below the 
cartilage erosions, osteophyte formation and consequently 
deformity of the knee joints. The osteoarthritic alterations in 
the collagenase model closely resembled the changes observed in 
spontaneous osteoarthritis in aged mice. The intra-articular 
injection with collagenase probably results in damage to collagen 
type I containing joint structures, such as tendons, ligaments and 
menisci, leading to an instable knee joint that results in the 
osteoarthritic joint lesions observed in this model. The 
collagenase-induced osteoarthritis model offers the possibility to 
study experimental osteoarthritis in large animal groups of inbred 
strains within a restricted time span at low costs. 
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INTRODUCTION 
Osteoarthritis is a common affliction of human joints 
characterized by fibrillation, erosion of articular cartilage, 
proliferation of normally non-dividing chondrocytes, formation of 
osteophytes at joint margins, and sclerosis of subchondral bone. 
The etiopathogenesis of osteoarthritis is multifactorial, various 
forms of osteoarthritis can be characterized as being the 
consequence of abnormal mechanical stress, or acquired or 
congenital abnormalities of articular cartilage. In all cases, the 
final common pathway is articular cartilage degeneration. 
Both spontaneous and induced osteoarthritis models in laboratory 
animals have been described. The incidence of spontaneous 
osteoarthritis in various mouse strains has been studied by 
Sokoloff (Sokoloff (1956), Sokoloff & Jay (1956)). A great 
variation in the development of osteoarthritis in the different 
mouse strains was observed. After 17 months of age, 93% of the 
STR/IN mice had osteoarthritis while this was only 2% in the A/LN 
strain (Sokoloff (1956), Sokoloff anfd Jay (1956)). Spontaneous 
articular cartilage degeneration in the medial site of the tibial 
plateau appears to be the initial event in the osteoarthritis 
prone STR/IN mice (Schunke et al. (1988)). In a closely related 
strain, the STR/ORT strain, spontaneous patella dislocation has 
been found to be associated with osteoarthritis of the knee joint 
(Walton (1977 a ,b and c, 1979)). Spontaneous osteoarthritis has 
been found in laboratory animals other than mice. For example, a 
high incidence of osteoarthritic lesions was observed in the 12-18 
months age group of Hartley strain guinea pigs (Bendele & Hulman 
(1988) ) . 
Induction of osteoarthritis in animal knee joints has mainly been 
carried out in two different ways. 1. Surgical damage to joint 
structures, like tendons and ligaments, resulting in instable 
joints and eventually osteoarthritis (Bendele (1987), Colombo et 
al (1983), Cooke & Chir (1986), McDevitt & Muir (1977), Moskowitz 
et al (1973), Pond & Nuki (1973), Schwartz et al. (1981)). 2. 
Intra-articular injection of chemicals interfering with cartilage 
metabolism (Bentley (1971), Goldenberg et al. (1982), Havdrup & 
Telhag (1977), Williams & Brandt (1984)). 
In the new model described herein, we have used intra-articular 
injection of bacterial collagenase to induce osteoarthritis in 
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young C57B1 mouse knee joints. Intra-articular injection of 
collagenase was shown to have minimal direct effects on joint 
cartilage but seems to result in an instable joint by way of 
damaging other joint structures (ligaments, menisci) . This 
eventually leads to osteoarthritic alterations in these joints 
closely resembling spontaneous osteoarthritis in C57B1 and other 
mouse strains (Schünke et al. (1988), Sokoloff (1956), Sokoloff & 
Jay (1956), Walton (1977 a, b and c, 1979)). 
MATERIAL AND METHODS 
Ten weeks old, male C57B110 mice were used in all experiments. The 
animals were kept in boxes with a sawdust bottom in an air 
conditioned room at constant temperature and were fed a standard 
laboratory diet (Hope Farms, Deventer, The Netherlands) with 
access to tap water ad libitum. 
The right knee joint of the mice was injected once (microlange 
needle, 30 Gl/2 L.B.,0.3 X 13 BL, Becton Dickinson, Dublin, 
Ireland), intra-articularly through the patellar ligament, with a 
6 microliter solution of bacterial collagenase (248 u/mg, 
Worthington Biochemical Corporation, Freehold, New Jersey). 
Stretching of the hind-leg facilitates the intra-articular 
injection. Before injection the collagenase solution was filtered 
through a 0.2 um bacteria filter. The left control knee joint was 
injected with a similar volume of physiological saline. Three 
collagenase concentrations were used in the experiments namely 
0.5% (w/v), 1.0% (w/v) and 1.5% (w/v). 
After 1, 3, 7, 21 and 42 days groups of five mice per collagenase 
concentration were killed by cervical dislocation. Carefully 
dissected knee joints were fixed in phosphate-buffered formalin 
(pH 7.4) for five days and subsequently decalcified in 5% formic 
acid for four days. Standard processing of the tissue in a 
automatic tissue processing apparatus was followed by embedding of 
the knee joints in paraffin wax [11, 24]. Total frontal joint 
section were prepared (6 um) and stained with safranin О and fast 
green. Osteoarthritic changes in the joints were evaluated with a 
histological score ranging from 0 (no alterations) to + 
(noticeable pathological alterations) to ++ (markedly pathological 
alterations). 
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RESULTS 
Three collagenase concentrations were used to induce 
osteoarthritic changes in the right knee joint of C57B110 mice. 
The alterations observed in the joints after the injection of 
0.5%, 1.0% and 1.5% were essentially similar. However, the lesions 
induced by 1% and 1.5% collagenase were more pronounced than the 
lesions observed after injection of 0.5% collagenase. Differences 
in the effect of 1% or 1.5% collagenase were not observed. Only 
the results of the 1% collagenase injection will be presented. In 
table 1 an overview of the osteoarthritic alterations is shown. 
Day 1 
One day after the intra-articular injection of collagenase a 
medial dislocation of the patella could be observed in four out of 
five animals injected with 1% collagenase (figure 1A). Dislocation 
of the patella was never observed in the control (left) knee 
joints. 
Patellar cartilage and cartilage of the facies patellaris femoris 
showed a moderate loss of safranin О staining, indicating a 
reduced proteoglycan concentration in these areas compared to 
controls (figure IB). The cartilage of the tibial plateau or the 
femoral condyles was normally stained when compared to control 
knee joints. Changes on the surface of the articular cartilage 
were neither observed in the femoropatellar joint nor in the 
femorotibial joint in both collagenase and saline injected joints. 
The structure of the cruciate ligaments appeared to be 
disorganized by the collagenase injection (polarized light 
examination). 
Signs of inflammation were also observed in the collagenase 
injected knee joints (figure IB) . Synovial infiltration of 
polymorphonuclear leukocytes and exudation of inflammatory cells 
in the synovial cavity was found. This was most marked in the area 
of the femoropatellar joint. 
Day 3 
Medial dislocation of the patella was evident in four of the five 
mice. Depletion of safranin 0 staining was greatly reduced in the 
cartilage of the femoropatellar joint compared to the depletion 
one day after injection. While depletion of safranin О staining 
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Table 1: Histologie evaluation of the osteoarthritic alterations 
in the collagenase injected (1%) right knee joints of individual 
male C57B110 mice (n=5) . (0 = no alterations, + = noticeable 
pathological alterations, ++ = markedly pathological alterations). 
Patellar 
dislocation 
Cartilage 
fibrillation 
Erosion of 
non-calcified 
cartilage 
Erosion of 
calcified 
cartilage 
Erosion of 
bone 
Chondrocyte 
loss 
Osteophyte 
formation 
Loss of 
Safranin 0 
staining, 
femoropatellar 
femorotibial 
cruciate 
ligament 
damage 
chondrocyte 
clusters 
Synovial 
infiltration 
Inflammatory 
exudation 
Synovium 
hyperplasie 
score 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
0 
+ 
++ 
day 1 
1 
0 
4 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
0 
5 
0 
5 
0 
0 
0 
5 
0 
5 
0 
0 
0 
5 
0 
0 
4 
1 
5 
0 
0 
day 3 
1 
0 
4 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
4 
1 
0 
2 
3 
0 
0 
5 
0 
5 
0 
0 
0 
5 
0 
2 
3 
0 
5 
0 
0 
day 7 
1 
0 
4 
2 
3 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
0 
1 
4 
0 
0 
5 
0 
5 
0 
0 
0 
5 
0 
4 
1 
0 
0 
2 
3 
day 21 
1 
0 
4 
0 
0 
5 
0 
1 
4 
2 
3 
0 
5 
0 
0 
0 
1 
4 
0 
1 
4 
5 
0 
0 
0 
0 
5 
0 
1 
4 
2 
3 
0 
0 
5 
0 
4 
1 
0 
0 
0 
5 
day 4 2 
1 
0 
4 
0 
0 
5 
0 
0 
5 
0 
0 
5 
0 
1 
4 
0 
0 
5 
0 
0 
5 
1 
4 
0 
0 
0 
5 
0 
0 
5 
1 
4 
0 
0 
5 
0 
4 
1 
0 
0 
0 
5 
88 
was overcome in the femoropatellar joint after three days, a 
slight reduction in the safranin 0 staining of the femorotibial 
cartilage was found three days after collagenase injection but not 
one day after this injection. 
The inflammation of the joints on day three was markedly reduced 
when compared to the inflammation on day one. Infiltration of 
inflammatory cells in the synovium was reduced and only a few 
inflammatory cells could still be seen in the joint cavities. 
Figure 1: Right knee joint of a male C57B110 mouse one day after 
injection of 1% collagenase. A. Photograph of femoropatellar joint 
showing patella dislocation to the medial side of the joint 
(original magnification X 40). B. Photograph of femoropatellar 
joint showing loss of safranin О staining, patellar displacement 
and the presence of some inflammatory cells (original 
magnification X 100).Ρ = patella, F = femur, GP = growth plate, С 
= cartilage, В = bone, Τ = tibia, CI = cruciate ligaments, S = 
synovium, 0 = osteophyte. 
Day 7 
The safranin О staining of the cartilage of the femoropatellar 
joint was not reduced anymore but the cartilage of the 
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femorotibial joint was less stainable by safranin O than the 
control joints. Also initial fibrillation of cartilage was seen in 
these areas. 
The synovial tissue on the medial side was thickened, indicating 
synovial cell proliferation (figure 2) . Also the synovium on the 
lateral side was slightly thickened in some animals. Infiltration 
of inflammatory cells was not observed in the proliferated 
synovium but inflammatory cells could be seen in the original 
synovial lining. 
Figure 2: Right knee joint of a male C57B110 mouse seven days 
after injection of 1% collagenase. Hyperplasia of the synovium can 
be observed but infiltration of inflammatory cells was absent in 
the proliferated areas (Original magnification X 40). See also 
legend figure 1. 
day 21 
The animals show pronounced depletion of safranin 0 staining in 
the cartilage of the femorotibial joint 21 days after collagenase 
injection. This was most severe on the medial side of the tibial 
plateau and femoral condyle. The cell number in the proteoglycan-
depleted cartilage was reduced but the cells still present in the 
depleted matrix were characterized by a highly safranin 0 
stainable pericellular matrix (figure 3). 
The cartilage on the medial side of the femoropatellar joint 
showed signs of degeneration. Fibrillation, clefts and eburnation 
of cartilage resulting in exposed bone was evident in this area 
(figure 4). Sometimes small chondrocyte clusters could be observed 
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in the affected cartilage. Degeneration of cartilage was also 
observed on the lateral side of the femoropatellar joint but this 
was always less severe than the alterations on the medial side. 
Osteoarthritic alterations in the femoropatellar joint were rare. 
There was a pronounced thickening of the medial synovium after 
injection of collagenase. On the lateral side the incidence was 
lower and the thickening less. Osteophyte formation could be seen 
on the medial side of the femoropatellar joint. The osteophytes 
were largest at the femoral condyles but also the tibial plateau 
showed pronounced osteophyte formation. Small osteophytes were 
present on the medial side of the femoropatellar joint in a few 
animals (figure 5). Hyperplasie changes in the menisci became 
evident 21 days after collagenase injection, and clearly enlarged 
ossifie centre in the menisci could be seen. 
Figure 3: Cartilage of the femorotibial joint 21 days after 
injection of 1% collagenase. The chondrocytes present in the 
proteoglycan depleted matrix, as indicated by loss of safranin О 
staining, show a highly safranin O stainable pericellular matrix 
(original magnification X 400). See also legend figure 1. 
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Day 42 
Forty-two days after collagenase injection the incidence of 
patellar dislocation was five out of five. The gross appearance of 
the affected joints was dramatically changed. Due to erosion of 
cartilage and bone and to osteophyte formation and synovial 
thickening the width of the knee joint was increased while the 
height of the joint appeared to be diminished in the knee joint 
sections compared to normal joints. 
Figure 4: Medial side of the right femorotibial joint 21 days 
after injection of 1% collagenase. Fibrillation, erosion of non-
calcified and calcified cartilage and sclerosis of subchondral 
bone can be observed ( original magnification X 400) . See also 
legend figure 1. 
The osteoarthritic lesions in the knee joints injected with 
collagenase were severe. The cartilage of the medial side of the 
tibial plateau was totally eroded and in three of the five mice in 
this group the growth plate cartilage was exposed to the surface 
(figure 6) . Below the cartilage and bone erosions, sclerosis of 
the remaining bone could be seen. Cartilage particles, apparently 
derived from the eroded sides, were present in the joint cavity. 
The lesions on the lateral side were less severe. The cartilage 
still present on the lateral side showed depletion of 
proteoglycans, as determined by loss of safranin О staining, and 
fibrillation and clefts. Small chondrocyte clusters, the 
pericellular matrix heavily stained by safranin 0, could be seen 
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in the cartilage adjacent to the clefts (figure 7). 
The tibial collateral ligament in the joint showed cartilaginous 
changes (figure 8) and ossification processes could be seen in the 
menisci. Osteophyte formation was advanced in the femerotibial 
joints and most severe on the medial side of the femorotibial 
joint. Small osteophytes on the medial side of the femoropatellar 
joint were also present in two out of five animals. 
Figure 5: Femoropatellar joint of a right knee 21 days after 
injection of 1% collagenase. Osteophytes can be seen on the medial 
side of the femorotibial joint (original magnification X 40). See 
also legend figure 1. 
DISCUSSION 
A single intra-articular injection of C57B110 mouse knee joints 
with a collagenase solution led to clear and progressive 
osteoarthritic lesions in the injected joint within two weeks. The 
incidence of osteoarthritis was five out of five mice after the 
injection of collagenase. The injection of the contralateral knee 
joint with physiological saline had no effects on the joint 
structures. The osteoarthritic alterations were characterized by 
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fibrillation of cartilage and matrix depletion in the femorotibial 
joint in the early stages (7 days) and erosion of cartilage and 
subchondral bone and osteophyte formation in the later stages (21 
days en 42 days). Also proliferative responses could be observed 
in the collateral ligaments and menisci from day 7 and later. 
Figure 6: Medial side of the femorotibial joint of a right knee 42 
days after injection of 1% collagenase. Erosion of cartilage on 
the tibial plateau and femoral condyle and of subchondral bone on 
the tibial plateau is clear. Sclerosis of subchondral bone below 
the cartilage lesions can be seen (original magnification X 40) . 
See also legend figure 1. 
Collagenase is an enzyme that will damage mainly the joint 
structures which contain collagenase type I in the extracellular 
matrix, such as tendons, ligaments and menisci. Although 
collagenase is frequently used in the digestion of cartilage 
slices (Glowack et al. (1983)), intact articular cartilage was 
resistent to the proteolytic activity of the collagenase we used 
in our experiments. In vitro incubation of anatomically intact 
patellae (undamaged cartilage) in 1% collagenase did not result in 
breakdown of the articular cartilage (data not shown). However, 
one day after collagenase injection in the knee joints a moderate 
loss of safranin О staining in the femoropatellar cartilage could 
be seen which was already overcome after 3 days. This depletion is 
to our opinion not due to the collagenase itself but to events in 
the joint tissues induced with collagenase e.g. enzyme release 
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from synoviocytes or 11-1 generation. The loss of safranin 0 
staining after 1 day (femoropatellar joint) did not seem to be 
associated with the localization of the osteoarthritic lesions at 
later stadia (femorotibial joint). 
Figure 7: Detail of a femoral osteophyte in the right knee joint, 
42 days after injection of 1% collagenase. A small chondrocyte 
cluster can be seen in the remaining articular cartilage (arrow) 
adjacent to the osteophyte (original magnification X 250). See 
also legend figure 1. 
A major effect of the collagenase injection is the medial 
dislocation of the patella, a trait which is also associated with 
spontaneous osteoarthritis observed in STR/IN and STR/ORT mice 
(Schunke et al. (1988), Walton (1977 a,b and c, 1979)). According 
to Walton, the patellar dislocation may be an important factor in 
the aetiology of the osteoarthritis while Schunke et al consider 
it to be the consequence of joint instability and deformity as a 
result of the osteoarthritic process (Schunke et al. (1988), 
Walton (1977a,b and c, 1979)). Collagenase injection resulted 
already after one day in a high incidence of patellar dislocation 
but osteoarthritic lesions were only observed at a later stage. We 
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think that the patellar dislocation indicates the presence of 
joint instability either as an outcome of collagenase injection or 
as a result of intrinsic changes in the joint leading to this 
instability in the case of the spontaneous models. The joint 
instability eventually results in development of osteoarthritic 
changes in the joint. The joint instability might lead to 
metabolic alterations in certain chondrocytes resulting in 
osteoarthritis in the area of the affected chondrocytes. Altman 
observed, in his study with STR/ORT mice, chondrocyte inactivation 
in cartilage areas prone to osteoarthritis before the histological 
evidence of degeneration (Altman (1981)). The altered chondrocyte 
metabolism might be a result of mechanical stress in the 
osteoarthritis prone cartilage. 
Figure 8: Medial side of a femorotibial joint of a right knee 42 
days after injection of 1% collagenase. Erosion of cartilage, 
sclerosis of subchondral bone and pronounced cartilaginous changes 
in the collateral ligaments are present (original magnification X 
40). See also legend figure 1. 
The most severe osteoarthritic changes we observed in the 
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collagenase-induced model were present on the medial side of the 
femoropatellar joint. This is also the case in the spontaneous 
models in the STR/IN and STR/ORT mice were the osteoarthritic 
changes are almost totally confined to medial side of the 
femorotibial joint (schunke et al. (1988), Walton (1977 а,Ъ and с, 
1979)). However, osteoarthritic lesions in the knee joint of old 
(18 month) C57B1 mice are not restricted to the medial side of the 
femoropatellar joint but can also be seen on the lateral side 
(figure 9) . This indicates that the etiopathogenesis of 
osteoarthritis in mice is multifactorial and can lead to a 
diversity of joint alterations. 
The formation of cartilage clefts and eburnation of the non-
calcified cartilage, extending to the tidemark, was followed by 
the loss of calcified cartilage exposing the subchondral bone to 
the surface in both the collagenase-induced and spontaneous 
osteoarthritis. Under the cartilage erosions the subchondral bone 
had become increasingly thicker. Similar phenomena are described 
for the STR/IN and STR/ORT strains by Walton and Schunke et al 
(Schünke et al. (1988), Walton (1977 a,b and c, 1979)) and were 
observed in the spontaneous osteoarthritis in the knee joint 
cartilage of old C57B110 mice at our laboratory (figure 9). 
Figure 9. Spontaneous osteoarthritis in the knee joint of a 18 
month old C57B110 mouse. Erosion of cartilage and subchondral bone 
is evident. Sclerosis of bone can be seen below the eroded sides 
and osteophytes are present, (original magnification X 40) 
97 
In both the induced and the spontaneous osteoarthritis, the 
cartilage adjacent to the observed cartilage clefts and erosions 
was more acellular than the cartilage in control joints. The cells 
remaining in the proteoglycan depleted matrix, as indicated by a 
loss of safranin О staining, were most times surrounded with a 
pericellular halo of strongly staining matrix. Chondrocyte 
clusters were present but only in small numbers. Similar 
observations were done in the spontaneous osteoarthritis in other 
mouse strains (Schünke et al. (1988), Walton et al. (1977 a,b and 
e, 1979)). In preliminary studies we observed that the 
glycosaminoglycan synthesis, measured by the incorporation of 
radiolabeled sulfate, was elevated in the osteoarthritic cartilage 
in the collagenase-induced model ( data not shown). The presence 
of the strong pericellular staining and the elevated 
glycosaminoglycan synthesis indicate that the chondrocytes present 
in the relatively acellular matrix have a high proteoglycan 
synthesis rate. As the surrounding matrix had a reduced safranin 0 
staining the synthesized proteoglycans do not remain in the 
osteoarthritic cartilage. 
The osteoarthritic alterations in the mouse knee joints are not 
confined to the articular cartilage and bone but also other joint 
structures are involved in the degenerative process. Metaplastic 
changes in the synovial tissue and collateral ligaments are 
frequently observed in the spontaneous models of murine 
osteoarthritis (Sokoloff (1956), Sokoloff & Jay (1956), Walton 
(1977 a,b and c, 1979)). Also cartilaginous changes in the 
collateral ligaments and ossification processes in the menisci are 
common in osteoarthritic mouse knee joints (Sokoloff (1956), 
Sokoloff & Jay (1956), Walton (1977 a,b and c, 1979). Similar 
alterations were seen in the collagenase-induced osteoarthritis 
here described. 
A moderate inflammation of the joint could be seen one day after 
the injection of collagenase. Cellular infiltration in the 
synovium and some exudation in the joint cavity were present. The 
exudate was transient and had already nearly completely 
disappeared after three days while a minor infiltration of the 
synovium with inflammatory cells was present throughout the entire 
study. When compared with the synovitis in the murine arthritis 
models we routinely use in our laboratory, the inflammation in the 
collagenase osteoarthritis model was, with respect to inflammatory 
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cell influx, moderate and a similar degree of inflammatory cell 
influx in our arthritis models does not result in loss of Safranin 
О staining and cartilage damage in these models (Kruysen et al. 
(1983), Kruysen et al. (1985), Van den Berg et al. (1981)). So, 
the role of the inflammatory cells in the pathogenesis of the 
collagenase-induced osteoarthritis will be a minor one. 
The joint alterations in the collagenase-induced osteoarthritis 
model were similar to the alterations observed in spontaneous 
osteoarthritis in aged mice. These changes closely resemble the 
corresponding lesions of articular cartilage in man, making the 
mouse a suitable experimental model for osteoarthritis studies 
(Silberberg & Silberberg (1971)). The collagenase-induced 
osteoarthritis model has several advantages compared to the 
currently used experimental models. The use of mice makes it 
possible to study osteoarthritic phenomena in whole knee joint 
sections of large animal groups in highly inbred strains. The 
intra-articular injection of collagenase in young animals (10 
weeks) results in joint alterations similar to those observed in 
spontaneous osteoarthritis in old mice but within a limited time 
span (a few weeks). In conclusion, the use of young mice and the 
non-time consuming setup of the experiments makes it possible to 
study experimental osteoarthritis in a convenient way at the 
lowest costs. 
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ABSTRACT 
Male , 10 week old, C57B110 mice received a single intra-
articular injection in the knee joints with papain, 
iodoacetate or collagenase. This led to osteoarthritic 
lesions, such as matrix depletion, chondrocyte proliferation 
and osteophyte formation, in the injected knee joints within 
several weeks. After injection of iodoacetate and papain the 
main osteoarthritic alterations were localized in the 
femoropatellar joint while injection of collagenase led to 
marked osteoarthritic lesions in the femorotibial joint. The 
mechanism of induction of these alterations appears to differ 
for iodoacetate and papain on one site and collagenase on the 
other site. Data are presented that collagenase injection 
results by way of damaging ligaments and tendons, to 
destabilization of the knee joint eventually leading to 
osteoarthritic alterations. In contrast, injection of papain 
or iodoacetate directly interferes with cartilage metabolism 
resulting in this way to osteoarthritic changes. 
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INTRODUCTION 
Osteoarthritis is an age-related disease of diarthrodial 
joints in which the predominant characteristic is degeneration 
of articular cartilage1. This process is often associated with 
proliferation of chondrocytes and formation of new cartilage 
and bone at joint margins leading to the formation of 
osteophytes. Osteoarthritis is presently considered as the 
clinicopathological consequence of various etiologic factors 
and most researchers agree that osteoarthritis is not a single 
disease entity1,2. The various forms of human osteoarthritis 
can be characterized as being the ultimate result of abnormal 
biomechanical stress or intrinsic or acquired abnormalities of 
articular cartilage. The final common pathway of this 
multifactorial disease is disturbed cartilage integrity. 
The changes occurring in the articular cartilage, as a result 
of the osteoarthritic process, are manyfold. Hydration of the 
extracellular matrix and the extractability of proteoglycans 
is increased in osteoarthritic cartilage compared to normal 
cartilage, both in human and experimental osteoarthritis3"5. 
Synthesis of cartilage proteoglycans is increased while the 
quantity of proteoglycans is reduced in osteoarthritic 
cartilage, indicating a highly increased breakdown of 
proteoglycans6"9. Also changes in the biochemical properties of 
proteoglycans from osteoarthritic cartilage are reported511"15. 
The normally non-proliferating articular cartilage 
chondrocytes are stimulated to divide as a result of the 
osteoarthritic process3^16"24. 
Besides changes in the articular cartilage, also other joint 
structures undergo alterations in the osteoarthritic joints. 
Formation of osteophytes at the joint margins is highly 
associated with the osteoarthritic changes in the articular 
cartilage16"26. Proliferation of synovial cells is observed both 
in human osteoarthritis and in animal models18,21,2'1'27"31. Another 
phenomenon seen in osteoarthritic joints is sclerosis of 
subchondral bone below the degenerated cartilage17,2'1·25,32,33. 
These observations point to anabolic processes in the joint in 
addition to the catabolic degeneration of articular cartilage. 
Since the pathogenesis of osteoarthritis can not adequately be 
studied in humans, interest has been directed to animal models 
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of osteoarthritis which simulate the human disease. 
Spontaneous osteoarthritis has been studied in mice, guinea 
pigs and dogs*,2*'25'33"*l>. In addition, osteoarthritis has been 
induced in animal knee joints in two different ways, induction 
of instability of the joint by surgical methods and intra-
articular injection of chemicals interfering with cartilage 
metabolism. Induction of joint instability has been carried 
out by (partial) meniscectomy, frequently in combination with 
dissection of collateral ligaments, and dissection of cruciate 
ligaments or myectomy5,9,1*·18"23·27·*1"". The intra-articular 
injection of papain or sodium iodoacetate leads to 
osteoarthritic alterations in the injected joints*5"57. 
since osteoarthritis is considered to be the final result of a 
multifactorial pathogenesis we have used three different ways 
of osteoarthritis induction in C57B110 mice. Knee joints of 
the mice were injected with papain, sodium iodoacetate or 
collagenase. Papain induces degeneration of cartilage 
proteoglycans, sodium iodoacetate is an inhibiter of cell 
metabolism and collagenase mainly attacks joint structures 
containing collagen type I, such as tendons and ligaments. 
MATERIALS AND METHODS 
ANIMALS 
Male C57B1/10 mice at 10 weeks of age were used in all 
experiments. The animals were kept in boxes in an air 
conditioned room at constant temperature and were fed a 
standard laboratory diet (Hope Farms, Deventer, The 
Netherlands) with access to tap water ad libitum. 
INDUCTION OF OSTEOARTHRITIS 
The right knee joints of the mice were injected once, intra-
articularly through the patellar ligament, with a 6 microliter 
solution of papain, sodium iodoacetate or collagenase. The 
left control knee joint was injected with 6 microliter 
physiological saline. Papain (Type IV, double crystallized, 15 
units/mg, Sigma, St. Louis, MO) was used in a concentration of 
0.5%, 1.0% and 2.0% (w/v) and these solutions were 
supplemented with 0.03 M L-cysteine.HCl (Sigma) to activate 
the papain. Sodium iodoacetate (Sigma) was injected in a 
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concentration of 0.1%, 0.5% and 1.0% (w/v) while collagenase 
(Clostridial, 248 units/mg, Worthington Biochemical 
Corporation, Freehold, New Jersey) was injected in the 
following concentrations 0.5%, 1.0% and 1.5% (w/v). Before 
injection the solutions were filtered through a 0.2 μτα filter 
to remove bacteria. 
HISTOLOGY 
Groups of 5 mice injected with papain or collagenase were 
killed by cervical dislocation 1, 3, 7, 21 and 42 days after 
intra-articular injection while a group of mice injected with 
iodoacetate was killed also after 64 days. Carefully dissected 
knee joints were fixed in phosphate-buffered formalin (pH 7.4) 
for 5 days and subsequently decalcified in 5% formic acid for 
four days. Standard processing of the knee joints in a 
automatic tissue processing apparatus was followed by 
embedding of the knee joints in paraffin wax. Frontal whole 
knee joint sections were prepared (6 μια) and stained with 
safranin О and fast green. 
DETERMINATION OF JOINT SWELLING 
Soft tissue joint swelling after intra-articular injection was 
assayed on day 1, 3, 7, 21, 41 and 64 (iodoacetate) by the 
"mTc-pertechnetate uptake method as described previously58. In 
short, mice were injected with 15 дСі 99mTc and sedated with 
choral hydrate (intraperitoneally). After 30 min the quantity 
of radiolabel in the right and the left knee joints was 
determined by measuring the gamma radiation with a collimated 
Nal-scintillation crystal while the knee joint was in a fixed 
position. Joint swelling was scored as the ratio of the 
radiolabel in the right and the left knee joint. 
GLYCOSAMINOGLYCAN SYNTHESIS 
After 1, 3, 7, 21, 42 and 64 (iodoacetate) days groups of 5 
mice were killed and the whole patellae along with a standard 
amount of surrounding tissue, were dissected from both the 
left and the right knee joints, according to the method of van 
den Berg et al.59. Patellae were incubated in RPMI 164 0 DM 
medium (Flow Laboratories, Irvine, UK) containing 2 0 дСі 
["sjsulfate (1200 Ci/mmol, Radiochemical Centre Amersham, 
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Amer sham, UK) for 2 hours at 37 °C in a humidified 5% C02 
atmosphere. The inorganic sulfate concentration was 0.8 mM. 
After incubation the patellae were washed twice with 
physiological saline to remove non-incorporated label and 
fixed in 4% phosphate-buffered formalin (pH 7.4). The patellae 
were isolated from the surrounding tissue after overnight 
decalcification in 5% formic acid. The patellae were digested 
with Lumasolve (Hicol, Oud-Beijerland, The Netherlands) and 
the incorporated radiolabel was determined by liquid 
scintillation counting. Radiolabel is incorporated almost 
exclusively in the proteoglycans of the patellar cartilage. 
Hardly any label is found in the underlying bone and bone 
marrow cells60. 
STATISTICAL EVALUATION 
The glycosaminoglycan synthesis was evaluated by means of 
analysis of variance in combination with the two tailed 
Student T-test. Joint swelling was evaluated with the Wilcoxon 
Rank Sum test. A Ρ value <0.05 was considered to be 
significant. 
RESULTS 
EFFECT OF INTRA-ARTICULAR INJECTION ON JOINT SWELLING 
Papain was injected intra-articularly in the right knee joint 
of mice in three different concentrations, 0.5%, 1.0% and 
2.0%. Only 1 day after the injection of 2% papain the right 
knee joint was significantly thicker than the left knee joint 
injected with physiological saline, as determined by the 
amount of radiolabel in the knee joints (figure 1A). At later 
stages, a significant joint swelling was not observed at any 
concentration. The injection of 0.5% and 1.0% iodoacetate 
resulted in a significant joint swelling 1 day after injection 
while the injection of 0.1% did not result in a significant 
response (figure IB) . The injection of collagenase had the 
most pronounced effects on joint swelling. All concentrations 
(0.5%, 1.0%, 1.5%) induced a significant joint swelling on day 
1 and day 3 after intra-articular injection (figure 1С). 
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Figure 1: Joint swelling after injection with papain, 
collagenase or iodoacetate. Mice were injected with 
radioactive technetium and after 30 min. the quantity of 
radiolabel in the left and the right knee joint were 
determined. Joint swelling was scored as the ratio of the 
radiolabel in the right and the left knee joint. Expressed are 
mean values ± s.d. of at least five mice ( A papain О 0.5%, 
• 1.0%, A 2.0%, В iodoacetate О 0.1%,· 0.5%, • 1.0%, 
С collagenaseO0.5%, · 1.0%,A 1.5%, * = significant different 
from control joints) 
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EFFECT OF INTRA-ARTICULAR INJECTION ON GLYCOSAMINOGLYCAN 
SYNTHESIS 
The intra-articular injection of papain resulted in an 
concentration dependent inhibition of glycosaminoglycan 
synthesis in patellar cartilage after 1 day (figure 2A). After 
3 days, the glycosaminoglycan synthesis in the patellae from 
mouse knees injected with 0.5% or 1.0% papain was 
significantly elevated while the synthesis in the patellae 
from knee joints injected with 2% papain was still inhibited. 
Seven days after the injection of papain, there was a slight 
but non-significant elevation of glycosaminoglycan synthesis 
in the patellae of all papain injected knee joints. 
Injection of iodoacetate in the knee joints resulted in a 
inhibition of patellar glycosaminoglycan synthesis up to more 
than 80% after 1 day (figure 2B). The glycosaminoglycan 
synthesis in the patellae of knee joints injected with 1% 
iodoacetate continued to be inhibited from day 1 till day 64. 
However, already 3 days after injection of 0.1% iodoacetate 
the glycosaminoglycan synthesis in the patellae was 
significantly increased compared to the control patellae. The 
patellae from the knee joints injected with 0.5% iodoacetate 
showed a normal overall synthesis of glycosaminoglycans in the 
whole patellae after 3 and 7 days but was significantly 
decreased at later stadia. 
Figure 2C shows the effect of collagenase injection on the 
patellar glycosaminoglycan synthesis. After one day, injection 
of 1.0% or 1.5% collagenase resulted in a significant 
inhibition of patellar glycosaminoglycan synthesis while a 
significantly elevated synthesis was observed after injection 
of 0.5% or 1.5% on day 7. An increased synthesis was also 
observed at all concentrations on day 21 and at 1.0% and 1.5% 
on day 42 but this was only significant for 1.0%. 
HISTOLOGICAL OBSERVATIONS 
Three concentrations of papain, iodoacetate or collagenase 
were used to induce osteoarthritic changes in the right knee 
joints of C57B110 mice. The joint alterations were essentially 
similar at all three concentrations and only quantitative 
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Figure 2: Glycosaminoglycan synthesis, as measured by sulfate 
incorporation, in patellar cartilage after injection of 
papain, iodoacetate or collagenase. The glycosaminoglycan 
synthesis is compared to the glycosaminoglycan synthesis in 
the left control joint. Expressed are the mean values ± s.d. 
of at least five patellae (A papainO0.5%,φ 1.0%, • 2.0%, 
В iodoacetateО0.l%, · 0.5%, • 1.0%, С collagenaseО0.5%,φ 1.0%, 
• 1.5%, ir = significant different from control joints). 
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differences were observed. The results of 1% papain, 1% 
collagenase and 0.5% iodoacetate will be reported and only 
major differences at other concentrations will be discussed. 
The results are summarized in table 1 and table 2. Table 1 
showes the changes in the articular cartilage while table 2 
presents the changes in other joint structures and the grade 
of inflammation. None of the control knee joints showed any 
evidence of osteoarthritic alterations. 
DAY 1 
One day after the injection of papain there was a pronounced 
depletion of safranin О staining in all the non-calcified 
articular cartilage of the joint, indicating a reduced 
proteoglycan concentration (figure 3). Injection with 2% 
papain even led to disruption of non-calcified cartilage from 
the calcified cartilage along the tidemark or to degradation 
of the cartilage surface. The effect of papain on articular 
cartilage was most extreme on the central part of the patella. 
The injection of iodoacetate had no effect on the safranin О 
staining or structure of the articular cartilage. One day 
after the intra-articular injection of collagenase a medial 
translocation of the patella was observed in 4 out of 5 
injected joints (figure 4). The cartilage of the patellaris 
femoris and the patella showed a mild loss of safranin 0 
staining while the cartilage of the femorotibial joint was 
normally stained. 
Signs of inflammation were observed in all three models. A low 
grade synovial leukocyte infiltration and exudation of 
inflammatory cells in the joint cavity was found. This was 
most pronounced in the cavity of the femoropatellar joint. 
DAY 3 
The depletion of safranin 0 staining in the femorotibial joint 
was less marked three days after papain injection than one day 
after papain injection. This was not observed in the 
femoropatellar joint. The intermediate zone of the 
femorotibial cartilage showed signs of chondrocyte 
proliferation and cell clusters could be seen in the safranin 
O-depleted cartilage. Acellular areas in the tibial cartilage 
could be seen in the group injected with 2% papain. The knee 
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Table 1: Histological observation of alterations in the 
articular cartilage of papain (1%), iodoacetate (0.5%) and 
collagenase (1%) injected knee joints of male C57B110 mice (0= 
no alterations, +++= pronounced pathological alterations, 
P=papain, I=iodoacetate/ C=collagenase, ND= not determined). 
DAY 1 3 7 21 42 64 
Cartilage 
fibrilation 
Erosion of 
non-calcified 
cartilage 
Erosion of 
calcified 
cartilage 
Chondrocyte 
death 
Chondrocyte 
clusters 
Loss of 
safranin О 
staining 
Ρ 
I 
С 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
++ 
0 
0 
+ 
0 
0 
0 
0 
0 
+ 
+ 
0 
0 
0 
0 
+++ 
0 
+ 
++ 
0 
0 
+ 
0 
0 
0 
0 
0 
+ 
++ 
0 
+ 
0 
0 
++ 
0 
0 
++ 
0 
0 
+ 
0 
0 
0 
0 
0 
+ 
++ 
0 
++ 
0 
0 
+ 
+ 
+ 
++ 
+ 
++ 
++ 
0 
++ 
0 
0 
+ 
++ 
++ 
++ 
++ 
+ 
+ 
++ 
++ 
++ 
++ 
+ 
++ 
++ 
+ 
+++ 
0 
0 
+++ 
++ 
++ 
+++ 
++ 
+ 
+ 
++ 
+++ 
+++ 
ND 
++ 
ND 
ND 
++ 
ND 
ND 
0 
ND 
ND 
++ 
ND 
ND 
+ 
ND 
ND 
+++ 
ND 
joints of mice injected with iodoacetate showed a very mild 
depletion of staining in the central part of the 
femoropatellar joint but other changes were not observed. 
Medial dislocation of the patella was evident in four of five 
mice injected with collagenase. The depletion of safranin 0 
staining in the femoropatellar joint was decreased compared to 
the depletion observed one day after collagenase injection. 
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Table 2: Histological observations of inflammation and 
alterations in non-articular cartilage joint structures in 
murine C57B1 knee joints after injection with papain (1%) , 
iodoacetate (0.5%) and collagenase (1%) (0= no alterations, 
+++= pronounced pathological alterations, P=papain, 
I=iodoacetate, C=collagenase, ND= not determined). 
DAY 1 3 7 21 42 64 
Patella 
displacement 
Erosion of 
bone 
Sclerosis of 
subchondral 
bone 
Osteophyte 
formation 
Synovium 
hyperplasia 
Inflammatory 
exudation 
Synovial 
infiltration 
Ρ 
I 
С 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
Ρ 
I 
с 
0 
0 
++ 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
++ 
++ 
++ 
++ 
++ 
+ 
0 
0 
++ 
0 
0 
0 
0 
0 
0 
0 
0 
0 
++ 
++ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
0 
0 
++ 
0 
0 
0 
0 
0 
0 
0 
+ 
0 
+ 
++ 
++ 
0 
0 
0 
+ 
+ 
+ 
0 
0 
++ 
0 
0 
+ 
0 
0 
+ 
+ 
++ 
++ 
0 
+ 
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0 
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0 
+ 
+ 
+ 
0 
0 
++ 
0 
0 
+++ 
0 
0 
++ 
++ 
++ 
+++ 
0 
+ 
+++ 
0 
0 
0 
0 
0 
+ 
ND 
0 
ND 
ND 
0 
ND 
ND 
0 
ND 
ND 
++ 
ND 
ND 
0 
ND 
ND 
0 
ND 
ND 
0 
ND 
The exudate of inflammatory cells in the joint cavity was 
greatly reduced compared with the exudate present after one 
day, in all three models studied. Only a few cells could still 
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be seen in the joint cavity. A mild infiltration of the 
synovium with inflammatory cells could still be observed. 
DAY 7 
Seven days after papain injection the non-calcified patellar 
cartilage showed areas devoid of cells lying next to 
hypercellular areas with numerous cell clusters (figure 5) . 
Highly safranin O-staining halos were seen around the cell 
clusters. Proliferation of cells and cluster formation was 
also evident in the femoropatellar cartilage and the menisci. 
The synovium appeared to be slightly thickened in the papain 
injected knee joints. 
Figure 3: C57B110 knee joint one day after the intra-articular 
injection of 1% papain. Note the depletion of safranin О 
staining in the non-calcified cartilage (frontal section, 
original magnification 40x, safranin O-fast green, 
A - injected joint, В - control joint). Ρ = patella, 
F = femur, Τ = tibia, GP = growth plate, С = cartilage, 
В = bone, CL = cruciate ligaments, О = osteophyte, 
L = ligament. 
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Cell death was observed in the central part of the patella and 
to a minor extend in the patellaris femoris in the knee joints 
of mice injected with iodoacetate (figure 6). The same 
cartilage areas also showed a moderate depletion of safranin О 
staining. In the depleted matrix some cells were present which 
markedly stained with safranin 0. Proliferation of 
chondrocytes was not observed. The femorotibial joint also 
showed a slight depletion of safranin О staining after 
injection with 1% iodoacetate. Early signs of 
osteochondrophyte formation was evident at the margins of the 
femoropatellar joint and in a few animals, to a minor extent, 
also at the margins of the femorotibial joint. 
Figure 4: Patellar displacement to the medial side of the 
joint one day after injection of 1% collagenase (frontal 
section, original magnification 40x, safranin O-fast green, 
see for legend and control joint figure 3). 
In the collagenase-injected joints the cartilage of the 
femorotibial joint showed a loss of safranin 0 staining while 
the staining of the femoropatellar cartilage was comparable 
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with the staining of control joints. The synovial tissue on 
the medial side of the was joint markedly thickened by 
proliferation of synovial cells while the synovium on the 
lateral side was only slightly thickened (figure 7) . 
Inflammatory cell infiltration in the synovium tissue was not 
observed. 
Figure 5: Proliferation of chondrocytes in the femoropatellar 
joint after the intra-articular injection of papain (day 7, 
frontal section, original magnification 250x, safranin O, fast 
green, see for legend figure 3, A - injected joint, 
В - control joint) 
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DAY 21 
Injection with papain led to acellular areas in the patellar 
cartilage lacking significant safranin О staining while other 
areas showed hypercellularity and a strongly staining matrix 
indicating cartilage repair (figure 8). Loss of cartilage in 
the depleted areas was seen in 2 out of 5 animals. Formation 
of osteophytes could be seen most pronounced at the medial 
side of the femoropatellar joint but in 1 out of 5 animals 
also at the medial side of the femorotibial joint. 
In the knees injected with iodoacetate a pronounced depletion 
of the central part of the patella was observed while some 
areas adjacent to the central part showed chondrocyte clusters 
with a markedly stained pericellular matrix. Also the 
femorotibial areas showed signs of chondrocyte proliferation. 
Osteophyte formation was seen at the margins of the 
femoropatellar joint. 
Figure 6: Femoropatellar knee joint 7 days after the injection 
of 0.5% iodoacetate. Formation of osteophytes at the margins 
of the joint and acellular areas in the central part of the 
patella can be seen (frontal section, original magnification 
lOOx, safranin 0-fast green, see for legend figure 3) 
A loss of safranin 0 staining was observed in the cartilage of 
the femorotibial joint of the collagenase-injected knees. This 
was most pronounced at the medial side of this joint. The 
depleted matrix appeared to be hypocellular but the cells 
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still present in the depleted matrix demonstrated a heavily 
stained pericellular matrix. 
DAY 4 2 
The knee joints injected with papain showed in the patellar 
cartilage the presence of chondrocyte clusters in an intensely 
stained extracellular matrix adjacent to acellular safranin 0-
depleted areas. Pieces of cartilage were disrupted from the 
degenerated cartilage. This was to a lesser extent also 
observed in the femoris patellaris. Osteophytes were observed 
on the margins of the femoropatellar joint, mainly on the 
medial side of this joint (figure 9) . Osteophytes on the 
femorotibial joint were less common. There were no signs of 
inflammation in the joints. 
Figure 7: Proliferation of synovial cells seven days after the 
injection of 1% collagenase, note the difference in 
proliferation on the medial side of the joint in contrast to 
the proliferation on the lateral side of the joint (frontal 
section, original magnification, safranin O-fast green, 40 x, 
see for legend figure 3) . 
Injection of iodoacetate led to the formation of large 
osteophytes on the margins of the femoropatellar joint (figure 
10) and sometimes to small osteophytes on the margins of the 
femorotibial joint. The osteophyte formation was most marked 
at the medial side of the joints. The central part of the 
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patella and to a lesser extent the opposite femoral cartilage 
showed a significant loss of safranin О staining. Areas 
neighboring depleted areas were hypercellular in some of the 
animals. Loss of safranin О staining was also observed in the 
cartilage of the tibial plateau. Signs of inflammation were 
absent in the joints. 
The injection of collagenase resulted in a gross change in the 
appearance of the knee joints. Due to osteophyte formation, 
thickening of the collateral ligaments and synovium and 
erosion of cartilage and bone the height of the joints was 
decreased and the width was increased. The osteoarthritic 
lesions were severe. Cartilage at the medial side of the 
femorotibial joint was totally eroded and the subchondral bone 
had become sclerotic (figure 11) . In two out of five mice the 
subchondral bone on the medial side of the femorotibial joint 
was exposed to the surface. Changes on the lateral side of the 
joint were always less pronounced than on the medial side of 
the joint. Formation of cartilage-like tissue, as indicated by 
safranin 0 staining, was observed in the collateral ligaments. 
Figure 8: Cartilage of the femoropatellar joint 21 days after 
the injection of 1% papain. Acellular areas in the patellar 
cartilage with little safranin О staining are observed lying 
next to highly stained cellular areas (frontal section, 
original magnification 250x, safrainin O-fast green, see for 
legend figure 3) . 
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DAY 64 
Sixtyfour days after the injection of iodoacetate the 
cartilage in the central parts of the patella appeared to be 
thinner in the iodoacetate injected knee joints than in the 
physiological saline injected knee joints. The central part of 
the patella was depleted of safranin 0 staining while 
chondrocyte clusters could be seen in non-depleted parts. 
Osteophytes were present most marked at the medial side of the 
femoropatellar joint but also at the other joint margins. 
DISCUSSION 
A single injection of male C57B110 mice with papain, 
iodoacetate or collagenase leads to osteoarthritic-like 
lesions in the injected knee joints after a few weeks. 
Interference with joint stability by injection of collagenase 
in the knee joints results in joint changes similar with 
changes observed in murine osteoarthritis (compare fig. 11 and 
fig. 12) . Injection of papain or iodoacetate leads to 
degenerative alterations in the knee joints, as a result of 
cartilage damage, with many aspects in common with 
osteoarthritis. 
Figure 9: Femoropatellar joint 42 days after the injection of 
1% papain. Cartilage fragments are disrupted from the 
cartilage surface and osteophytes are present on the margins 
of the joint ( frontal section, original magnification lOOx, 
safranin O-fast green, see for legend figure 3). 
121 
The injection of papain, iodoacetate or collagenase leads in 
the initial phase to a moderate inflammatory reaction in the 
knee joint. This inflammatory response was characterized by 
synovial infiltration with inflammatory cells and the presence 
of these cells in the joint cavities. The exudate was 
transient in all three models and had almost disappeared three 
days after injection. A low grade synovial infiltrate could be 
observed until day 21. An inflammatory response was also 
indicated by the joint swelling observed after injection of 
papain, iodoacetate or collagenase. The joint swelling, as 
indicated by radiolabel uptake of the knee joints, was also 
transient and significant joint swelling was not observed by 
three days after intra-articular injection. The joint swelling 
induced by the injection of collagenase was higher than could 
be expected by the histological evaluation of the inflammatory 
response in the injected knee joints58. The collagenase 
injection probably has a direct effect on endothelial 
structures in the joint and leads by this way to a more 
pronounced joint swelling than expected by the observed 
inflammation. 
The inflammatory response in all three models was low grade 
when compared to the inflammatory response in the murine 
arthritis models we routinely use in our laboratory61"63. A 
grade of inflammation in the arthritis models comparable with 
the grade observed in the osteoarthritis models does not 
result in a loss of safranin О staining or cartilage damage in 
the later stages in the arthritis models. Therefore, the role 
of the inflammatory response in the induction of the 
osteoarthritic lesions will be an insignificant one. In 
addition, 18 month old C57B110 mice with spontaneous 
osteoarthritis also showed a low grade synovial infiltrate. An 
inflammatory reaction is also observed in other animal models 
of osteoarthritis and is regularly a component of human 
osteoarthritis6'"69. 
Injection of collagenase resulted already after one day in a 
high incidence of patellar dislocation to the medial side of 
the injected knee joint. Injection of papain, iodoacetate or 
physiological saline never led to patellar displacement. 
Patellar dislocation to the medial side of the knee joints is 
also associated with spontaneous osteoarthritis in STR/IN and 
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STR/ORT mice25·33,37'39. The patella dislocation demonstrates the 
presence of joint instability either as a result of inherent 
joint malformation (STR/IN and STR/ORT strains) or as the 
consequence of the collagenase injection. The effect of 
collagenase on collagen type I containing joint structures, 
such as ligaments and tendons, induces the observed joint 
instability. collagenase (1%) had no degradative effect on the 
anatomically intact cartilage of patellae after in vitro 
incubation but degrades sliced bovine cartilage under the same 
conditions (data not shown). 
Figure 10: Formation of osteophytes on the medial side of the 
femoropatellar joint 42 days after the injection of 0.5% 
iodoacetate. The cairtilage of the femoropatellar joint clearly 
shows depletion of safranin О staining (frontal section, 
original magnification 40X, safranin O-fast green, see for 
legend figure 3). 
The injection of papain and iodoacetate had the most 
pronounced effects on the cartilage of the femoropatellar 
joint while the injection of collagenase resulted in marked 
pathological changes in the femorotibial joint. The central 
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parts of the patellae, and to a lower extent the opposite side 
on the femur, expressed the most distinct depletion of 
safranin 0 and cell death after the injection of papain or 
iodoacetate. A similar predisposition was observed in the 
antigen (methylated bovine serum albumin) induced arthritis 
model in C57B110 mice in our laboratory59. Moreover, in vitro 
incubation of murine patellae with hydrogen peroxide resulted 
in more severe inhibition of proteoglycan synthesis and higher 
cell death in the central chondrocytes than in more peripheral 
situated chondrocytes70. This indicates that chondrocytes from 
certain areas of knee joint joint cartilage are more 
vulnerable to the effects of harmful compounds than 
chondrocytes from other areas. As the central part of the 
patella in mice is one of the load bearing parts of the joint, 
the susceptibility of chondrocytes in this area might be 
related to the in vivo stress on these chondrocytes. 
Figure 11: Destruction of the femorotibial joint 42 days after 
the injection of 1% collagenase. Erosion of bone is clear on 
the medial side of the tibial plateau and the ligaments show 
cartilaginous alterations (frontal section, original 
magnification 40x, safranin O-fast green, see for legend 
figure 3). 
Osteoarthritic lesions on the medial side of the 
femoropatellar joint was the most pronounced effect on the 
knee joint cartilage of mice injected with collagenase. Also 
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the spontaneous osteoarthritis models in STR/IN and STR/ORT 
mice show a preferential development of the osteoarthritic 
lesions on the medial side of the femoropatellar joint and the 
same localization is also reported for the spontaneous 
osteoarthritis in guinea pigs24,25,33,37'39. Intrinsic factors in 
the structure of the knee joints of these animals, or of the 
chondrocytes on the medial side of the femoral joint71, might 
predispose to osteoarthritis in this area. A similar 
localization of the osteoarthritic lesions is observed in some 
of the surgically induced models of osteoarthritis but this 
might be due to the localization of the surgical 
intervention 
Figure 12: Spontaneous osteoarthritis in a 18 month old 
C57BL/10 mouse (frontal section, original magnification 40x, 
safranin O-fast green, see for legend figure 3). 
In all three models, one of the main and first observed 
aspects of the alterations in the cartilage, preceding the 
erosive alterations, was loss of safranin О staining. After 
injection of papain this could be seen already after one day 
but in the other models depletion of stages severely affected 
cartilage areas in later stages, could be observed from day 
seven. A cellular reaction could be seen in these proteoglycan 
depleted cartilage in all three models, as in human 
osteoarthritis1. Some areas showed a decrease of cell number 
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while other adjacent areas showed chondrocyte proliferation 
and the presence of chondrocyte clusters. Chondrocyte 
proliferation was observed in the papain injected knee joints 
already after three days but in the knee joints injected with 
iodoacetate or collagenase proliferation was only observed at 
day 21 and later stages. Also the number of cell clusters 
observed was much higher after injection of papain than after 
injection of iodoacetate or collagenase. A high proliferative 
response of chondrocytes, indicating an attempt to repair the 
damaged matrix, is also observed in rabbits and guinea pigs 
after intra-articular papain injection*8-51-52,72. Proteoglycan 
loss from cartilage matrix might trigger a proliferative 
response in chondrocytes. The proliferative response might be 
related to the more pronounced depletion of proteoglycans 
after injection of papain than after injection of the other 
two compounds. Iodoacetate could also have affected the 
chondrocyte metabolism in such a way that many of these cells 
loose the ability to proliferate while the changes in joint 
loading after collagenase injection might limit the 
proliferative response in the severely affected cartilage of 
the femorotibial joint. 
In all three models we found that the remaining cells in the 
proteoglycan-depleted matrix and the chondrocyte clusters were 
often surrounded with a pericellular halo of strongly staining 
matrix. Similar observations have also been reported in the 
spontaneous osteoarthritis in other mouse strains25,33,37"39 and in 
the spontaneous osteoarthritis in 18 month old C57B110 mice 
(own observations, data not shown). The presence of the strong 
staining around the cells might demonstrate that the 
chondrocytes remaining in the proteoglycan depleted matrix 
have a high rate of proteoglycan synthesis. 
Also the glycosaminoglycan synthesis in the whole patellae 
shows a high rate of proteoglycan synthesis at certain stages 
(figure 2 ) . After an initial inhibition on day one, an 
elevation of proteoglycan synthesis on day 3 and 7 after 
papain injection (1%) and a normal proteoglycan synthesis on 
day 3 and 7 after iodoacetate injection was observed. As 
chondrocyte death was observed after the injection of 
iodoacetate or papain, the high level of proteoglycan 
synthesis in the whole patella shows that certain chondrocytes 
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had an increased rate of proteoglycan synthesis. However, the 
rate of proteoglycan synthesis measured in the whole patella 
after seven days and at later stages can be affected by the 
formation of osteophyte cartilage at the margins of the 
patellae. The stimulation of proteoglycan synthesis in the 
patellae at day 3 and day 7 after collagenase injection might 
be due to the initial depletion of proteoglycans observed in 
the patellae on day one and day 3. At later stages, the 
elevated synthesis can be caused by osteophyte formation. 
Autoradiography studies are being carried out at the moment to 
solve these questions. 
The osteoarthritic alterations observed after the injection of 
iodoacetate, papain or collagenase were not confined to 
changes in the articular cartilage. Osteophyte formation, a 
characteristic of osteoarthritis in humans and animal models, 
could be seen in all three models. Like the erosion of 
cartilage, also the formation of osteophytes was most 
pronounced at the margins of the femoropatellar joint after 
papain or iodoacetate injection and at the margins of the 
femorotibial joint after injection of collagenase. This 
demonstrates that the localization of osteophyte formation is 
associated with the localization of cartilage erosion in these 
models. The osteophytes were most times bigger on the medial 
side of the joint than on the lateral side of the joint. This 
can be related to the distribution of loading in the mouse 
knee joint. 
Metaplastic changes were observed in the synovial tissue in 
all three models. This was most pronounced in the knee joints 
of mice injected with collagenase. The collateral ligaments on 
the medial side of the joints and to a lesser extent on the 
lateral side showed striking cartilaginous changes. Sclerosis 
of subchondral bone was evident 42 days after the injection of 
collagenase but not in the other two models. The last 
phenomenon might be related to the erosion of the calcified 
part of the cartilage which was observed in the collagenase 
model but not in the other two models. Similar changes, 
metaplasia of synovium, sclerosis of ligaments and subchondral 
bone, are reported for the spontaneous mouse models25,33"35,37"39. 
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ABSTRACT 
The effect of sulfate concentration in the medium on the 
glycosaminoglycan synthesis in articular cartilage of five 
different species was examined in relation to the 
physiological serum sulfate concentration in these species. 
Only the rate of sulfated glycosaminoglycan synthesis in human 
articular cartilage was sensitive to small deviations from the 
physiological sulfate concentration. A reduction of the 
sulfate concentration from 0.3 mM (physiological) to 0.2 mM 
resulted in a 33% reduction in glycosaminoglycan synthesis. In 
addition, we studied the effect of arthritic and 
"osteoarthritic" alterations in murine cartilage on the 
dependence of glycosaminoglycan synthesis on low sulfate 
concentrations. Arthritic and "osteoarthritic" cartilage had a 
similar dependence for the sulfate concentration in the medium 
as normal cartilage. Glycosaminoglycan synthesis in human 
articular cartilage appears to be very sensitive for the 
potential sulfate-depleting effects of drugs used in the 
treatment of rheumatoid arthritis and osteoarthritis. 
134 
INTRODUCTION 
Proteoglycans are, with collagen type II, the major structural 
components of articular cartilage. While collagen type II is 
responsible for the tensile strength, the proteoglycans are 
responsible for the pressure resistant properties of articular 
cartilage [2]. The highly sulfated glycosaminoglycans which 
are covalently bound to the core protein of the cartilage 
proteoglycans, are accountable for these pressure resistant 
traits. The negatively charged sulfate esters on the 
glycosaminoglycans are crucial for the optimal functioning of 
articular cartilage [2]. 
Inorganic sulfate is an essential substrate for the synthesis 
of glycosaminoglycans and the rate of synthesis of these 
biopolymers depends both in vivo and in vitro on the quantity 
of sulfate available to the chondrocytes [1, 3, 4, 10, 16]. 
Depletion of inorganic sulfate in serum of mice or rats by 
salicylate or paracetamol respectively, can lead to a 
diminished synthesis of sulfated glycosaminoglycans in vivo 
[3, 4, 16]. We studied if the physiological serum sulfate 
concentration in C57B110 mice, Wistar rats, hamsters and cows 
and men is at such a level that the maximal rate of 
glycosaminoglycan synthesis would be readily achieved in vivo 
and if small variations in sulfate concentration would 
significantly affect the in vivo synthesis rate. 
As there is considerable variation in serum sulfate levels 
among healthy human individuals (0.08-0.58 mM, [11, 13]), the 
synthesis of sulfated glycosaminoglycans could also be highly 
variable as a result of the variation in serum sulfate levels. 
We wondered if glycosaminoglycan synthesis in cartilage from 
individuals with a low serum sulfate concentration would be 
less sensitive to low sulfate concentrations than individuals 
with higher serum sulfate concentrations. As a model of this, 
we investigated the serum sulfate concentration in relation to 
the susceptibility of glycosaminoglycan synthesis to low 
sulfate concentrations in several mouse strains and other 
animal species. 
Several drugs, used in the treatment of rheumatoid arthritis 
and osteoarthritis for their analgesic and/or antiinflammatory 
properties, have the potential to reduce the sulfate 
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concentration in the serum of laboratory animals and humans 
[3, 4, 11, 16]. Depletion of serum sulfate can lead to 
inhibition of glycosaminoglycan synthesis in vivo [3, 4]. In 
addition, we have studied if arthritic cartilage, 
characterized by a decreased glycosaminoglycan synthesis [15], 
or "arthrotic" cartilage, characterized by an increased 
glycosaminoglycan synthesis [9, 10, 12], would have an altered 
sulfate dependence compared with normal cartilage. 
MATERIAL AND METHODS 
CARTILAGE SOURCES 
Articular cartilage from ten weeks old male mice of various 
strains, male Wistar rats (150-200 g) and male Syrian hamsters 
(150-200 g) was obtained by careful dissection of the patella 
with surrounding tissue from the knee joints of these animals, 
according to the method of van den Berg et al [14]. Bovine 
metacarpal joints were purchased from a local slaughterhouse 
within 6 hours after killing of the animals. Slices of 
articular cartilage (3x3x3 mm) were cut and used for sulfate 
incorporation studies. Fresh human articular cartilage slices 
(3x3x3 mm), from the tibial plateau, were obtained from 
amputation specimens within four hours after amputation. The 
cartilage donors were elderly persons (range 60-75 year). All 
cartilage specimen were placed in sulfate free RPMI 1640 DM 
medium (Serva, Heidelberg, FRG) immediately after dissecting. 
INDUCTION OF MURINE "ARTHRITIC" AND "ARTHROTIC" CARTILAGE 
Unilateral arthritis was induced in the right knee joint of 10 
weeks old male C57B110 mice by the intra-articular injection 
of (60 дд, 6 μΐ) zymosan in this joint. Two days after the 
zymosan injection the patellae were carefully dissected from 
both knee joints and placed in sulfate free medium. The 
zymosan arthritis leads to a decreased synthesis of sulfated 
glycosaminoglycans in the articular cartilage of the patella 
[15]. Articular cartilage with a stimulated synthesis of 
sulfated glycosaminoglycans, used as a model of "arthrotic" 
cartilage, was obtained by the intra-articular injection of 
the right knee joints of 10 weeks old male C57B110 mice with a 
1% (w/v) papain solution (6 μΐ). The papain solution (type IV, 
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Sigma, St. Louis, MO) contained 0.03M cysteine (Sigma) to 
activate the papain. Three days after the papain injection the 
patellae from both knee joints were dissected and placed in 
sulfate free medium. 
CULTURE OF ARTICULAR CARTILAGE 
The articular cartilage specimens were washed with sulfate 
free RPMI 1640 DM medium for at least two hours. After the 
washing procedure the cartilage specimen were incubated for 
two hours in RPMI 1640 DM medium with various magnesiumsulfate 
(Merck, Darmstadt, FRG) concentrations (0.1-1.5 mM) at 37° С 
in a humidified 5% C02 atmosphere. In the medium containing 
less than 1.5 mM magnesiumsulfate, the deficient ions were 
replaced by magnesiumchloride (Merck). In pilot experiments, a 
sulfate concentration of 1.5 mM appeared to be an optimal 
concentration for glycosaminoglycan synthesis of all species 
studied. The RPMI medium was supplemented with 2 0 ßCi 
[35S]sulfate (carrier free, spec. act. 1200 Ci/mmol, 
Radiochemical Centre, Amersham, U.K.). 
After incubation, the patellae (mouse, rat and hamster 
cartilage) were washed twice with physiological saline and 
subsequently fixed in ethanol (96%, v/v, Merck). 
Decalcification of the patellae with 5% formic acid (Merck) 
was followed by stripping of the patellar cartilage layer [5]. 
Patellar cartilage was digested overnight by lumasolve (Hicol, 
Oud-Beijerland, The Netherlands) and the amount of 
incorporated radiolabel was assayed by liquid scintillation 
analysis. As a measure of glycosaminoglycan synthesis the 
total sulfate incorporation per patella was calculated. 
The articular cartilage slices (human and bovine cartilage) 
were washed twice with physiological saline to remove the free 
radiolabel. Thereafter, the cartilage slices were rapidly 
dried with a paper tissue and immediately weighed. The slices 
were digested by lumasolve and the quantity of incorporated 
radiolabel was determined by liquid scintillation analysis. 
The total sulfate incorporation per mg wet weight was 
calculated. 
DETERMINATION OF SERUM SULFATE CONCENTRATION 
To assay the sulfate concentration in the serum of mice, 
137 
rats and hamsters, blood samples were taken by orbita-punction 
under ether anesthesia. Human blood was collected from five 
healthy volunteers. Synovial fluid was collected from the 
bovine metacarpal joints and the sulfate concentration in the 
fluid was assayed. The sulfate concentrations in serum and 
synovial fluid are identical [5]. The inorganic sulfate 
concentration in synovial fluid and serum was determined by a 
modification of the benzidine method of Dogson and Spencer as 
recently described [5]. 
STATISTICAL ANALYSIS 
Statistical analysis of data was performed by the two-tailed 
Student t-test and the Pearson correlation test. A P-value 
<0.05 was considered significant. We calculated for the 
different species the deviation of the sulfate concentration 
from the physiological serum sulfate concentration resulting 
in a significant inhibition of glycosaminoglycan synthesis. If 
none of the sulfate concentrations tested was in the range of 
the sulfate concentration ± s.d. we used the concentration 
just above the physiological sulfate concentration for 
statistical evaluation. 
RESULTS 
Figure 1 shows the effect of the sulfate concentration in the 
medium on the synthesis of sulfated glycosaminoglycans in 
murine patellar cartilage. Major differences in inhibition of 
glycosaminoglycan synthesis at low sulfate concentrations 
between the six mouse strains tested were not observed. A 
significant inhibition of sulfate incorporation was observed 
at sulfate concentrations below 0.5 mM for al mouse strains. 
In table 1 the sulfate concentration in the medium resulting 
in a 50% inhibition of glycosaminoglycan synthesis together 
with the serum sulfate concentrations in the mouse strains is 
presented. The serum sulfate concentration in the Balb/c 
strain was significantly higher than in the ICR-Br, Swiss and 
C57B110 strains. There was no correlation between the serum 
sulfate concentration of the various mouse strains and the 
susceptibility to low sulfate concentrations of cartilage 
glycosaminoglycan synthesis of the mouse strains. The sulfate 
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concentration in the serum of the mouse strains was sufficient 
for an optimal synthesis of glycosaminoglycans. 
Sulfate concentration in medium (mM) 
Figure 1: The effect of the sulfate concentration in the 
medium on the incorporation of sulfate in articular cartilage 
of various mouse strains. The values are expressed as a 
percentage of the sulfate incorporation at 1.5 mM sulfate. 
Each bar shows the mean ± s.d. of the incorporation of at 
least five patellae. 
Of five different species, the physiological serum sulfate 
concentration and the sulfate concentration resulting in 50% 
inhibition of sulfated glycosaminoglycan synthesis are 
expressed in table 2. Figure 2 shows the sulfate dependence of 
glycosaminoglycan synthesis in relation to the physiological 
sulfate concentration in the different species. The serum 
sulfate concentration in human serum was significantly lower 
than the concentration in the serum of the other species and 
the physiological sulfate concentration in cows and mice was 
significantly higher than this level in rats and hamsters. 
There was no correlation between the serum sulfate 
concentration in the serum or synovial fluid of the species 
studied and the susceptibility of articular cartilage for low 
sulfate concentrations. 
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Table 1: Sulfate concentration in the medium resulting in a 
50% inhibition of maximal in vitro sulfate incorporation in 
murine articular cartilage and the corresponding physiological 
sulfate concentration. The sulfate concentration of 1.5 mM is 
considered to be optimal under the culture conditions used and 
the sulfate incorporation at this concentration is set at 
100%. The sulfate concentrations resulting in a 50% inhibition 
are expressed as the mean values (range) of at least three 
experiments. The values of the physiological sulfate 
concentration are expressed as the mean ± s.d.. 
Mouse Sulfate concentration Sulfate concentration 
strain 50% inhibition (mM) in serum (mM) 
ICR-Br 0.25 (0.23-0.27) 0.95 ± 0.13 (n=10) 
HSD-ola 0.22 (0.20-0.25) 1.15 ± 0.14 (n=10) 
DAP 0.26 (0.23-0.30) 1.18 ± 0.19 (n=10) 
Swiss 0.26 (0.25-0.27) 0.99 ± 0.13 (n=10) 
C57B110 0.25 (0.22-0.29) 1.03 ± 0.09 (n=10) 
Balb/c 0.22 (0.20-.025) 1.27 ± 0.14 (n=10) 
We calculated for the different species the deviation of 
sulfate concentration in the medium from the physiological 
sulfate level resulting in a significant suppression of 
glycosaminoglycan synthesis. A change in sulfate concentration 
in the medium from 0.3 mM to 0.2 mM led to a significant 
inhibition of glycosaminoglycan synthesis (33%) in human 
cartilage. A decrease in sulfate concentration from 0.9 to 0.5 
mM led to a significantly reduced rate of synthesis in 
hamsters and rats. Mouse and bovine cartilage appeared to be 
least sensitive to alterations in sulfate concentration. 
Reduction from 1.1 to 0.5 Mm sulfate resulted in a 
significantly diminished glycosaminoglycan synthesis in these 
species. Human articular cartilage was far more sensitive to 
changes in sulfate availability than the other species tested. 
We also studied the effects of a decreased glycos-aminoglycan 
synthesis and an enhanced glycosaminoglycan synthesis of 
articular cartilage on the susceptibility for low sulfate 
concentrations. Arthritic cartilage, with a decreased 
glycosaminoglycan synthesis, as well as "arthrotic" cartilage, 
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Figure 2: The effect of the sulfate concentration in the 
medium on the sulfate incorporation in articular cartilage of 
five different species. The values are expressed as a 
percentage of the sulfate incorporation at 1.5 mM sulfate. 
Each point shows the mean ± s.d. of at least five patellae or 
cartilage slices. The bars represent the physiological sulfate 
concentration ± s.d. in the corresponding species (A mouse, В 
rat, С hamster, D cow, E human). 
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with an elevated glycosaminoglycan synthesis was induced in 
the right knee joints of C57B110 mice. The incorporation of 
sulfate in the arthritic joints was 70% and in the "arthrotic" 
joints 155% of the sulfate incorporation in the contralateral 
control knee joints. As can be seen in figure 3, both 
arthritic cartilage and "arthrotic" cartilage showed no 
significantly different susceptibility for low sulfate 
concentration compared to normal cartilage. 
Table 2: Sulfate concentration in the medium resulting in a 
50% inhibition of maximal in vitro sulfate incorporation in 
articular cartilage and the corresponding physiological 
sulfate concentration in five different species. The mouse 
values are the mean values of table 1. The sulfate 
concentration of 1.5 mM is considered to be optimal under the 
culture conditions used and the sulfate incorporation at this 
point is set at 100%. The sulfate concentrations resulting in 
a 50% inhibition are expressed as the mean values (range) of 
at least three experiments. The values of the physiological 
sulfate concentration are expressed as the mean ± s.d.. 
Species Sulfate concentration 
50% inhibition (mM) 
Sulfate concentration 
in serum (mM) 
Mouse 
Hamster 
Rat 
Cow 
Human 
0.24 (0.20-0.30) 
0.39 (0.36-0.43) 
0.23 (0.20-0.25) 
0.49 (0.45-0.54) 
0.25 (0.22-0.27) 
1.10 + 0.13 (n=60) 
0.80 ± 0.07 (n=10) 
0.83 + 0.08 (n=10) 
0.98 ± 0.08 (n=3) 
0.30 ± 0.03 (n=5) 
DISCUSSION 
Inorganic sulfate is an essential substrate in the synthesis 
of cartilage glycosaminoglycans and this and other studies 
show that sulfate availability can be a rate limiting factor 
in the synthesis of these glycosaminoglycans [1, 3, 4, 10, 
16] . The incorporation of sulfate is a reflection of the rate 
of synthesis of sulfated glycosaminoglycans in cartilage. The 
reduced incorporation of sulfate, seen at low sulfate 
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concentrations, is not the result of the synthesis of 
undersulfated glycosaminoglycans. Undersulfation of 
glycosaminoglycans occurs only at very low sulfate 
concentrations in the medium but not in the sulfate 
concentration range we tested in the above described 
experiments [17, 18]. 
« 
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Sulfate concentration in the medium (mM) 
Figure 3: The effect of the sulfate concentration in the 
medium on the sulfate incorporation in arthritic, "arthrotic" 
and normal murine cartilage. The values are expressed as a 
percentage of the sulfate incorporation at 1.5 mM sulfate. 
Each bar shows the mean ± s.d. of at least five patellae. The 
incorporation of sulfate in the arthritic joints was 70% and 
in the "arthrotic" joints 155% of the sulfate incorporation in 
the contralateral knee joints. 
Of all species studied, only the sulfate concentration in 
human serum was significantly suboptimal for the incorporation 
of sulfate in articular cartilage while the sulfate 
concentration in the serum of the other species was sufficient 
to support maximal sulfate incorporation, at least in vitro 
(figure 2). Moreover, already small variations in serum 
sulfate concentrations in humans will result in an altered 
rate of glycosaminoglycan synthesis in articular cartilage 
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while the rate of glycosaminoglycan synthesis in the other 
species was relatively insensitive to concentration changes. 
So, glycosaminoglycan synthesis in human cartilage will be 
very sensitive for the potential sulfate-depleting effects of 
drugs used in the treatment of rheumatoid arthritis and 
osteoarthritis [3, 4, 11, 16]. 
There was neither a correlation between the sulfate 
concentration in the serum of the mouse strains and the 
susceptibility of glycosaminoglycan synthesis in murine 
articular cartilage nor a correlation between serum sulfate 
concentration in the different species and the sensitivity of 
glycosaminoglycan synthesis for low sulfate concentrations of 
these species. So, species and strains with a low serum 
sulfate concentration do not appear to be less susceptible to 
lowering of the sulfate concentrations than species with a 
high serum sulfate concentration. When these results can be 
extrapolated to human individuals, the rate of 
glycosaminoglycan synthesis will be highly variable among 
human individuals as a conseguence of the observed variation 
in serum sulfate concentrations [13]. One of the first events 
in the pathogenesis of osteoarthritis is an reduced content of 
glycosaminoglycans in the affected articular cartilage [8, 9]. 
Individuals with a low serum sulfate concentration might have 
a lower capacity of glycosaminoglycan synthesis and as a 
result of this also a more limited potential of matrix repair 
than individuals with a high serum sulfate concentration. As a 
consequence of this, individuals with a low serum sulfate 
concentration might be more vulnerable to the development of 
osteoarthritis than those with a higher serum sulfate level. 
The dependence of glycosaminoglycan synthesis on the sulfate 
concentration in the medium was similar for arthritic, 
"arthrotic" and normal cartilage. Arthritic and "arthrotic" 
cartilage was not more or less vulnerable to low sulfate 
concentrations than normal cartilage. Variation in serum 
sulfate concentrations, potentially induced by antirheumatic 
medication [3, 4, 6, 16], will result in similar changes in 
the rate of glycosaminoglycan synthesis in normal and 
arthritic or "arthrotic" cartilage. 
The results of this study show that already a slight 
alteration in sulfate availability will result in a 
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significant change in glycosaminoglycan synthesis in human 
cartilage, this in contrast to the other species tested. As a 
consequence of this the rate of glycosaminoglycan synthesis in 
humans will be sensitive to drug-induced depletion of serum 
sulfate [11] and this sensitivity might play a role in the 
susceptibility of certain individuals to osteoarthritis. 
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CHAPTER 10 
SUMMARY AND FINAL REMARKS 
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Articular cartilage is a specialized form of connective tissue 
consisting of chondrocytes surrounded by an extracellular 
matrix of mainly giant macromolecules synthesized by these 
chondrocytes. The extracellular matrix macromolecules, 
predominantly proteoglycans and collagen type II, are 
responsible for the biomechanical and biochemical properties 
making articular cartilage unique in its function as gliding 
surface and shock absorber for the diarthrodal joint. The 
proteoglycan molecules in the extracellular matrix are 
responsible for the resiliency and water binding capacity of 
articular cartilage. The sulfate esters of the 
glycosaminoglycan side chains of proteoglycans are essential 
for these functions. 
Several drugs used in the treatment of osteoarthritis and 
rheumatoid arthritis have the potential of serum sulfate 
depletion (chapter 2) and can theoretically lead by this way 
to: 
1 A decreased synthesis of glycosaminoglycans in articular 
cartilage. 
2 The synthesis of undersulfated cartilage 
glycosaminoglycans. 
3 A combination of both 1 and 2. 
To test this hypothesis we have incubated murine patellar 
cartilage in incubation medium with various sulfate 
concentrations (chapter 3 and 4) . A medium sulfate 
concentration below 0.5 mM significantly inhibited the 
glycosaminoglycan synthesis as measured by incorporation of 
sulfate. The incorporation of glucosamine was unaltered at low 
sulfate concentrations indicating the synthesis of 
undersulfated glycosaminoglycans. Characterization of 
glycosaminoglycans synthesized at a sulfate concentration of 
0.1 mM (physiological sulfate concentration), by anion 
exchange chromatography and HPLC disaccharide analysis, could 
not confirm the synthesis of undersulfated glycosaminoglycans 
(chapter 3). The synthesis of aberrant glycosaminoglycans only 
occurred at very low sulfate concentrations (10 nM, in our 
experiments), irrelevant for the in vivo situation. The 
observation of a unaltered incorporation of glycosaminoglycans 
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at reduced sulfate concentrations might be the result of an 
increase in intracellular specific activity of glucosamine 
under conditions favouring a reduced glycosaminoglycan 
synthesis. 
We also tested the effect of serum sulfate depletion on 
articular cartilage synthesis in vivo (chapter 5 and 6) . 
Depletion of serum sulfate was induced in Wistar rats by the 
oral administration of paracetamol. Administration of 190 
mg/Kg paracetamol to these rats led within five hours to a 
reduction of inorganic serum sulfate from 0.8 mM to 0.1 mM 
(chapter 5). The reduced availability of sulfate resulted in a 
35% inhibition of glycosaminoglycan synthesis in the patellar 
cartilage. The biochemical characteristics of the 
glycosaminoglycans synthesized under these conditions were 
similar with those of glycosaminoglycans produced at 
physiological sulfate concentrations. 
Long-term treatment of Wistar rats with paracetamol resulted 
during the first three weeks in a significantly reduced 
concentration of serum sulfate (chapter 6). From four weeks up 
to the end of the experiments (nine weeks) the serum sulfate 
level in the paracetamol-treated rats was however not 
significantly different from this level in control rats. An 
adaptation of the Wistar rats to the paracetamol-treatment 
appears to overcome the sulfate depletion within several 
weeks. Similar results are reported for the human situation. 
Although short-term administration of paracetamol leads to 
significantly reduced serum sulfate levels in human 
volunteers, long-term administration of paracetamol to 
patients even elevates the serum sulfate levels above normal 
(1). 
The glycosaminoglycan content of patellar cartilage was only 
significantly lower in the paracetamol-treated rats than in 
the control rats after three and four weeks of treatment. 
After two weeks or nine weeks treatment the patellar 
glycosaminoglycan content of the paracetamol-treated rats was 
comparable with that content in control rats. A two week 
treatment was probably to limited to induce a significantly 
reduced patellar glycosaminoglycan content while after nine 
weeks the patellar cartilage has been able to recover from the 
reduced glycosaminoglycan content. 
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In addition to the routinely used murine arthritis models, 
three murine osteoarthritis models were developed (chapter 7 
and 8). A intra-articular injection of murine knee joints with 
collagenase led to joint instability eventually resulting in 
osteoarthritis (chapter 7). Injection of papain or iodo-
acetate led to osteoarthritic lesions in the knee joints by 
interference with cartilage metabolism (chapter 8). 
Both articular cartilage with an inhibited glycosaminoglycan 
synthesis (arthritic) or an elevated glycosaminoglycan 
synthesis (osteoarthritic) appeared to have a similar 
dependence on sulfate availability as normal articular 
cartilage (chapter 9). 
The susceptibility of glycosaminoglycan synthesis in articular 
cartilage of five different species to deviations in inorganic 
sulfate concentrations from the physiological serum sulfate 
concentration in the corresponding species was studied 
(chapter 9) . Human articular cartilage glycosaminoglycan 
synthesis appeared to be more sensitive to small deviations 
from the normal serum sulfate level (0.3 mM) than the 
glycosamino-glycan synthesis in the other species tested. 
Finally, the above described studies demonstrate that the 
glycosaminoglycan synthesis in human articular cartilage will 
already be inhibited by a slight reduction in serum sulfate 
concentration. As many drugs currently used in the treatment 
of patients suffering from osteoarthritis and rheumatoid 
arthritis have the potential, at least in laboratory animals, 
to reduce inorganic serum sulfate levels, these drugs might 
interfere with glycosaminoglycan synthesis. However, from our 
data it appears unlikely that the synthesis of aberrant 
glycosaminoglycans will be induced by drug-induced sulfate 
depletion. Moreover, a drug well known for its serum sulfate 
depleting effects in humans and animals after short-dosing, 
paracetamol, had no significant effects on serum sulfate 
during long-term treatment both in rats and humans (1). 
Reference 
1 Hendrix-Treacy S, Wallace SM, Hindmarsch KW, Wyant GM, 
Danilkewich A, The effect of acetaminophen 
administration on its disposition and body stores of 
sulphate. Eur J Clin Pharmac 30:273-278, 1986 
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NEDERLANDSE SAMENVATTING 
van het proefschrift, getiteld 
EFFECT VAN SDLFAATVERLAGENDE FASMACA OF HET KRAAKBEENMETABOLISME 
Articulair kraakbeen is een gespecialiseerd type bindweefsel dat 
het contactvlak vormt tussen articulerende gewrichten. Het bestaat 
uit een extracellulaire matrix van reusachtige macromolekulen, 
voornamelijk collageen type II en proteoglycanen, spaarzaam 
bezaaid met kraakbeencellen (chondrocyten) die de extracellulaire 
matrix produceren. De extracellulaire matrixmolekulen zijn 
verantwoordelijk voor de unieke schokabsorberende en 
wrijvingreducerende eigenschappen van articulair kraakbeen. De 
negatief geladen sulfaatesters op de glycosaminoglycaan zijketens 
van de proteoglycaanmolekulen zijn essentieel voor de reversibele 
vervormbaarheid (veerkracht) van het kraakbeen. Verstoring van de 
sulfatering of de synthesesnelheid van kraakbeen glycosamino-
glycanen kan derhalve leiden tot verlies van de funktionele en 
anatomische integriteit van het gewrichtskraakbeen. 
Verschillende farmaca gebruikt bij de behandeling van arthrose 
en/of reumatoide arthritis patiënten (b.v. salicylaten, 
tiaprofeenzuur, chloroquine diphosphaat) kunnen potentieel de 
sulfaatconcentratie in het serum verlagen (op zijn minst in muizen 
en ratten, hoofdstuk 2 en 5) en via deze weg aanleiding geven tot: 
1 Een verminderde synthese van glycosaminoglycanen in 
articulair kraakbeen. 
2 De synthese van ondergesulfateerde kraakbeen 
glycosaminoglycanen. 
3 Een combinatie van 1 en 2 
Deze hypothesen hebben we getest door muizeknieschijfjes in vitro 
(in glas) te incuberei! in aanwezigheid van verschillende 
sulfaatconcentraties in het kweekmedium (hoofdstuk 3 en 4). Een 
sulfaatconcentratie in het medium beneden 0,5 mM leidde tot een 
verminderde inbouw van sulfaat in de kraakbeenglycosamino-
glycanen. De inbouw van glucosamine (een andere bouwsteen van 
glycosaminoglycanen) bleef echter constant. Dit duidde op de 
synthese van ondergesulfateerde glycosaminoglycanen. Echter 
analyse van de glycosaminoglycanen gesynthetiseerd bij 1,0 mM 
sulfaat (physiologisch voor de muis) en 0,1 mM sulfaat kon de 
synthese van ondergesulfateerde glycosaminglycanen bij een 
verlaagd sulfaataanbod niet bevestigen. Alleen bij een zeer lage 
sulfaatconcentratie (10 nM) kon de synthese van ondergesulfateerde 
glycosaminoglycanen worden aangetoond. 
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De verminderde sulfaatinbouw is een gevolg van de verminderde 
produktie van glycosaminoglycanen bij een laag sulfaataanbod. Het 
feit dat de inbouw van glucosamine niet afneemt bij een 
verminderde glycosaminoglycaan synthese wordt waarschijnlijk 
veroorzaakt door veranderingen in de intracellulaire specifieke 
activiteit van glucosamine onder condities met een geremde 
glycosaminoglycaan synthese. 
Naast deze in vitro experimenten is ook het effect van sulfaat 
verlaging in vivo op glycosaminoglycaan synthese bestudeerd 
(hoofdstuk 5 en 6). Orale toediening van 190 mg/Kg paracetamol aan 
Wistar ratten leidde binnen vijf uur tot een verlaging van de 
sulfaatconcentratie in het serum van 0,8 mM tot 0,1 mM ( hoofdstuk 
5). Deze verlaging van de serumsulfaat-concentratie resulteerde in 
een 35% remming van de glycosaminoglycaan synthese in het 
kraakbeen van de ratteknieschijfjes. Het verminderde sulfaataanbod 
had geen effect op de biochemische eigenschappen van de 
gesynthetiseerde glycosaminoglycanen. 
Het langdurig toedienen van paracetamol aan Wistar Ratten 
resulteerde gedurende de eerste drie weken in een significant 
verlaagde serum sulfaatconcentratie (hoofdstuk 6). Na deze eerste 
drie weken had paracetamol minder effect dan verwacht en een 
significante verlaging van de serum sulfaatconcentratie werd niet 
meer waargenomen. De chronische paracetamol behandeling had geen 
aantoonbaar effect op de nier- en leverfunctie. Het glycosamino-
glycaangehalte was na 3 en 4 weken behandeling met paracetamol 
significant lager in het kraakbeen van het knieschijfje van de 
behandelde groep dan in het kraakbeen van de controle groep. Na 2 
en 9 weken waren er geen significante verschillen aantoonbaar. 
Twee weken paracetamol behandeling was waarschijnlijk te kort om 
een significant verschil te bewerkstelligen terwijl na negen weken 
het kraakbeen weer de kans had gekregen voor herstel van het 
glycosaminoglycaangehalte gedurende de fase dat paracetamol geen 
effect had op de serum sulfaatconcentratie. 
In alle bovenbeschreven experimenten is het effect van een laag 
sulfaataanbod op normaal kraakbeen bestudeerd. Om het effect van 
een laag sulfaataanbod tevens op artritisch en artrotisch 
kraakbeen te kunnen bestuderen is naast de in ons laboratorium 
routinematig gebruikte gewrichtsontstekingsmodellen in muizen een 
aantal arthrose modellen in muizen ontwikkeld (hoofdstuk 7 en 8) . 
Een éénmalige intra-articulaire injectie met collagenase in het 
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muizekniegewricht leidt tot gewrichtsinstabiliteit en dit 
resulteert uiteindelijk in osteoarthrotische veranderingen in het 
kniegewricht (hoofdstuk 7) . Een injectie met papaine of 
joodacetaat in het kniegewricht leidt tot osteoarthrotische 
veranderingen in het gewricht door middel van interferentie met 
het kraakbeenmetabolisme (hoofdstuk 8) . 
Zowel muizekraakbeen met een geremde glycosaminoglycaan synthese 
(arthritisch) als muizekraakbeen met een gestimuleerde 
glycosaminoglycaan synthese (arthrotisch) bleek even gevoelig te 
zijn voor een laag sulfaataanbod als normaal kraakbeen (hoofdstuk 
9) . De glycosaminoglycaan synthese in humaan kraakbeen bleek 
gevoeliger te zijn voor kleine afwijkingen in het sulfaataanbod 
(ten opzichte van de fysiologische serum sulfaatconcentratie) dan 
de glycosaminoglycaan synthese in vier andere bestudeerde soorten 
(hoofdstuk 9). 
Uit het bovenbeschreven onderzoek blijkt dat de synthese van 
glycosaminoglycanen in het kraakbeen van de mens al kan worden 
geremd bij een geringe verlaging van het sulfaataanbod. 
Verscheidene farmaca momenteel in gebruik bij de behandeling van 
patiënten met gewrichtsziekten, blijken op zijn minst in 
proefdieren aanleiding te kunnen geven tot een verlaagde 
sulfaatconcentratie in het serum van deze dieren en kunnen via 
deze weg mogelijk aanleiding leiden tot een verminderde synthese 
van glycosaminoglycanen in het kraakbeen. Echter, onze studies 
wijzen erop dat de verlaging van de serum sulfaatconcentratie door 
middel van farmaca niet zal leiden tot de synthese van kwalitatief 
inferieure glycosaminoglycanen. Tevens blijkt dat het medicament 
paracetamol, bekend om zijn sulfaatverlagende eigenschappen zowel 
bij proefdieren als bij de mens na een éénmalige dosis, geen 
significant effect heeft op de serum sulfaatconcentratie bij 
langdurige toediening. 
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STELLINGEN 
I 
Verlaging van de sulfaatconcentratie in het serum van ratten leidt tot een 
verminderde synthese van glycosaminoglycanen in articulair kraakbeen. 
Dit proefschrift 
II 
Synthese van biochemisch afwijkende glycosaminoglycanen in articulair 
kraakbeen zal nooit het gevolg zijn van een verlaagd sulfaataanbod in 
vivo. 
Dit proefschrift 
III 
Wanneer het effect van farmaca op de synthese van glycosaminoglycanen in 
vivo wordt gemeten met behulp van de inbouw van radioactief sulfaat moet 
het effect van deze farmaca op de sulfaathomeostase worden verdisconteerd. 
Dit proefschrift 
IV 
In tegenstelling tot een eenmalige dosis leidt de langdurige toediening 
van paracetamol niet tot een verlaagde serum sulfaatconcentratie. 
(Ξ. Hendrix-Treacy et al., Eur. J. Clin. Pharmacol. 30:273-278, 1986) 
Dit proefschrift 
V 
De glycosaminoglycaansynthese in humaan articulair kraakbeen is uitermate 
gevoelig voor veranderingen in de serum sulfaatconcentratie rond de 
fysiologische concentratie. 
Dit proefschrift 
VI 
Een eenmalige intra-articulaire injectie van collagenase resulteert in 
arthrotische veranderingen in het muizekniegewricht ten gevolge van het 
ontstaan van gewrichtsinstabiliteit. 
Dit proefschrift 
VII 
De observatie dat transforming growth factor β de glycosaminoglycaan­
synthese van geïsoleerde runderchondrocyten de ene keer remt en de andere 
keer stimuleert toont aan dat opheldering van de regulerende rol van 
groeifactoren op het celmetabolisme nog een lange weg te gaan heeft. 
(eigen waarneming) 
Vili 
De verlaagde proteoglycaanconcentratie in arthrotisch kraakbeen is niet 
alleen het gevolg van de proteolytische afbraak van proteoglycanen maar 
tevens van een verminderde hyaluronzuurconcentratie in arthrotisch 
kraakbeen. 
(D.H. Manicourt & J.C. Pita, Arthritis Rheum. 31:538-544, 1988) 
IX 
Dat een hogere concentratie van een bepaalde werkzame stof niet altijd 
meer effect heeft dan een lagere concentratie is gemeengoed onder 
biochemici, maar dat meer soms leidt tot minder is voor velen een te grote 
gedachtensprong. 
(P.M. van der Kraan et al., Biochim. Biophys. Acta 927:213-221, 1987) 
X 
Een intense communicatie tussen de leden van een organisatie is niet 
alleen noodzakelijk voor uitmuntendheid van innovatieprocessen binnen een 
industriële setting maar ook binnen een onderzoekslaboratorium. 
(Naar: T.J. Peters & R.H. Waterman, "In search of excellence", Harper & 
Row, New York, 1982) 
XI 
De vergrijzing van de Nederlandse bevolking maakt het noodzakelijk om het 
onderzoek naar arthrose zodanig te stimuleren dat het tempo van "voetje 
voor voetje" verandert in een "gestrekte draf". 
XII 
Het feit dat een eeneiige tweeling door velen beschouwd wordt als een 
bijzondere bezienswaardigheid is niet bevorderlijk voor de gemoedsrust van 
de ouders. 
(eigen waarneming) 
XIII 
De onder het grote publiek heersende opvatting dat het doel van karate 
voornamelijk ligt in het vernielen van bouwmateriaal wordt in de hand 
gewerkt door de ledenwervende activiteiten van commerciële sportscholen. 
XIV 
Het is niet alleen bij verzekeringen maar ook bij dissertaties van belang 
om "de kleine lettertjes" te lezen. 
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